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Abstract 
 
Neural Crest (NC) derived mesenchyme has previously been shown to play 
an important role in the early development of the foetal thymus. Using Wnt1-
Cre and Sox10-Cre mice crossed to Rosa26
eYfp reporter mice, NC derived 
mesenchymal cells were revealed in the adult murine thymus. It is reported 
here  that  NC  derived  cells  infiltrate  the  thymus  before  E13.5,  and 
differentiate into cells with characteristics of smooth muscle cells associated 
with  large  vessels,  and  pericytes  associated  with  capillaries.  In  the  adult 
organ at three months of age, NC derived perivascular cells continue to be 
associated  with  the  vasculature  providing  structural  support  to  the  blood 
vessels and possibly regulating endothelial cell function.  
 
Thymus  organogenesis  requires  co-ordinated  interactions  of  multiple  cell 
types  including  NC  cells  that  orchestrate  the  formation,  separation  and 
subsequent migration of the developing thymus from the third pharyngeal 
pouch  to  the  thoracic  cavity.  The  molecular  mechanisms  driving  these 
processes are unclear, however NC derived mesenchyme has been shown 
to be important. Here, it is shown that the separation process of the thymus 
from  the  pouch  is  independent  of  ephrin-B2  expression  on  thymic  NC 
derived  mesenchyme,  however  in  its  absence  the  thymus  remains  in  the 
cervical  area  instead  of  migrating  into  the  thoracic  cavity.  Analyses  of 
individual NC derived thymic mesenchymal cells shows that the absence of Abstract 
  4 
ephrin-B2 impairs their polarisation, and thus motility, as a result of defective 
EphB  receptor  signalling.  This  implies  a  NC  derived  cell  specific  role  of 
EphB-ephrin-B2  interactions  in  the  collective  migration  of  the  thymic 
rudiment during organogenesis. Acknowledgements 
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1.1 Overview of the immune system 
 
In order for an organism to survive, it must be able to defend itself from 
infection by disease-causing pathogens and even basic immune responses 
are present in unicellular bacteria. A number of mechanisms have evolved to 
recognise  and  eliminate  pathogens.  Higher  vertebrates  have  developed 
complex  adaptive  defence  mechanisms  consisting  of  specialised  cells, 
organs  and  tissues,  which  interact  through  cell  contact  and  secreted 
molecules (1). The adaptive immune response in vertebrates is specific to 
each different pathogen encountered and allows each recognised antigen to 
be  remembered.  This  immunological  memory  provides  for  a  faster  and 
stronger response to secondary encounters with the same pathogen. 
 
The cells of the adaptive immune response, B and T cells, are derived from 
hematopoietic stem cells generated in the bone marrow and foetal liver. B 
cells develop in the bone marrow and are involved in humoral responses. In 
contrast, T cells develop in the thymus and are involved in cell-mediated 
immune responses. T cells recognise a peptide-antigen target, such as a 
pathogen,  through  T  cell  receptor  (TCR)  binding  to  peptide  antigen 
processed  and  presented  in  combination  with  a  “self”  Major 
Histocompatibility  Complex  (MHC)  molecule.  There  are  two  major  TCR 
bearing T cell classes; αβTCR and γδTCR. αβT cells can be subdivided into 
two major types; cytotoxic, which express the CD8 cluster of differentiation Chapter One 
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gene and recognise antigen coupled to Class I MHC molecules; and helper, 
which express the CD4 gene and recognise Class II MHC molecules. γδ T 
cells can recognise intact antigen not bound to MHC receptors (2). 
 
The thymus is the site of T cell maturation and selection. Immature T cell 
progenitors generated in the bone marrow enter the circulating blood supply, 
and  home  to  the  thymus.  In  the  thymus,  they  undergo  differentiation  into 
mature naïve T cells that are exported into the periphery. The thymus has a 
distinct  structure  consisting  of  epithelial  cells  (TECs),  mesenchymal  cells, 
thymic macrophages, thymic dendritic cells (DCs), developing T cells and 
blood  vasculature,  generating  a  unique  microenvironment.  Through 
interactions with thymic epithelial and dendritic cells, immature thymocytes 
undergo positive and negative selection. Only those T cells expressing non-
self antigen with the correct affinity and avidity for MHC molecule-peptide 
conjugates will survive and be exported to the periphery. In contrast, those 
which react at high affinity with self, or do not receive a positive MHC-TCR 
interaction, will be eliminated. 
 Chapter One 
 
  23 
1.2 Thymus development 
 
The thymus is formed from cells in the pharynx, a widened anterior portion of 
the foregut lined with a layer of endodermal cells, which expands into the 
pharyngeal  pouches  extending  between  the  pharyngeal  arches  (Figure 
1.1A). Development of the thymus in the mouse begins at E9.5 and involves 
the expression of transcription factors including Hoxa3, Pax1/9, Eya1 and 
Six1 (3-9) within the third pharyngeal pouch endoderm and neural crest (NC) 
derived  mesenchyme  (Figure  1.1B).  Epithelial  cells  derived  from  the 
endoderm begin to proliferate causing the pouch to grow and bud to form a 
shared  thymus  and  parathyroid  primordium.  Simultaneously,  NC  derived 
mesenchymal cells derived from the anterior to fifth somite in the posterior 
hindbrain  undergo  an  epithelial  to  mesenchymal  transition  (EMT), 
delaminate from the neural tube and migrate towards the bilateral epithelial 
pouches,  completely  surrounding  them  (Figure  1.1C).  Subsequently,  the 
epithelial bud detaches from the pharynx and separates into two separate 
primordia;  the  thymus,  which  gradually  descends  into  the  thoracic  cavity 
where  it  resides  above  the  heart  by  E13.5;  and  the  parathyroid,  which 
remains in the neck and becomes associated with the thyroid. The molecular 
mechanisms that control separation and migration are unclear, but appear to 
involve,  amongst  others,  Pax3,  Pax9,  Alk5,  Fibroblast  Growth  Factors 
(FGFs),  FGF  Receptor  Substrate  2α  (FRS2α)  and  Bone  Morphogenic 
Proteins  (BMPs)  (Figure  1.1D).  Lymphoid  progenitor  cells  from  the  aorta-Chapter One 
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gonad-mesonephros  (AGM)  circulating  in  the  nascent  blood  supply  leave 
vessels  nearby  to  the  rudiment  and  migrate  through  the  surrounding 
perithymic mesenchyme to enter the thymus primordia starting after E11.5 
(10, 11), and begin the process of proliferation and differentiation (reviewed 
in (12)). 
 
1.3 Initiation and Specification 
 
The  mechanisms  of  initiation  and  positioning  of  the  thymic  rudiment  are 
unknown, but appear to involve signals emanating from the endoderm (13). 
The  transcription  factor  network  Hoxa-Pax-Eya-Six  is  considered  to  be  a 
likely candidate for this process, since in their absence the third pharyngeal 
pouch forms normally, but the thymus and parathyroids which arise from it 
are often hypoplastic or missing (3-9). A similar signalling cascade involving 
Pax, Eya and Six operates to control development of the eye in Drosophila 
(14) and patterning of the kidney region in vertebrates (Reviewed in (15)). 
Since  the  anterior  boundary  of  Hoxa3  expression  is  the  third  pharyngeal 
pouch, an attractive hypothesis is that the Hox-Pax-Eya-Six pathway might 
determine the position of initial rudiment formation. This hypothesis is based 
on  the  model  of  colinear  expression  of  Hox  genes  in  different  embryonic 
axes, whereby translation of genetic information into a combinatorial code 
controls the regulation of regional identity (16). 
 Chapter One 
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Hoxa3 is expressed at E9.5 in the third pharyngeal pouch endoderm and NC 
derived  mesenchyme,  and  appears  to  be  a  crucial  player  in  thymus 
organogenesis. Mice deficient in Hoxa3 have defects in the derivatives of the 
third pharyngeal arch and pouch, and lack thymus and parathyroid glands. 
Part of the role of Hoxa3 in thymus development may be its regulation of 
Pax1  and  Pax9  expression  in  the  third  pouch  endoderm,  since  both  are 
downregulated in Hoxa3
-/- mutant mice at E10.5. Pax9 mutants exhibit an 
early failure in thymus organogenesis, whilst Pax1 mutant have more subtle 
defects.  In  Pax1  mutants  a  thymus  rudiment  does  form,  albeit  severely 
reduced  in  size,  and  is  colonised  by  T  cell  progenitors.  However,  these 
precursors fail to mature and the rudiments do not migrate into the superior 
mediastinum.  Loss  of  one  allele  of  Hoxa3  in  Hoxa3
+/-  Pax1
-/-  compound 
mutants results in hypoplastic thymi and there is a delay in separation of the 
primordia from the pharynx leading to ectopic location of the organ.  
 
Six1  is  a  member  of  the  homeobox  Six  gene  family,  homologous  to  the 
Drosophila  sine  oculis  (so)  gene.  Six1  is  expressed  in  the  pharyngeal 
endoderm, mesenchyme and ectoderm. Six proteins bind directly to DNA to 
regulate gene transcription, and interactions with various cofactors including 
Eya1 modulate their activity (14, Ohto, 1999 #1, Ikeda, 2002 #619). In the 
absence  of  Six1,  the  patterning  of  the  third  pouch  into  thymus  and 
parathyroid primordia is normal but the endodermal cells fail to maintain the 
expression  of  Glial  Cells  Missing-2  (GCM2)  and  Forkhead  transcription Chapter One 
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factor-N1  (FoxN1),  and,  thus,  the  rudiments  disappear  by  E12.5.  eyes 
absent (Eya) 1, which encodes a transcription coactivator, is expressed in 
the pharyngeal endoderm, mesoderm and ectoderm at E9.5 (7, 17). In Eya1 
deficient embryos the thymus and parathyroid primordia fail to form and this 
is thought to be due to a failure of patterning of the combined rudiment into 
thymus- and parathyroid-domains, rather than initiation. 
 
Eya1 and Six1 are thought to act downstream of Hoxa3 since both mutants 
show normal levels of Hoxa3 expression by in situ hybridisation. However, it 
is unclear whether they act upstream or downstream of Pax1/Pax9. Zou and 
colleagues (8) report that whilst Pax1 is undetectable in Eya1;Six1 double 
mutants  by  in  situ  hybridisation,  Pax9  expression  was  not  altered  in  the 
pharyngeal  endoderm  in  Six1  single  or  Eya1;Six1  double  mutants.  Thus 
Eya1-Six1 is required for the expression of Pax1, but not Pax9. However, in 
another  report,  Xu  and  colleagues  (7)  showed  that  both  Pax1  and  Pax9 
expression levels in Eya
-/- embryos were comparable to those in wild type 
controls. 
 
Other molecules, which may contribute to the mechanisms of initiation and 
positioning  of  the  thymus,  include  Tbx1,  GCM2  and  Ehox.  Pharyngeal 
pouches do not form in Tbx1 homozygous mutants, and in these mutants 
NCCs  fail  to  migrate.  Tbx1,  a  gene  implicated  in  the  development  of  Di 
George’s  syndrome  (18),  which  is  characterised  by  anomalies,  such  as Chapter One 
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cardiac  outflow  tract  abnormalities,  cleft  palate,  craniofacial  abnormalities 
and thymic aplasia, resulting from defective pouch formation. The Drosophila 
gene GCM2, which encodes a transcription factor, is specifically expressed 
in the parathyroid gland during its organogenesis (19). GCM2 is expressed 
at E9.5 in the second and third pharyngeal pouches, and is further confined 
to a small domain of the third pouch endoderm by E10.5. It is proposed that 
its expression of GCM2 suppresses the thymus identity specified by the Hox-
Pax-Eya-Six  network  and  replaces  it  with  a  parathyroid  fate.  GCM2 
expression  itself  also  appears  to  be  regulated  by  the  Hox-Pax-Eya-Six 
network, since it is not initiated in the Hoxa3
-/- (3) or Eya1
-/- mice (7), and is 
downregulated in the Hoxa3
+/- Pax1
-/- compound mutants (5). Expression of 
Ehox, a distant member of the paired box of homeo-domain transcription 
factors, is expressed throughout the endoderm at E8.5 but is limited to a 
ventral domain in the second and third pharyngeal pouches by E9.5 (20). At 
E10.5 it is further restricted to a domain that is complementary to the GCM2-
expressing  parathyroid-fated  domain,  and  thus  may  also  have  a  role  in 
thymus organogenesis. At 11.5, Ehox is not detected by in situ hybridisation, 
and instead is replaced by the expression of FoxN1.  
 
1.4 Separation from the pharynx and migration 
 
Prior to migration, the thymus must detach from the pharynx and parathyroid 
primordia. The Hox3 and Pax1/9 transcription factors act in a pathway that is Chapter One 
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required for proper separation and/or migration of the developing thymic and 
parathyroid primordia from the pharynx, although the cell-type-specificity of 
these functions is poorly understood (5, 21, 22). In Pax9 mutants, separation 
of the rudiments from the pharynx does not occur, and is delayed in the 
Hoxa3
+/-Pax1
-/-  mutants.  Hoxa
+/-Hoxb3
-/-Hoxd3
-/-  combined  mutants  have 
normal sized lobes, which do separate from the pharynx but do not migrate. 
Splotch embryos, which have a null allele of Pax3 and are largely deficient in 
NCCs, also exhibit pharyngeal pouch defects including an ectopic thymus 
(23, 24). Deficiency in NCCs results in delayed separation of the thymus and 
parathyroid  from  the  pharynx,  and  the  boundary  between  thymus  and 
parathyroid-fated  domains  is  abnormal,  leading  to  ectopic  thymyi.  These 
results strongly implicate NCC migration to the third pharyngeal pouch in 
patterning  and  morphogenesis  of  the  thymus  and  parathyroids  (23). 
Interestingly, embryos which have deleted the TGF-β type-1 receptor, ALK5, 
in  NC  derived  cells  also  have  ectopically  located  thymi  and  delayed 
separation of the parathyroid from the thymic rudiment without histological or 
other differentiation defects. Moreover, this defect is not due to defective NC 
migration  to  the  third  pharyngeal  pouch,  but  is  thought  to  be  due  to 
increased apoptosis in post-migratory NCCs (25).  
 
In  addition  to  regulating  mesenchymal-epithelial  interactions  in  thymocyte 
development,  FGFs  are  also  important  players  in  the  separation  of  the 
thymus  rudiment  from  the  pharynx  and  its  subsequent  migration.  FRS2α Chapter One 
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mediates  FGF  signalling  by  providing  a  link  between  FGF  receptors  and 
intracellular  signals.  Disruption  of  the  FRS2α  gene  is  embryonic  lethal  at 
E7.0-7.5,  but  targeted  disruption  of  the  Shp2-binding  site  yields  viable 
embryos until E18.5. In these embryos, there is impaired cerebral cortex and 
eye development, the carotid body is absent, the parathyroid hypoplastic and 
the thymus fails to migrate. Failure of the thymus to migrate results from 
incomplete separation of the mutant thymus from the pharyngeal epithelium 
(26). However, to date no mutants with ectopic thymi have been verified to 
have  migration  defects  without  additional  defects  in  separation  from  the 
pharynx. 
 
Interestingly,  FGFs  are  also  required  for  cranial  NCC  migration  to  the 
pharyngeal pouches. Several members of the FGF family are expressed in 
the cranial region, near the cranial regions, or both, which are colonised by 
NCCs. For example, FGF2 is localised in facial mesenchyme (27), which is 
the  migratory  and  homing  region  of  mesencephalic  and  prosencephalic 
NCCs. FGF8 expression is found in the epithelium of branchial arches, and 
is  expressed  during  premigratory  and  migratory  stages  of  cephalic  NC 
development  (28,  29).  Moreover,  FGF8  controls  craniofacial  development 
(30) and regulates gene expression in NC-derived ectomesenchymal cells 
(31), thus both FGF2 and 8 are candidates to control cranial NC migration to 
the pharyngeal arches (32). 
 Chapter One 
 
  30 
FGF signalling also plays a crucial role in the formation of the great vessels 
associated with the heart. In addition to tissues and organs that derive from 
the pharyngeal pouches, each pharyngeal arch gives rise to an artery. The 
common carotid artery derives from the third pharyngeal arch and connects 
the aortic sac with the dorsal aorta. All pharyngeal arch arteries are formed 
by E10.5, but undergo a remodelling process leading to the mature aortic 
arch development and great vessel patterning at around E11.5 (33). T box 1 
(Tbx1), mediated by FGFs, is required for the formation of the pharyngeal 
arch  arteries.  Tbx1  is  not  expressed  by  the  structural  components  of  the 
arteries, but instead in the surrounding pharyngeal endoderm.  
 
Both Tbx1 and FGF mutants exhibit vessel and heart defects, and also have 
defects in thymus organogenesis. Moreover, since the thymus appears to 
follow the common carotid artery into the thorax during its migration, FGFs 
and/or  Tbx1  expression  may  be  attractive  candidates  in  directing  the 
migration of the thymus. However, since mutants for Tbx1 and FGFs exhibit 
an early defect in thymus initiation and patterning, the roles of these genes in 
thymus migration remain unknown.  
 
For a summary of mice with thymic and parathyroid defects, see Table 1.1. 
 
1.5 Vascularisation and influx of lymphoid progenitors 
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The  thymic  rudiment  is  first  colonised  by  passively  migrating  lymphocyte 
progenitor cells from the nascent blood vessel network between E10.5 and 
E12.5  (34)  in  response  to  chemoattractant  factors  (35).  Lymphocyte 
progenitors leave the blood in the region of the dorsal aorta and migrate 
through  the  perithymic  mesenchyme  to  enter  the  epithelial-mesenchymal 
mass that constitutes the foetal thymic primordium (13, 34, 36). Chemokines, 
CCL21 & CCL25, are produced in the primordium and their receptors, CCR9 
and  CCR7,  are  expressed  on  T  cell  progenitors.  These  molecules  play 
significant  roles  in  the  early  vasculature-independent  pathway  (37-40). 
Interestingly,  musculoaponeurotic  fibrosarcoma  oncogene  homolog  B 
(MafB),  expressed  on  CD45-IA
-  Platelet  Derived  Growth  Factor  Receptor 
alpha
+ (PDGFRα) mesenchymal cells, also appears to be important in this 
process.  Mice  deficient  for  MafB  exhibit  significantly  reduced  T  cell 
progenitor  accumulation  in  the  embryonic  thymus,  reduced  expression  of 
Wnt3  and  BMP4  in  mesenchymal  cells  and  reduced  CCL21  and  CCL25 
expression on epithelial cells (9). 
 
After blood vasculature development, direct lymphocyte trafficking between 
the  blood  circulation  and  the  thymus  becomes  the  main  mode  of  thymus 
colonisation. Functional vessels are formed at E14.5 in the thymus following 
inward branching of endothelial cells from existing blood vessels that are 
present nearby the thymic capsule (for review see (41)). Later in gestation, 
the  thymic  artery  branches  at  the  cortico-medullary  boundary  into  many Chapter One 
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arterioles  dividing  further  into  capillaries  that  ascend  into  the  cortex  and 
subsequently loop back to merge with post capillary venules (42).  
 
It  is  thought  that  endothelial  cells  from  vessels  surrounding  the  thymus 
proliferate and migrate into the organ towards angiogenic stimuli, such as 
vascular endothelial growth factor (VEGF) (43). VEGF, produced by thymic 
epithelial cells and mesenchymal cells (44), is an endothelial cell mitogen 
and  a  permeability  enhancing  factor  that  stimulates  angiogenesis  in 
response  to  hypoxia,  increased  glucose  concentration  or  pH  (45).  VEGF 
receptor  positive  endothelial  cells  upon  binding  VEGF  are  induced  to 
proliferate, resulting in formation of sprouting processes or immature blood 
vessel  structures.  Recently,  it  was  demonstrated  that  pericytes  are  an 
important  source  of  VEGF  and  may  migrate  ahead  of  endothelial  cells 
guiding the sprouting processes (46). Other factors thought to play a role in 
angiogenesis  include  angiopoietin1  that  is  produced  by  surrounding 
mesenchymal cells (47) and induces pericyte and vascular smooth muscle 
cell  development.  Endothelial  cells  produce  PDGF-B  that  in  turn  attracts 
PDGFRß
+  perivascular  cells  to  the  walls  of  growing  blood  vessels  (48). 
Perivascular cells, such as pericytes and smooth muscle cells, wrap around 
the  vessels  providing  structural  support  and  regulating  endothelial  cell 
function. In the absence of perivascular cells or PDGFRß signalling, vessel 
structures are abnormal and prone to haemorrhage (49). Indeed, this is a 
characteristic  of  pathological  states  such  as  oedema  and  diabetic Chapter One 
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retinopathy,  where  vessels  appear  abnormal  and  fragile  (50).  Within  the 
thymus cortex, the structure formed by the association of perivascular cells 
with the vessels themselves is unique among the lymphoid organs, resulting 
in  vessels  with  a  double-walled  morphology.  The  putative  function  of  this 
double-layer  constituting  a  “blood-thymus  barrier”  is  to  block  the  entry  of 
blood borne antigens into the areas where T cells undergo maturation (51, 
52). 
 
1.6 T cells in the thymus 
 
Thymocytes  are  generated  from  bone  marrow  derived  hematopoietic 
progenitors in the adult and from hemangioblasts in the embryo. Thymocytes 
enter  the  post-natal  thymus  in  waves,  a  process  dependent  upon  the 
maturation state and number of cells already within the organ (13, 53, 54). 
Once  inside  the  thymus,  progenitors  undergo  complex  selection  and 
maturation processes resulting in the generation of a diverse T cell repertoire 
essential for the establishment of protective immunity.  
 
These  progenitors,  or  thymocytes,  are  guided  through  a  number  of 
differentiation processes into functional α/β or γ/δ T lymphocytes by thymic 
stromal  cells  and  the  cytokines  they  produce.  The  spatial  context  of 
thymocyte development is vital (Figure 1.2). Lymphoid progenitors enter the 
thymus  through  large  venules  deep  inside  the  organ  near  the  cortico-Chapter One 
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medullary  junction;  at  this  stage  they  are  CD25
-  CD44
+  and  are  double 
negative  for  CD4  and  CD8  (DN1).  After  the  DN1  stage,  they  migrate 
outwards  into  the  mid  cortex,  and  become  CD25
+  CD44
+  (DN2).  The 
progenitors  undergo  T  cell  receptor  (TCR)  beta  chain  rearrangement, 
migrate  into  the  outer  cortex  and  lose  expression  of  CD44  (DN3). 
Thymocytes  in  the  cortex  are  highly  motile  (55,  56),  pausing  to  interact 
through  their  TCR  with  peptide-MHC  complexes  that  are  expressed  by 
stromal  cells,  cTECs,  and  dendritic  cells  (55).  Notch-mediated  signals 
delivered by binding of Delta ligands (57, 58) on cortical epithelial cells, and 
chemokines, CXCR4, CCR7 and 9, are required for the outward movement 
to the subcapsular zone (59-61). To progress from the DN3 to DN4 stage, 
thymocytes must have a functional pre-TCR expressed on the surface to 
survive (62). 
 
The  TCR  is  responsible  for  recognising  antigens  bound  to  major  MHC 
molecules. It consists of variable and constant domains which are encoded 
by  different  gene  segments.  The  TCR  α  chain  is  generated  by  VJ 
recombination whereas the β chain is generated by V(D)J recombination, 
whereby gene segments are randomly joined to generate the complete TCR 
chain.  There  are  multiple  genes  for  the  variable  regions  and  by  random 
joining of these gene segments it is possible to generate an enormous TCR 
repertoire. However, not all will be functional, self-restricted and self-tolerant 
and will be eliminated (63, 64). Chapter One 
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Through positive selection, immature CD4
+CD8
+ DP thymocytes expressing 
an α/βTCR are rescued from programmed cell death. If successful, they will 
downregulate CD4 or CD8 expression and become a single positive (SP) 
thymocyte  and  migrate  to  the  medulla  (56).  Success  depends  on  the 
strength  and  length  of  signal  with  which  the  TCR  binds  peptide-MHC 
expressed on cTECs. In the medulla, T cells that recognise self peptide-self 
MHC molecules presented by mTECs or DCs with high affinity and avidity 
will  also  undergo  apoptosis,  preventing  the  maturation  of  auto-reactive  T 
cells (65, 66). A final mechanism, termed neglect, ensures that if they have a 
functional  TCR  that  can  interact  with  self-MHC  peptide  complexes  at  low 
affinity, the thymocyte fails to receive a survival signal and dies. More than 
95% of developing T cells will die through neglect or negative selection. 
 
T cells spend approximately twelve days in the medulla before egress into 
the periphery (67). During this period, they undergo a maturation process, 
identified  by  expression  of  CD62L  and  loss  of  CD69,  to  acquire  the 
functional capacity of mature but naïve T cells (68-70). Once exported from 
the  thymus  into  the  circulation,  T  cells  populate  the  peripheral  lymphoid 
organs. Emigration of T cells from the thymus is regulated by sphingosine-1-
phosphate  (S1P)  and  S1P  receptor  1  (S1P1).  S1P  is  produced  by 
hematopoietic  cells  and  non-hematopoietic  cells  including  the  vascular 
endothelium (71) and is present at a higher concentration in blood than in Chapter One 
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the  thymus  (72).  Conversely,  the  S1P1  receptor  is  highly  expressed  on 
mature lymphocytes, and is upregulated during the last stage of thymocyte 
development  (73-75).  Expression  of  integrin  α5β1  by  mature  thymocytes 
(76),  the  downregulation  of  CD69  expressed  by  semi-mature  thymocytes 
(77), and the repulsion from CXCL12, a chemokine abundantly expressed in 
the thymus (78, 79), are also required for egress of T cells into the periphery.  
 
1.7 Epithelial Cells 
 
In  addition  to  the  haemopoietic  cells,  the  thymic  parenchyma  is  also 
comprised  of  blood  vessels,  connective  tissue  and  epithelial  cells,  which 
form a highly specialised microenvironment (80, 81). Thymic stromal cells 
are  composed  of  thymic  epithelial  cells  (TECs),  mesenchymal  cells, 
endothelial cells, and hematopoietic cells such as dendritic cells (DCs) and 
macrophages  (82).  Thymic  epithelial  cells  compartmentalise  developing 
thymocytes and support distinct stages of T cell development (79). TECs 
produce IL7, a cytokine that is essential for survival of DN thymocytes (83). 
They also produce IL-1, IL-6, Stem Cell Factor (SCF) and Tumour Necrosis 
Factor alpha (TNFα) that promote thymocyte development (for review see 
(84). 
 
The two subpopulations of TECs, cortical TEC (cTEC) and medullary TEC 
(mTEC) are so named because of the areas of the thymus in which they are Chapter One 
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restricted  to.  They  are  differentiated  based  on  their  expression  of 
intermediate  filament  proteins,  Keratin  (K)8  and  K5.  Whereas  the  cortex, 
K8
+K5
-,  is  a  site  that  promotes  immature  T  cell  development,  the  thymic 
medulla, K8
-K5
+, contains mature T cells and supports their interactions with 
DCs. Both subsets of TECs derive from common progenitors cells that are 
K8
+K5
+, and are generated from the endoderm of the third pharyngeal pouch 
(85-88),  a  process  that  is  dependent  upon  transcription  factors  including 
Tbx1, Hoxa3, Pax1 and Foxn1 (18, 22, 89, 90). 
 
Cortical TECs appear to require interactions with thymocytes committed to 
the T cell lineage, whilst medullary TECs require αβTCR
+ thymocytes (91). 
The bifurcation that gives rise to cTECs and mTECs occurs in the absence 
of lymphocytes, thus, until E11.5 all TECs are homogenous (92). The signal 
for bifurcation is unknown. The medullary lineage differentiates further under 
the control of lymphotoxin and TNF signals and arrives at a postmitotic stage 
characterised by AIRE expression. Both subsets play a crucial role in the 
development  and  repertoire  formation  of  T  cells  (93),  and,  in  turn,  are 
supported by developing thymocytes, via crosstalk (94-97).  
 
In mice that carry a transgene encoding human CD3ε, and thus are deficient 
for thymocyte development beyond the DN1 stage, TECs are arrested at an 
immature stage where they are K5
+ and K8
+ and are unable to differentiate 
into K5
-K8
+ cTECs (98). The cortex of thymi from these mice is histologically Chapter One 
 
  38 
abnormal and contains large cysts. In contrast, K5
-K8
+ cTECs are generated 
and the cortex appears histologically normal in mice that are deficient for 
thymocyte  development  beyond  the  DN3  stage  such  as  recombination-
activating gene 1 (RAG1)-deficient mice (98). Therefore signals emanating 
from DN1-3 thymocytes are required for differentiation of cTECs to form the 
cortex (94, 99-101). 
 
On  the  other  hand,  formation  of  the  medullary  areas  is  dependent  on 
thymocytes  which  have  undergone  positive  selection  (96,  102,  103).  This 
process is unclear, but molecules including Nuclear Factor Kappa-light-chain 
enhancer of activated B cells (NF-κB), through Lymphotoxin beta Receptor 
(LTβR), Tumour necrosis factor Receptor-Associated Factor 6 (TRAF6), NF-
κB-Inducing Kinase (NIK) and Reticuloendotheliosis viral oncogene homolog 
B (RelB) are known to be important for this process (104-107). Thus in mice 
with blocks in later thymocyte development, such as Rag1-deficient mice, 
the medulla is hypoplastic (41).  
 
Growth  and  differentiation  of  all  TECs  subsets  is  dependent  on  the  cell-
autonomous function of FoxN1, and loss of this transcription factor causes 
athymia. In FoxN1 deficient mice, TECs cannot progress beyond an early 
progenitor stage and cannot attract lymphoid progenitor cells, similar to mice 
which have blocks in thymocyte development. In addition, TECs also require Chapter One 
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FGF signals from NC derived mesenchymal cells in order to proliferate and 
mature (108). 
 
1.8 NC derived mesenchyme 
 
Mesenchyme consists of primitive cells which develop into supportive cells 
and connective tissues of organs, and is derived from mesoderm or from 
NCCs. The earliest NCCs are derived from the ectoderm in the region of the 
neural folds (Figure 1.3A). During neurulation, a region of ectoderm thickens 
along  the  axis o f  the  early  embryo  to  form  the  neural  plate,  the  lateral 
borders of which curve upward to form the neural folds (Figure 1.3B). As this 
curling process continues, the folds from each side unite in the midline. The 
thickened  neural  epithelium  fuses  to  complete  the  neural  tube,  and  the 
ectoderm from each side fuses to form a continuous dorsal covering (Figure 
1.3C). NCCs delaminate and migrate ventrally and laterally from the area of 
the neural folds and differentiate to form a variety of structures (Figure 1.3D). 
The cephalic NC, the portion from the fifth somite onwards, also contributes 
a large proportion of cells that differentiate into mesenchymal cells (109). 
 
In order for NCCs to migrate, they must undergo a process of Epithelial to 
Mesenchymal Transition (EMT). During EMT, NCCs lose their apical-basal 
polarity  characteristic  of  epithelial  cells  and  acquire  a  front-rear  polarity, 
required for mesenchymal cell migration. NCCs lose cell-cell adhesions and Chapter One 
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undergo cytoskeletal rearrangements and morphological changes that allow 
them  to  delaminate  and  emigrate  from  the  neuroepithelium  along  three 
pathways; dorsal, ventral and lateral. They concomitantly acquire migratory 
ability,  with  acquisition  of  cell-surface  receptors,  metalloproteases  and 
adhesion molecules that allow them to respond to cell-cell interactions and 
environmental cues that influence their pathway of migration. The process of 
delamination  involves  the  upregulation  of  N-cadherin  and  vimentin,  the 
nuclear localisation of β-catenin and increased production of the transcription 
factors such as Snail1, Snail2, Twist, EF1/ZEB1, SIP1/ZEB2 and/or E47 that 
inhibit  E-cadherin  production  (For  review  see  (110)).  Once  they  have 
reached their destination NCCs differentiate and contribute to pigment cells, 
most of the peripheral and autonomous nervous systems, the facial skeleton, 
teeth and aortic arches and participate in the formation of the pharyngeal 
glands such as the thymus and parathyroids (111-113). 
 
Induction of neurulation is dependent on a number of factors including Wnts, 
BMPs  and  FGFs  (114-116).  Notably,  inhibition  of  BMP  signalling  in  the 
premigratory rhombencephalic NC blocks either the production or migration 
of  NCCs  (116).  NCCs  are  essential  for  various  aspects  of  vertebrate 
development (111), and aberrant NCC migration, survival or differentiation 
contributes to DiGeorge’s syndrome (117, 118). Di George’s syndrome is 
characterised by cardiac and facial abnormalities, thymic aplasia, cleft palate 
and hypocalcaemia. Moreover, specific inactivation of TGFβ signalling in NC Chapter One 
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stem  cells  results  in  cardiovascular  defects  and  thymic,  parathyroid  and 
craniofacial  abnormalities,  similar  to  DiGeorge’s  syndrome.  In  DiGeorge’s 
syndrome  it  is  though  that  mutant  NCCs  migrate  into  the  pharyngeal 
apparatus but are unable to acquire non-neural cell fates (119). 
 
1.9 NCCs and the Thymus 
 
NCCs have been shown to play a major role in the formation of the thymic 
rudiment. NCCs were first shown to contribute to connective tissues in the 
thymic capsule and to surround blood vessels inside the thymus of chick-
quail chimeras (13). Cells from these two species can be distinguished due 
to  morphological  differences  in  interphase  chromatin  organisation.  Thus, 
quail  NC  was  implanted  into  chick  hosts,  which  showed  that  the  capsule 
surrounding  the  developing  host  thymus  was  from  donor  quail  NC.  More 
recent experiments using lineage tracing tools have confirmed these results. 
In the recent experiments, Cre recombinase expressed under the Wnt1 NC 
specific  promoter  was  used  to  activate  expression  of  a  LacZ  reporter 
inserted  into  the  ubiquitously  expressed  Rosa26  locus  (120).  Jiang  and 
colleagues presented evidence that NC derived cells surround the thymus at 
E13.5 but their numbers decline thereafter and are eventually lost by E17.5 
(121).  
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The functional importance of NC derived cells during thymus organogenesis 
has been suggested by experiments whereby their removal or reduction in 
the pharyngeal region results in greatly reduced size or complete absence of 
the organ (122). Of particular interest are experiments where mesenchyme 
surrounding the thymic rudiment is removed following trypsin treatment. In 
these  experiments,  cultured  lobes  devoid  of  such  mesenchyme  failed  to 
grow, while intact lobes grew and became lobulated. These results indicated 
that the normal expansion of the epithelial compartment does not occur if NC 
derived  cells  are  absent  (123).  Additionally,  lobes  that  were  stripped  of 
mesenchyme  and  cultured  overnight  in  medium  containing 
Bromodeoxyuridine  (BrdU)  showed  a  three-fold  decrease  in  BrdU 
incorporation compared to intact lobes, demonstrating the marked decrease 
in proliferation of cells in these rudiments (124). Furthermore, ablation of the 
premigratory cardiac NC in chicks results in disrupted development of the 
pharyngeal arches, including thymus and parathyroid hypoplasia or agenesis 
(125).   
 
In addition to the role of FGFs in early thymus development as discussed 
earlier, FGFs are also required for the proliferation and maturation of TECs, 
which occurs later in thymus development. Recently, it was demonstrated 
that  NC  derived  mesenchyme  stimulates  proliferation  and  possibly  also 
maturation of epithelial cells, which upon differentiation express molecules 
required for T cell development (126). Revest et al have shown that FGFs, Chapter One 
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which  are  expressed  by  mesenchymal  cells,  are  important  signalling 
molecules in thymic development (108). Thus, absence of FGFs results in 
impaired  thymic  growth  due  to  a  lack  of  epithelial  cell  proliferation. 
Additionally,  MHCII  expression  by  TECs  has  also  been  demonstrated  to 
require mesenchymal cells (127).   
 
In vitro foetal thymic organ culture experiments have shown that NC derived 
mesenchyme  might  also  be  required  for  the  differentiation  of  lymphoid 
progenitors into functional T cells (128). These authors, and others, have 
shown  that  whilst  epithelial  cells  can  support  later  stages  of  T  cell 
development, mesenchymal cells are required for their development beyond 
the  CD4
-  CD8
-  double  negative  stage  (128,  129).  Moreover,  reaggregate 
thymic  organ  culture  experiments  using  E14  lobes  showed  that  both 
epithelium  and  non-epithelium  stromal  cells  were  required  for  T  cell 
development from the DN2-DN3 stage (93, 129). 
 
Clearly, early stages of thymus development is dependent upon interactions 
between  epithelial  and  NC  derived  cells.  However,  it  has  been  reported, 
based on tissue specific heritable genetic labelling, that once epithelial cells 
have fully gained the competence to support lymphocyte differentiation, and 
the vasculature of the thymus is complete, the contribution of NCCs in the 
thymus  is  greatly  reduced  or  absent  (120,  121).  Thus,  although  it  has 
previously been shown that NC derived cells are critically important for the Chapter One 
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normal  development  and  function  of  the  thymus,  there  is  controversy 
regarding their role beyond the early stages of organogenesis.  
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1.10 Eph/ephrins 
 
Eph receptors and their ligands, ephrins, are members of a family of receptor 
tyrosine  kinases,  and  are  named  after  the  erythropoietin-producing 
hepatocellular  (Eph)  carcinoma  cell  line  from  which  their  cDNA  was 
obtained. Eph/ephrin interactions were first recognised as cell guidance cues 
in vertebrate and invertebrate development. However, it is now known that 
they are required for a number of developmental processes, such as cell 
patterning,  guidance,  migration  and  adhesion.  The  mechanisms  by  which 
Eph/ephrins control these processes are thought to involve regulation of the 
actin  cytoskeleton  by  activating  members  of  the  Rho  family  GTPases 
(reviewed in (130) & (131)). They are expressed in virtually all tissues in the 
embryo, including the thymus where they appear to have immunoregulatory 
properties (132-140). 
 
1.11 Structure of Eph/ephrins 
 
Eph receptors comprise a subfamily of receptor tyrosine kinases (RTKs) that 
interact with cell surface-bound ephrin ligands, which are part of a family of 
related  proteins.  There  are  two  classes  of  ephrins;  ephrin-A’s,  which  are 
tethered to the membrane by a glycosyl phosphatidyl inositol (GPI) moiety, 
and ephrin-B’s, which span the membrane and have a short cytoplasmic tail. 
The extracellular part of the Eph receptors includes an N-terminal ephrin-Chapter One 
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binding  domain,  a  cystein-rich  region  and  two  fibronectin  type-III  repeats. 
The  extracellular  domain  is  separated  by  a  membrane-spanning  segment 
from  the  cytoplasmic  part,  which  includes  a  juxtamembrane  segment,  a 
tyrosine kinase domain and a sterile a-motif (Figure 1.4A). However, unlike 
the other Eph receptors, the tyrosine kinase domain of the EphB6 receptor is 
non-functional. The first step in the formation of a “signalling cluster” is the 
monovalent interaction between an Eph receptor and an ephrin ligand. It is 
important  to  note  that  interaction  between  receptor  and  ligand  can  occur 
both in trans (between two opposing cells), and may also occur in cis (within 
the same cell) (141).  
 
Both receptor and ligand are capable of transducing a signalling cascade 
upon interaction, referred to as forward and reverse signalling respectively. 
Upon  binding  to  an  ephrin  ligand,  Eph  receptors  activate  downstream 
signalling cascades, termed forward signalling. Additionally, the ligand also 
has  biological  activity,  known  as  reverse  signalling.  Reverse  signalling  is 
activated  by  the  transmembrane  domain  of  ephrins,  whereby  tyrosine 
phosphorylation  of  its  cytoplasmic  tail  permits  interactions  with  various 
signalling molecules. Most Eph receptors and the B-type ephrins also have a 
carboxy-terminal  PDZ  domain-binding  site,  whilst  the  GPI  linked  A-type 
ligands are thought to use associated transmembrane proteins in order to 
signal (Figure 1.4A). Within the A or B class, interactions between receptor 
and ligand are promiscuous. Thus multiple receptors can bind to a ligand Chapter One 
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and multiple ligands can bind to a receptor, giving rise to redundancy (Figure 
1.4B).  
 
1.12 Downstream signalling pathways 
 
Eph/ephrins do not act in isolation; they are part of a complex network of 
regulatory pathways that act together to control various biological responses. 
This network of pathways includes cell surface receptors (FGF Receptors, 
Receptor-like  Tyrosine  Kinase  (Ryk),  chemokine  receptors);  adhesion 
molecules (integrins, immunoglobulin superfamily (IgSF) proteins, cadherins, 
claudins);  channels  and  pores  (Connexins/innexins,  N-methyl-D-aspartic 
acid  (NMDA)  receptors);  and  cell  surface  proteases  (A  Disintegrin  And 
Metalloprotease (ADAM), Presenilins) (for review, see (142)). 
 
Of particular interest is a common pathway shared by Eph and ephrins; the 
Ras/Rho family of GTPases, which regulates the organisation of the actin 
cytoskeleton and cell adhesion. In this kinase-dependent pathway guanine 
exchange  factors  (GEFs)  such  as  Tiam  1,  kalirin-7  and  intersectin  that 
catalyse the Rho family GTPases Rac1 and Cdc42 into the active state, are 
phosphorylated  by  the  Eph  receptor  (143-145).  Rho  family  GTPases 
regulate the formation of contractile actin-myosin filaments in response to a 
variety of extracellular stimuli. In particular, Rac induces actin polymerisation 
at  the  cell  periphery  to  produce  lamellipodia,  and  Cdc42  promotes  actin Chapter One 
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filament assembly and filopodia formation. Molecules downstream of Cdc42 
include members of the WASP/WAVE family of Arp2/3 complex activators, 
which promote actin polymerisation (143, 144) (Figure 1.5). 
 
For a cell to migrate it must generate front-rear polarity, a process that is 
largely controlled by localised activation of the Rho family of small GTPases 
(146). Cdc42 is a master regulator of polarity (147), and is active towards the 
front of migrating cells (148). Cdc42 mediates polarity via two mechanisms; 
restricting  where  lamellipodia  form  (149);  and  localising  the  microtubule 
organising  centre  (MTOC)  and  golgi  apparatus  in  front  of  the  nucleus, 
orientated  towards  to  the  leading  edge  (150-152).  The  latter  mechanism 
involves the Cdc42 effector, Par6, which exists in a complex with Par3 and 
atypical Protein Kinase C (aPKC) (153). Also downstream of Cdc42 is Pak1, 
which  itself  can  mediate  Cdc42  activation  via  a  positive  feedback 
mechanism (154). Once polarity is established and the cell has formed an 
active  protrusion,  the  protrusion  is  stabilised  by  attachment  to  the 
surrounding extracellular matrix via integrins. Integrins preferentially locate to 
the leading edge of migrating cells (155), and large clusters of integrins are 
termed focal adhesions. Focal adhesions are also dependent on Rac and 
Cdc42, which mediate their attachment to the ECM.  
 
1.13 Adhesion/Repulsion 
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An  interesting  paradox  of  Eph/ephrin  signalling  is  that  it  can  be  both 
repulsive  and  attractive.  Forward  signalling  by  activation  of  Eph  receptor 
tyrosine kinases can lead to repulsion of Eph receptor expressing NCCs. 
Likewise, Eph expressing axonal growth cones can be triggered to retract 
away from tissues expressing the corresponding ligand (156-158). However, 
the  same  receptor-ligand  pairs  can  also  promote  adhesion  in  certain 
instances. Eph receptor signals of different intensities can produce opposite 
effects, for example, high concentrations of ephrin-A2 triggers a repulsive 
response,  whereas  low  concentrations  promotes  growth  of  cultured  nerve 
cells (159). Molecules involved in adhesion, such as integrins, are through to 
act  downstream  of  Eph  receptors,  controlled,  in  part,  by  Focal  Adhesion 
Kinase (FAK) and R-Ras (Figure 1.5). 
 
1.14 Axon guidance 
 
Axons  grow  towards  their  target  tissues  where  they  form  synapses  with 
appropriate  cells  in  order  to  establish  neuronal  connectivity.  Axons  are 
guided  by  molecular  cues  within  the  extracellular  matrix  or  by  signals 
expressed on the surface of nearby cells. Cells expressing Eph receptors 
were  first  observed  to  avoid  territories  expressing  ephrins,  thus  providing 
necessary cues to guide axons to their appropriate targets (160). However, 
Eph/ephrins  can  also  regulate  axon  pathfinding  through  attractive Chapter One 
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interactions  (161-165),  depending  on  which  receptors  and  downstream 
signalling pathways are activated.  
 
The  trajectories  of  axons  have  been  shown  to  be  dependent  on  Eph 
receptors and ephrins distributed in gradients or forming boundaries (157, 
158,  166).  Moreover,  EphB  and  B  type  ephrins  are  known  to  regulate 
multiple steps in assembly and maturation of the pre- and postsynaptic sides 
of  excitatory  synapses  (167).  For  example,  activation  of  ephrin-B  reverse 
signalling by postsynaptic EphB2 has been implicated in the morphological 
and  functional  maturation  of  developing  retinotectal  synapses  in  Xenopus 
optic  tectum  (168).  Additionally,  the  EphB2  extracellular  portion  also 
associates with NMDA neurotransmitter receptors and promotes clustering 




In  addition  to  axon  guidance,  Eph  and  ephrins  are  expressed  in  a 
segmented pattern in the hindbrain and in the somites, and are implicated in 
segmentation during embryogenesis (170). In Xenopus, Eph and ephrins are 
normally  expressed  in  alternating  rhombomeres.  Thus,  expression  of  a 
dominant negative form of EphA4 lacking the kinase domain in the hindbrain 
can disrupt segmental expression of certain genes (171). The sorting of cells 
at  rhombomere  boundaries  appears  to  involve  forward  signalling  since  a Chapter One 
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dominant negative form of ephrin-B2 lacking the cytoplasmic domain was 
still competent to induce sorting (172). In mouse, EphA4 and ephrin-B2 are 
expressed in similar expression domains, but unlike in Xenopus, there are 
no defects in hindbrain segmentation in mice deficient for these molecules, 




Angiogenic remodelling in the mouse is defective in the absence of ephrin-
B2 and its preferred receptor, EphB4 (175-177). EphB4 expression is largely 
restricted to veins, whilst ephrin-B2 is expressed on arteries, and thus may 
be involved in determining arterial and venous identity. Reverse signalling 
through the ligand has been demonstrated to be required for blood vessel 
remodelling,  since  expression  of  a  deleted  form  lacking  the  cytoplasmic 
domain was unable to rescue the angiogenic defects associated with the 
loss of ephrin-B2 (174). EphB4 induced forward signalling is also implicated 
in regulating angiogenic growth in Xenopus (178). Here EphB4, ephrin-B1 
and ephrin-B2 are expressed in complementary patterns in the developing 
vasculature and somites respectively. Moreover, disruption of the Eph/ephrin 
interaction  leads  to  defects  in  intersomitic  vessel  migration  (176,  178). 
Additionally,  overexpression  of  EphB4  lacking  the  tyrosine  kinase  domain 
induced  disorganisation  of  the  intersomitic  vascular  network,  thus  forward Chapter One 
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signalling  is  though  to  be  an  important  player  in  intersomitic  vessel 
development.  
 
Mural cell association with blood vessels is also dependent on Eph/ephrin 
interactions.  When  the  ephrin-B2  gene  is  inactivated  specifically  in  mural 
cells,  the  vessels  become  leaky  leading  to  oedema  and  extensive 
haemorrhaging  into  the  skin  (179).  In  these  mice,  ephrin-B2  deficient 
perivascular  cells  were  only  loosely  attached  to  vessel  walls,  made 
insufficient  contact  with  endothelial  cells  and  failed  to  envelope  the 
endothelial  monolayer.  Likewise,  mutant  vascular  Smooth  Muscle  Cells 
(vSMCs)  showed  attachment  defects  and  covered  microvessels  in  a 
discontinuous  manner.  Interestingly,  these  cells  also  showed  defects  in 
spreading,  focal  adhesion  formation  and  increased  migration  due  to 
unpolarised motility. 
 
1.17 NC migration 
 
Eph/ephrins regulate migration of cranial and trunk NCCs by repulsion (180, 
181). In Xenopus, Eph and ephrins are expressed on adjacent streams of 
migrating branchial NCCs, thus, repelling those expressing different Eph or 
ephrin molecules. Moreover, disruption of Eph receptor function results in 
NCC  migration  into  areas  where  they  would  not  generally  be  found.  For 
instance, dominant negative EphA4 mutants induced scattering of NCCs and Chapter One 
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allowed  them  to  invade  improper  territories  that  they  would  normally  be 
repelled  from.  This  was  demonstrated  to  be  due  to  cell  autonomous 
signalling since only EphA4 expressing, and not other NCCs, were affected 
(182). In the mouse, forward signalling also regulates NCC migration into the 
pharyngeal arches (174).  
 
In ephrin-B2 null mice, there is a defect in NCC migration into the second 
pharyngeal  arch.  Thus,  the  arches  were  hypoplastic  and  abnormally 
vascularised. This was due to a lack of NCC migration into the arch, and was 
partially  rescued  by  a  mutant  form  of  the  ephrin-B2  ligand  lacking  the 
cytoplasmic domains, thus indicating that forward signalling was responsible 
for  NCC  migration  into  the  arch.  It  has  been  proposed  that  ephrin-B2  is 
expressed  in  the  neural  tube,  specifically  in  rhombomeres  (r)4  and  r6, 
repulsing Eph-expressing NCCs away into r3 and r5 (183).  
 
Likewise, ephrin-B1 is also required for proper migration of NCCs and, thus, 
mice deficient for ephrin-B1 have a cleft palate that is attributed to a defect in 
NCC migration to the second pharyngeal pouch (184). ephrin-B1 deficient 
NCCs, and those from mice expressing a mutant form of the ligand in which 
the PDZ-containing domain was disrupted, also invaded improper territories 
(184).  ephrin-B1  null  mice  display  malformations  of  the  axial  and 
appendicular skeleton that includes the asymmetric attachment of ribs to the 
sternum, lack of joints and polydactyl (185). ephrin-B1 null, or mice with an Chapter One 
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NCC  specific  deletion  of  ephrin-B1,  do  not  exhibit  defects  in  other 
pharyngeal  pouch-derived  organs,  such  as  those  from  the  third  pouch, 
indicating the specificity of ephrin-B1 for migration of NCCs into the second 
pouch. 
 
Most  molecules,  including  Eph/ephrins,  involved  in  NC  migration  act  by 
repulsion,  allowing  NCCs  to  migrate  into  permissive  areas  and  repelling 
them from forbidden areas. Moreover, there is a lack of evidence for the 
existence of a chemoattractant involved in NC migration. Moreover, cultured 
NCCs  have  been  shown  to  migrate  with  a  high  directionality  even  in  the 
absence of external chemoattractants. Several permissive molecules have 
been  suggested,  such  as  fibronectin,  laminin  or  collagen,  but  there  is  no 
evidence that these molecules can control the directionality of NC migration. 
Instead, a process of chemokinesis has been suggested, whereby a factor 
stimulates  the  migration  of  cells  but  with  no  directionality.  In  contrast,  a 
molecule  that  is  chemoattractant  would  stimulate  both  mobility  and 
directional movement along a gradient (186).  
 
Since NCCs migrate with very persistent directionality, either as a mass of 
migrating  cells  or  individual  cells,  it  is  possible  that  directionality  in  these 
cells  is  controlled  by  regulation  of  cell  polarity  and  the  cytoskeletal 
machinery, which controls the formation of cell protrusions. The Planar Cell 
Polarity (PCP), or non-canonical Wnt, pathway is a likely candidate to control Chapter One 
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directional migration in NCCs, since inhibition of this pathway abolishes the 
directionality of NCC migration.  
 
Usually, the PCP pathway controls the polarity of epithelial tissues. However, 
it  was  recently  demonstrated  that  migration  of  NC  derived  mesenchymal 
cells is also regulated by the PCP pathway. Inhibition of several of the PCP 
factors, including Wnt11, Frizzled (Fz)7, and dishevelled (Dsh), leads to a 
complete block in NC migration (187). Analysis of NCC migration indicates 
that they keep in close contact with others whilst migrating (188), thus, it was 
speculated  that  cell-cell  contacts  maintain  the  integrity  of  the  tissue  and 
coordinates  the  formation  of  lamellipodia  at  the  leading  edge  (186).  PCP 
signalling  is  required  in  the  context  of  NCC  migration  to  stabilise  cell 
protrusions through the small GTPases, Rho and Rac (187, 189).  
 
1.18 Eph/ephrin expression in the thymus 
 
A significant number of Eph receptors and ephrin ligands are expressed in 
the thymus, and are known to have immuno-regulatory properties (see Table 
1.2  for  pattern  and  timing  of  Eph/ephrin  expression  in  the  thymus). 
EphB/ephrin-B  molecules  have  been  demonstrated  to  have  important 
functions  in  T  cell  development  in  a  number  of  in  vitro  and  in  vivo 
experiments. Addition of EphB2-Fc or ephrin-B1-Fc to foetal thymic organ 
cultures  (FTOC)  increases  the  number  of  DPs  and  SPs  and  increases Chapter One 
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apoptosis  in  all  thymocyte  subsets,  whilst  their  addition  to  reaggregate 
thymic organ cultures (RTOC) disrupts the three dimensional architecture of 
epithelial cells (190). EphB-Fc or ephrin-B-Fc fusion proteins bind to their 
respective  partners,  but,  since  they  lack  biological  activity,  they  block 
signalling  downstream  of  their  respective  ligand  or  receptor  partner. 
Additionally,  deficiency  in  EphB2  and  B3  receptors  results  in  profound 
alteration in both the differentiation of T cell precursors and the organisation 
of  the  TEC  network  (191).  Moreover,  EphB6
-/-  mice  have  impaired  T  cell 
responses  such  as  lymphokine  secretion  and  proliferation,  and  develop 
delayed-type skin hypersensitivity and EAE. This was demonstrated to be 
not due to defective T cell development, however, but due to a lack of EphB6 
on mature T cells (139).  
 
Eph/ephrins  may  exert  their  functions  by  modulation  of  the  actin-
cytoskeleton,  which  influences  the  TCR-peptide-MHC  interaction.  Indeed, 
EphB receptors have been shown to concentrate in lipid rafts in peripheral T 
cells when the TCR is strongly engaged (136, 137, 139). The role of EphB 
receptors  in  this  context  is  to  direct  the  polymerisation  of  the  actin 
cytoskeleton at the point of TEC contact, and to facilitate the formation of a 
stable immunological synapse. Moreover, another key process in synapse 
formation,  adhesion  (192),  also  appears  to  be  regulated  by  Eph/ephrin 
signalling  (158),(157).  Formation  of  an  immunological  synapse  brings 
together  numerous  scaffold  proteins,  and  whilst  Ephs  have  not  been Chapter One 
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demonstrated to be required for raft aggregation, they do appear to be part 
of the TCR signalling complex, or signalosome, through adapter molecules 
associated with their intracellular tails, once it has formed.  ephrin-B2 has 
also been demonstrated to translocate to lipid rafts, assisting TCR signalling 
after being triggered (136). Cytoskeletal rearrangements are pivotal for T cell 
signalling (193), and this appears to be regulated by Eph/ephrin activation of 
the Ras and Rac pathways.  
 
Ephrin  ligands  have  also  been  shown  to  regulate  the  homeostatic 
mechanism that keeps the number of T cells stable, by triggering apoptosis 
in these cells (138). Additionally, ephrin-B2 has been shown to stimulate T 
cell  proliferation  by  augmenting  stimulation  by  IFNγ,  and,  thus,  can  co-
stimulate T cells in the presence of suboptimal TCR ligation. In this respect, 
ephrin-B2 may function to reduce the threshold for stimulation by suboptimal 
foreign antigens. 
 
ephrins are also required for chemotaxis during T cell development. Both 
ephrin-As and ephrin-B ligands modify the chemotactic response of T cells 
mediated  by  stromal  cell-derived  factor  1α  (SDF1α)  and  macrophage 
inflammatory  protein  3β  (MIB3β)  (194,  195).  Therefore  ephrins  may  play 
additional  roles  in  adhesion  and  transmigration  through  HEV  endothelial 
cells into secondary lymphoid organs and to sites of inflammation.  
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EphA4, expressed by TECs, and its preferred ligands, ephrin-As, expressed 
by thymocytes, also affects T cell development. The EphA/ephrin-A family 
appear to have a role in the development of the TEC network since in their 
absence the three dimensional TEC architecture is disordered, which in turn 
disrupts the development of thymocytes. By modulation of the thymocyte-
TEC interaction, Eph/ephrins were demonstrated to provide the necessary 
signals for T cell development, and in the absence of these signals, T cells 
died due to a failure in differentiation (196).  
 
A  further  role  in  colonisation  of  the  thymic  primordium  and  intrathymic 
migration  by  reverse  ephrin  signalling  has  also  been  suggested  (197). 
However,  the  function  of  Eph/ephrins  in  early  organogenesis  and 
morphogenesis is yet to be fully described. 
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Figure 1.1: Model of thymus organogenesis. A E9.5: Positioning. Pax1/9 and 
FGF8  (green)  are  required  for  pharyngeal  pouch  formation.  Hoxa3  (red)  is 
required for third pouch (p3) axial identity. B E11: Initiation. Rudiment outgrowth 
beings  at  E11.  The  Hox-Pax-Eya-Six  cascade  is  required  in  the  endoderm 
(yellow); Hoxa3, Eya1 and Six1 might also be required in NCCs. C E11.5-12.5: 
Outgrowth and Patterning of the Rudiment. Regionalisation of the rudiment 
into thymus- and parathyroid-specific domains. Patterning begins at E10 with the 
expression of GCM2 (red) in the third pouch, controlled at least in part by the 
Hox-Pax-Eya-Six  cascade.  High-level  expression  of  Fonx1  (blue)  begins  at 
E11.25.  D  E12.5  Separation  from  the  Pharynx  and  Migration  of  the 
Rudiment.  Pax9,  Alk5,  FRS2α  and  possibly  FGF  and  BMP  expression  is 
required for separation from the pharynx. Pax3, FRS2α and Alk5 are required for 
the  separation  of  the  parathyroid  and  thymus  domains.  Migration  might  be 
controlled by Hox3 genes expressed by NCCs. (Adapted from Figure 5 of (85)). 
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Figure 1.2: Thymus structure and T cell development. The thymus is broadly 
divided into two histologically defined regions, the cortex and medulla, each of 
which contains several different thymic epithelial cell (TEC) subtypes. In adults, 
T-cell precursors enter the thymus through the cortico-medullary junction, and 
then  begin  a  highly  ordered  differentiation  programme,  which  is  linked  to 
migration through the thymic stroma. Thus, uncommitted progenitors, CD4
-CD8
- 
double negative (DN) 1 cells are found near the cortico-medullary junction; cells 
differentiate to the DN2 stage and undergo a proliferative clonal expansion; T-cell 
lineage commitment and onset of TCR β-chain rearrangement occurs in DN3 
cells;  and  the  transition  from  DN  to  CD4
+CD8
+  DP  status
  occurs  near  the 
subcapsule.  DP  cells  then  migrate  back  through  the  cortex  and,  having 
differentiated into either CD4
+ or CD8
+ single positive (SP) cells, into the medulla. 
Positive  selection  occurs  mainly  in  the  cortex,  and  requires  cortical  TECs, 
whereas negative selection occurs mainly in the medulla, and is mediated by 
medullary  TECs  and  peripheral  dendritic  cells  (DCs).  SP  cells  that  have 
completed  the  differentiation  programme  egress  from  the  medulla  to  the 
periphery through the blood vessels. (Adapted from Figure 1 of (85)). Chapter One 
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Figure 1.3: The process of Neurulation. A Shortly after gastrulation, the neural 
plate (yellow) is open. B The neural plate folds, bringing together the neural folds 
(blue). C The neural folds fuse, forming the neural tube (yellow). D Neural crest 
cells (NCCs; blue) delaminate away from the neural tube. (Adapted from Figure 1 
of (300)). Chapter One 
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Figure  1.4:  Schematic  of  Eph  receptors  and  ephrin  ligands.  A  ephrin-A 
ligands  are  attached  to  the  cell  surface  through  a  glycosylphosphatidylinositol 
(GPI)-anchor.  The  ephrin-B  ligands  are  transmembrane  proteins  with  a  short 
conserved cytoplasmic region consisting of a PDZ-binding motif and a kinase 
domain.  Both  classes  of  ephrins  have  an  extracellular  Eph-receptor-binding 
domain. EphA and EphB transmembrane receptors consist of an ephrin-binding 
domain, a cystein rich region, two fibronectin type-III domains. The cytoplasmic 
part of the receptors contain a juxtamembrane segment, the kinase domain and 
a sterile α-motif (SAM). It is important to note that signalling may occur both in 
trans  and  in  cis.  Not  to  scale.  (Adapted  from  Figure  1  of  (157)).  B  There  is 
promiscuous  binding  of  Eph  receptors  and  ephrin  ligands.  Interaction  of  high 
affinity are indicated in bold; weaker affinities with dashed lines. (Adapted from 
(301)). Chapter One 
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Figure 1.5: Downstream signalling pathways of EphB receptors. A simplified 
schematic of some of the effectors that bind to EphB receptors are indicated. 
Pathways of the left are predominantly involved in repulsion, whilst those on the 
right concern adhesion. (Adapted from (301, 302, 144)). Chapter One 
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Table  1.1:  Summary  of  mutant  mice  with  known  thymic  and  parathyroid 
defects.  Table  of  mice  with  thymic  and  parathyroid  defects,  detailing  which 
genes are disrupted and the associated thymus/parathyroid phenotype.  Chapter One 
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Table 1.2: Eph/ephrin expression in the murine thymus. Table describing the 
pattern and timing of Class A and B Eph receptor and ephrin ligand expression in 
the thymus. Chapter One 
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Thymus/Parathyroid Phenotype  Ref 
Hoxa3




Thymic hypoplasia and mild thymocyte 
defects; Pax1/Pax9 double mutants have 
defective pouch formation 
(4) 
Pax9 
Thymus is ectopic and hypoplastic, 





Thymus is ectopic due to delayed 
separation, abnormal boundary between 










Hypoplastic thymi, delayed separation from 






Ectopic, hypoplastic thymi, due to delayed 
separation of the thymus/parathyroid 
primordia from the pharynx 
(5) 
Pbx1 
Absent or hypoplastic primordia, delayed 
expression of organ-specific markers, 
reduced proliferation of TECs 
(249) 
Eya1 
Failure of initial thymus and parathyroid 
organogenesis 
(7) 
Six1  Patterning of the third pouch into thymus  (8) Chapter One 
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and parathyroid domains occurs normally, 
but there is a failure to maintain Gcm2 and 
Foxn1 expression, thus complete 
disappearance of the thymus/parathyroid 
by E12.5 
Foxn1 
Initial development of the thymus is normal, 
but arrests at E11.5-E12.5, no colonisation 
of primordium by lymphocytes 
(89, 293-295) 
Tbx1  Thymic aplasia or severe hypoplasia  (296) 




Ectopic thymi and delayed separation of 




Ectopic thymus, hypoplastic parathyroid, no 
separation from the pharynx and of thymus 
and parathyroid from each other 
(26) 
FGF8 
Thymic agenesis or ectopia, delayed 
separation from the pharynx 
(298) 
BMP  Hypoplastic and ectopic thymus  (299) 
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Pattern of Expression  Timing  Ref 
EphA1  Low levels on stromal cells in 
medulla. (not on thymocytes) 
Adult  (135) (284, 285)  
EphA2  Low levels on stromal cells in 
medulla (not on thymocytes). 
Dendritic cells 
Adult  (135) (286, 287)  
EphA3  SP Thymocytes and stromal cells 
in medulla 
Adult  (135) (251, 288) 
EphA4  SP thymocytes  Adult  (135) 
EphA5  (Not on thymocytes)  Adult  (135, 251) 
EphA6  All thymocyte subsets  Adult  (135) 
EphA7  Stroma of cortex and subcapsule, 
all thymocyte subsets 
Adult  (135) 
EphA8  Stroma of subcapsule, scattered 
SPs in medulla 
Adult  (135) 
ephrin-
A1 
Subcapsula region, less in cortex, 
not in the medulla. All thymocyte 







Throughout the thymus, but less in 
the medulla. All thymocyte 
subsets. 
Adult  (135, 251) 
ephrin-
A3 
All thymocyte subsets.  Adult  (135, 251) 
ephrin-
A4 
All thymocyte subsets.  Adult  (135) 
ephrin-
A5 
Most highly expressed in 
subcapsule, less in vicinity of the 
blood vessels, not in the medulla. 
All thymocyte subsets. 
Adult  (135) (251) 
EphB1  Dendritic cells. Broadly detected in 
thymus 
Adult  (288, 289) 
EphB2  Total thymocytes, thymic 
epithelium (cortex and medulla) 
stroma and thymocytes 
Foetal and 
adult 
(132, 191, 195) 
EphB3  Total thymocytes, thymic 
epithelium (cortex and medulla) 




EphB4  Broadly detected in thymus  Adult  (290) 






(133, 134, 252) 






Total thymocytes, thymic 
epithelium (cortex and medulla) 
stroma and thymocytes 
Foetal and 
adult 




Total thymocytes, thymic 
epithelium (cortex and medulla) 
stroma and thymocytes. Less in 
cortico-medullary junction. 
Monocytes and macrophages 
Foetal and 
adult 
(136, 138, 140, 
191, 291, 292) 
ephrin-
B3 




Adult  (136, 138, 140)  
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2.1 Chemicals and Reagents 
 
Chemicals  were  obtained  from  Sigma-Aldrich  and  VWR  International  Ltd. 
Antibodies  were  purchased  from  Invitrogen,  eBiosciences,  R&D  systems, 
Abcam,  BD  Pharmingen,  DAKO,  BD  Biosciences  and  Sigma-Aldrich  (see 
Table  2.1).  Microscope  slides,  coverslips,  and  other  microscopy  supplies 
were obtained from Agar Scientific and MatTek. Tissue culture plastics were 
obtained  from  Corning-Costar,  Nalge  Nunc  International  and  Beckton 
Dickinson. Media, Foetal Calf Serum and other supplements were obtained 
from  GlobePharm,  Gibco  and  Sigma-Aldrich.  Proteinase  K,  PCR  and  gel 
electrophoresis reagents were purchased from Thermoscientific, Amersham 
Biosciences,  Biowhitaker  Molecular  Applications  and  Sigma-Aldrich. 
Custom-made oligonucleotides were obtained from Eurofins MWG Operon 




Wnt1-Cre  (198),  Sox10-Cre  (199),  IL7-Cre  (200),  Rosa26
eYfp  (201), 
EphrinB2
Lx/Lx  (202),  DIP-R  (Williams  A,  PhD  Thesis  2007),  and  C57BL/6 
mice  were  bred  at  the  animal  facilities  in  MRC-NIMR.  EphrinB2
ΔV/ΔV, 
EphrinB2
5Y/5Y  (203)  and  PDGFRβ
-/-  (204)  mice  were  bred  at  the  animal 
facilities in the London Research Institute, Cancer Research UK, London. All 
mice  were  bred  and  kept  under  specific  pathogen  free  conditions. Chapter Two 
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Experiments  were  carried  out  according  to  the  UK  Home  Office  rules  for 
animal experimentation. 
 
2.3 Genomic DNA preparation 
 
5mm  of  tail  was  clipped  and  put  into  a  sterile  eppendorf  tube  containing 
500µl of tail lysis buffer and 10µl proteinase K (10mg/ml), and incubated at 
55ºC overnight. After centrifugation at 13000rpm in a benchtop centrifuge for 
30 minutes, the supernatant was transferred to a fresh tube and mixed with 
1ml isopropanol at -20ºC for 10 minutes to extract the DNA. After a second 
centrifugation step, the supernatant was removed and 70% ethanol added to 
wash the remaining pellet. The pellet was resuspended in double distilled 
H2O  to  a  concentration  of  100ng/µl,  as  determined  by  spectrophotometry 
according to the following formula; 
  [DNA]ug/ul = (Abs 260x50xdilution) / 1000 
 
Tail Lysis Buffer; 




100ng of DNA was added to a mix of 1x Reaction Buffer IV, 10nm dNTP’s, 
25mM magnesium chloride solution, 50pmol/µl of each appropriate primer in Chapter Two 
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a  final  volume  of  20µl  (See  Table  2.1  for  PCR  primers).  The  PCR  was 
carried out in a DYAD PCR machine and the products analysed by agarose 
gel electrophoresis. 
 
2.5 Agarose Gel Electrophoresis 
 
1% agarose gels were prepared by heating agarose powder in 1xTAE until 
boiling, and then adding 0.5µg/ml ethidium bromide. Orange G Loading Dye 
was added at 1:5 volume of PCR products and loaded into an agarose gel 
and run horizontally submerged in a tank containing 1x TAE at 85V. DNA 
bands were observed and photographed under short wave UV light. 
 
50x TAE 
2M Tris-Acetate, 100mM EDTA pH 8.0 
 
Orange G Loading Dye 
20% ficoll, 110mM Tris-HCl, pH 7.5, 0.25% (w/v) Orange G Dye 
 
2.6 BrdU administration 
 
Pregnant female mice were given a pulse of one intraperitoneal injection of 
BrdU (66µg/g of mouse) or PBS at E13.5, E14.5 or E15.5. Embryos were 
recovered  two  days  later,  and  microdissected  to  remove  the  thymic Chapter Two 
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rudiment.  After  fixation  in  4%  PFA  for  30  minutes  at  RT,  thymi  were 
incubated with 2M hydrochloric acid and washed with borate buffer before 




  6.18g boric acid; 1L H2O, pH 8.5. 
 
2.7 Whole-mount Immunohistochemistry 
 
Embryos and organs were fixed in 4% PFA at 4ºC and washed in 0.15% 
PBS-Triton-X100.  100µm  sections  were  cut  after  embedding  the  fixed 
organs  in  8%  agarose  and  using  a  Vibratome  (Leica  Microsystems). 
Sections  were  washed  and  blocked  in  10%  serum  (species  of  serum 
appropriate to the secondary antibody used) and subsequently stained with 
antibodies (See Table 2.2). Embryos negative for Cre resulting from Wnt1-
Cre;Rosa26
eYfp x C57Bl/6 breedings were stained with an antibody detecting 
eYFP  and  used  as  negative  controls.  Background  autofluorescence  was 
collected  by  excitation  with  488nm  laser  and  emission  collected  between 
490nm and 515nm. 
 
Paraformaldehyde; 
  4g PFA powder; 90ml H2O; 10ml 10x PBS. pH 7.3 with HCl. Chapter Two 
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8% Agarose; 
  4% low melting point agarose; 4% high melting point agarose; H2O. 
 
2.8 Frozen section preparation and staining 
 
Tissues were embedded in Optical Cutting Temperature (OCT) compound 
(Tissue-Tek, VWR), snap frozen on dry ice and stored at -80ºC. Sections 
(10µm) were cut using a cryostat (Leica CM1900) and collected onto poly-L-
lysine  coated  glass  slides.  Sections  were  air  dried  for  20  minutes  before 
being  fixed  for  two  minutes  in  100%  acetone  (-20ºC)  and  air  dried  for  a 
further 20 minutes. Sections were blocked in 5% serum and subsequently 
stained with antibodies. Slides were rinsed with water and air dried before 




Embryonic and adult tissues and organs were stained in wholemount using 
antibodies described in Table 2.1. Tissues were fixed in 4% PFA at 4ºC, 
washed in 0.15% PBS-Triton-X100 prior to blocking non specific antibody 
staining with serum of species appropriate to the secondary antibody used. 
Samples  were  incubated  with  primary  antibody  for  4  hours  at  room 
temperature, or at 4ºC overnight. After washing, the samples were stained Chapter Two 
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with a fluorescently labelled secondary antibody, washed and fixed with 4% 
PFA. Fluorescence was detected by stereo or confocal microscopy  
 
Stereo Microscopy 
eYFP expression was analysed using a Zeiss M2Bio (Carl Zeiss) stereo-
fluorescent  microscope.  Pictures  were  acquired  with  an  Orca  ER 
(Hammamatsu)  camera  and  Open  Lab  software  (Improvision).  eYFP 
expression was analysed using a wide band GFP filter cube (470/500LP) 
(Krammer  scientific)  with  Green  (525)  and  Red  (630)  filters  (Chroma). 
Images were merged in OpenLab (Improvision) and contrast enhanced in 
Photoshop (Adobe). 
 
Confocal Microscopy  
For detection of immunofluorescence, samples were analysed using a Leica 
SP2 confocal, or Leica AOBS confocal microscope (Leica). Tissue stained in 
wholemount was dehydrated in methanol and optically cleared using Benzyl 
Alcohol and Benzyl Benzoate (BABB, 1:2 dilution) before imaging. Confocal 
images are presented as single sections, as a merge of a number of serial 
sections, or a three-dimensional rendering of many serial sections. Three-
dimensional renderings were generated in Volocity software (Improvision). 
 
2.10 Cell Migration assay 
 Chapter Two 
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Foetal thymic lobes were isolated from E13.5 Wnt1-Cre;Rosa26
eYfp embryos 
obtained  from  timed  matings  of  Wnt1-Cre;Rosa26
eYfp  heterozygous  males 
with  C57BL6  females  and  Ef.B2
-/-;Wnt1-Cre;Rosa26
eYFP    embryos  from 
EF.B2
Lx/-  with  Ef.B2
Lx/Lx;Wnt1-Cre;Rosa26
eYFP  breedings.  Transgenic 
embryos  were  identified  by  YFP  expression  as  observed  by  stereo 
microscopy.  The  lobes  were  digested  with  1mg/ml  Collagenase  D  in  Air 
Buffered Iscove’s Modified Dulbecco’s Medium (AB-IMDM) at 37ºC for 30 
minutes, washed and resuspended in 250µl IMDM supplemented with 10% 
heat  inactivated  Foetal  Calf  Serum  (FCS),  2mM  L-Glutamine,  0.06mg/ml 
penicillin  and  0.1mg/ml  streptomycin.  Glass  bottom  culture  dishes  were 
incubated  with  medium  at  37
oC  for  15  minutes  and  then  removed  by 
aspiration. 250uL of single-cell suspension prepared from foetal thymi was 
added to each microwell onto the glass surface. The cells were left to attach 
to the glass by incubation at 37
oC for 1 hour. Subsequently, 2mL of medium 
was added to the dish and cultured for two hours or overnight. Subsequently, 
the  medium  was  removed,  washed  twice  and  incubated  with  serum-free 
medium  for  two  hours.  Cell  movements  were  imaged  with  a  DeltaVision 
widefield  fluorescent  imaging  system  for  four  hours  and  analysed  with 
softWoRx  (Applied  Prescision)  and  Volocity  (Improvision)  software 
packages.  Results  are  presented  as  total  displacement  and  meandering 
index, a measurement of directional movement where 1 = migration in one 
direction and 0 = totally random movement. 
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2.11 Foetal Thymic Organ Culture 
 
Foetal thymic lobes were isolated from E13.5 Wnt1-Cre;Rosa26
eYfp embryos 
obtained  from  timed  matings  of  Wnt1-Cre;Rosa26
eYfp  heterozygous  males 
with C57BL/6 females (198). Transgenic embryos were identified by eYFP 
expression.  Lobes  were  transferred  to  Nucleopore  polycarbonate 
membranes  and  cultured  at  37ºC,  5%  CO2  in  Roswell  Park  Memorial 
Institute (RPMI)-1640 supplemented with 10% heat inactivated FCS, 2mM L-
glutamine,  0.06mg/ml  penicillin,  0.1mg/ml  streptomycin,  and  50µM  2-
Mercaptoethanol. Inhibitors of blood vessel development, DC101 antibody 
and  Sunitinib  Malate,  were  added  at  40µg/ml  and  50ng/ml  respectively. 
Biotinylated  anti-human  CD2  (IgG1)  40µg/ml  was  used  as  a  control  for 
DC101. Negative control for Sunitinib Malate was no addition of biochemical 
inhibitor. The lobes were left in culture for four days before fixation in 4% 
PFA  at  RT  for  15  minutes.  Subsequently,  the  lobes  were  stained  with 
antibodies and imaged by confocal microscopy. 
 
2.12 Whole Organ Culture 
 
Thymic  rudiments  from  E13.5  control  Wnt1-Cre;Rosa26
eYfp  and  mutant 
Ef.B2
Lx/Lx;Wnt1-Cre;Rosa26
eYFP embryos were dissected and embedded into 
a collagen gel. The collagen gel was prepared by diluting a concentrated 
stock of collagen in acetic acid and 10x DMEM to the desired concentration Chapter Two 
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(1mg/ml). Using an aliquot of the appropriate volume of the diluted collagen 
solution, the pH was neutralised to pH7.5 with 1M sodium hydroxide. 500µl 
of neutralised collagen stock was pipetted into a 8-multi-well slide. The thymi 
were embedded into the collagen and left to set for 2 hours at 4ºC. The gels 
were  then  incubated  for  48  hours  at  37ºC  before  fixing  with  4% 
paraformaldehyde  for  15  minutes.  The  paraformaldehyde  was  quenched 
with 0.15M glycine for 10 minutes before washing three times in PBT for 10 
minutes  each.  Once  washed,  the  gels  were  stained  with  an  anti-eYFP 
antibody  as  described  for  whole-mount  staining,  and  imaged  by  confocal 
microscopy. 
 
Collagen Gel (5ml); 
  500µl 10x DMEM (with sodium bicarbonate) 
648µl Rat tail Collagen Type I (9.03mg/ml) 
3.852ml 0.02M acetic acid 
 
PBT; 
  0.1% Triton X-100 in phosphate buffered saline 
 
2.13 Flow Cytometry 
 
Single  cell  suspensions  were  obtained  from  the  thymus  or  spleen  by 
digestion with 1mg/ml collagenase D for 1 hour at 37
oC, or mashing through Chapter Two 
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a cell strainer. 1x10
6 cells were stained in 100ul ice-cold PBS supplemented 
with  0.5%  BSA  and  0.02%  sodium  azide.  Cells  were  incubated  with 
appropriate antibodies for 30 minutes on ice before washing twice with 100ul 
PBS  azide  (See  Table  2.1  for  list  of  antibodies).  Prior  to  staining  with 
intracellular  antibodies,  cells  were  fixed  in  2%  paraformaldehyde  and 
permeabilised  with  90%  Methanol.  Samples  were  acquired  on  a  FACS 
Calibur (BD Biosciences) with Cellquest software and analysed in FlowJo 
(TreeStar). 
 
2.14 Embryo preparation 
 
C57BL/6  females  were  mated  with  Wnt1-Cre;Rosa26
eYFP  males,  and 
EF.B2
Lx/-  females  were  mated  with  Ef.B2
Lx/Lx;Wnt1-Cre;Rosa26
eYFP  males, 
and the embryos dissected and collected at 11.5 – 13.5 days of gestation. 
The  litter  was  screened  by  stereomicroscopy  to  detect  YFP
+  transgenic 
embryos. Tails were taken from the embryos and digested with Proteinase K 
(PK) to extract DNA for genotyping. The embryos were fixed with 4% PFA at 
4ºC  overnight,  then  washed  in  PBS  containing  0.1%  Triton-X  100  three 
times,  dehydrated  in  increasing  concentrations  of  methanol  in  PBS  and 
stored at -20ºC. 
 
2.15 Probe preparation 
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DNA sequences from FoxN1 and GCM2 genes were ligated into polylinker 
sites of pBSII SK and T-Easy (Promega) vectors respectively. The vectors 
were linearised at a suitable site and “run-off” transcripts were produced by 
PCR incorporating DIG labelled UTP. 
 
 
2.16 In situ Hybridisation 
 
Embryos and tissues were fixed in 4% PFA at room temperature. Fixation 
times varied depending on the thickness of the tissue sample, or embryonic 
stage.  Embryos  were  washed  in  PBT  three  times  over  15  minutes  and 
incubated in 6% hydrogen peroxide for 1 hour at room temperature. Samples 
were  washed  three  times  over  15  minutes  and  incubated  in  10µg/ml 
proteinase K in PBT at room temperature. The activity of proteinase K was 
quenched by incubating the samples with 2µl/ml glycine in PBT and fixed in 
0.2% gluteraldehyde in 4% PFA for 20 minutes at room temperature. The 
samples  were  incubated  in  hybridisation  buffer,  which  was  prewarmed  to 
70ºC,  for  one  hour  at  70ºC.  The  samples  were  then  transferred  to  fresh 
hybridisation buffer with 10mg/ml torula yeast RNA, 10mg/ml herring sperm 
DNA and DIG labelled denatured probe (1:100-1:200 dilution) and incubated 
at 70ºC overnight in a humidified chamber. 
 
The  samples  were  washed  twice  in  solution  I  for  30  minutes  at  70ºC, 
followed by one wash with solution I:II for 10 minutes at 70ºC, three washes Chapter Two 
 
  87 
with solution II for 5 minutes each at room temperature before two 30 minute 
incubation steps with RNAase A (100µg/ml) in solution II at 37ºC. After the 
second incubation step, the samples were washed once with solution II, then 
once with solution III for 5 minutes at room temperature, followed by two 
washes  with  solution  III  for  30  minutes  at  65ºC.  The  samples  were  then 
washed three times with TBST, each for 5 minutes at room temperature and 
preblocked with 10% sheep serum in TBST for 1 hour at room temperature. 
The samples were incubated overnight rocking at 4ºC with anti-DIG-AP FAB 
fragments (1/2000 dilution) in 1% sheep serum in TBST.  
 
PBT; 
  Phosphate buffered saline; 0.1% tween 20. 
 
Hybridisation buffer; 








  20ml 5M NaCl; 2ml 1M Tris pH7.5; 200µl Tween 20 ; 177.8ml H2O. Chapter Two 
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Solution III; 
  10ml Formamide; 2ml 20x SSC pH4.5, 8ml H2O. Prewarmed. 
 
TBST; 
  4g NaCl; 0.1g KCl; 12.5ml 1M Tris pH7.5; 0.1% Tween 20 in 500ml 
H2O. 
 
Following  overnight  incubation,  the  samples  were  washed  six  times  with 
TBST for one hour each at room temperature, and then overnight at 4ºC, 
rocking.  
 
After washing overnight, the samples were washed with NTMT three times 
for 10 minutes each at room temperature, then incubated with 4.5µl NBT and 
3.5µl BCIP per ml of NTMT in the dark at room temperature. The reaction 
was stopped with two washes with NTMT, then washed with  PBT before 
fixation  with  4%  PFA  in  0/1%  gluteraldehyde  and  transferred  to  0.1% 
PFA/PBT. Sections were cut and imaged by wide-field light microscopy. 
 
NTMT; 
  3ml 5M NaCl; 15ml 1M Tris pH9.5, 7.5ml 1M MgCl2 ; 150µl Tween 20; 
124.35ml H2O. 
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Table 2.1. Antibodies used in Immunohistochemistry and Flow Cytometry Chapter Two 
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Table 2.2 PCR Primers for Genotyping Chapter Two 
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 Antibodies 
 
Antibody  Conjugate  Company 
BrdU  Alexa Fluor 568  Invitrogen 
GFP  Alexa Fluor 488, 594, 647  Invitrogen 
Endomucin  Un-conjugated  Prof D. Vestweber 
αSMA  Cy3  Abcam 
PDGFRα  Biotinylated  R&D Systems 
PDGFRβ  Biotinylated  R&D Systems 
Anti-rat IgG  Alexa Fluor 488, 594  Invitrogen 
Anti-mouse IgG  Alexa Fluor 568, 594  Invitrogen 
Anti-rabbit IgG  Alexa Fluor 594  Invitrogen 
CD31  Un-conjugated  BD Pharmingen 
PanK  Un-conjugated  Dako 
CD45  PE  eBiosciences 
MHCII  PE  BD Biosciences 
CD31  APC  eBiosciences 
Ng2  Un-conjugated  Sigma-Aldrich 
Anti-mouse IgG  PE  eBiosciences 
Streptavidin  APC  eBiosciences 
Streptavidin  PE  eBiosciences 
Anti-DIG-AP Fab 
Fragments 
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In this chapter, the current hypothesis that NC derived cells only 
play  an  important  role  in  the  early  stages  of  thymus 
organogenesis,  and  are  lost  or  replaced  by  cells  of  other 
mesenchymal  origin  at  later  stages,  is  challenged.  Instead, 
evidence is presented which shows that NC derived cells persist 
in the thymus beyond birth and remain there up to nine to ten 
months of age. Moreover, these cells differentiate into pericytes 
and smooth muscle cells and surround blood vessel endothelium, 
indicating a further role of NC derived cells in thymic blood vessel 
development and function.  Chapter Three 
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3.1 Experimental Rationale 
 
Neural  crest  cells  (NCCs)  have  been  shown  to  play  a  major  role  in  the 
formation of the thymic rudiment. NCCs migrate extensively from the neural 
folds and contribute to various cell populations in different tissues throughout 
the embryo (112, 113, 122). Interestingly, NCCs were shown to contribute 
also  to  connective  tissues  in  the  thymic  capsule  and  to  surround  blood 
vessels inside the thymus of chick-quail chimeras (13).  
 
Between  E9.5  and  E12.5  the  development  of  the  murine  thymus  is 
dependent  upon  interactions  between  epithelial  and  neural  crest  (NC) 
derived cells. NC derived mesenchyme stimulates proliferation and possibly 
also  the  maturation  of  epithelial  cells,  which  upon  differentiation  express 
among  other  molecules,  SCF,  Delta-Like  Ligand  4  (DII4)  and  Immune 
response (Ia) antigen, required for T cell development (126). Additionally, 
Revest et al have shown that fibroblast growth factors (FGFs), which are 
expressed  by  mesenchymal  cells,  are  important  signalling  molecules  in 
thymic  development  (108).  These  authors  showed  that  in  the  absence  of 
FGFs  growth  of  the  thymus  is  impaired  due  to  a  lack  of  epithelial  cell 
proliferation. Furthermore, in vitro foetal thymic organ culture experiments 
have shown that NC derived mesenchyme might also be required for the 
differentiation  of  lymphoid  progenitors  into  functional  T  cells  (128).  These 
authors have shown that whilst epithelial cells can support the later stages of Chapter Three 
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T cell development, mesenchymal cells are required for their development 
beyond the CD4
- CD8
- double negative stage. 
 
The functional importance of NC derived cells during thymus organogenesis 
has  been  further  suggested  by  experiments  in  which  their  removal  or 
reduction  in  the  pharyngeal  region  results  in  greatly  reduced  size  or 
complete  absence  of  the  organ  (122).  Notably,  normal  expansion  of  the 
epithelial compartment does not occur, if NC derived cells are absent (123). 
However, it has been reported, based on tissue specific heritable genetic 
labelling,  that  once  epithelial  cells  have  fully  gained  the  competence  to 
support  lymphocyte  differentiation,  and  the  vasculature  of  the  thymus  is 
complete,  the  contribution  of  NCCs  to  the  thymus  is  greatly  reduced  or 
absent  (120,  121).  Thus,  although  it  has  previously  been  shown  that  NC 
derived cells are critically important for the normal development and function 
of  the  thymus,  there  is  controversy  regarding  their  role  beyond  the  early 
stages of organogenesis.  
 
3.2 Experimental Strategy 
 
To  dissect  the  contribution  of  NC  derived  cells  in  thymus  development  a 
tissue  specific  heritable  genetic  labelling  system  was  used.  Thus,  Cre 
recombinase was expressed under the control of either the Wnt1 (198) or 
Sox10  (199)  promoter  and  regulatory  elements,  and  Cre  activity  was Chapter Three 
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reported via activation of a ‘silent eYFP’, in which the eYfp gene preceded by 
a triple polyadenylation signal flanked by two loxP sites is knocked into the 
Rosa26  locus  (201)  (Figure  3.1).  As  Wnt1  and  Sox10,  and  consequently 
Cre,  are  expressed  in  the  neural  plate  where  NCCs  originate  (113,  199, 
205), the latter cells will have the transcriptional stop in front of the eYfp  





3.3.1 NC derived cells in foetal and adult mice 
  
In order to determine the pattern of eYFP expression in Wnt1-Cre;Rosa26
eYfp 
reporter mice, both embryonic and three month old mice were analysed by 
stereo  and  confocal  microscopy.  At  day  13.5  of  embryonic  development 
(E13.5) eYFP
 is expressed in the craniofacial region (Figure 3.2A, left) and in 
the neurons in the trunk of the embryo (Figure 3.2A, left and right). In the 
thoracic cavity at E15.5, eYFP expression is detected on the aorta and other 
arteries  derived  from  the  pharyngeal  arches  (not  shown),  as  well  as  the 
thymic rudiment (Figure 3.2B, left). Analysis of E15.5 Rosa26
eYfp embryos, in 
which Cre is not expressed under the control of the Wnt1 promoter, showed 
no eYFP
+ cells in the thymus indicating specific activation of the reporter 
only in mice which express Cre (Figure 3.2B, right). Chapter Three 
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In the three month old mouse, eYFP expressing cells are seen in craniofacial 
bones and tissues (Figure 3.2C, left), as well as in peripheral nerves (Figure 
3.2C, right). Similar patterns of expression were observed in another reporter 
mouse in which eYFP is also expressed by NC derived cells following Cre 
expression under the control of NC specific promoter from the Sox10 gene 
(not shown). These analyses showed that eYFP expression in tissues and 
organs from embryonic and three month old Wnt1-Cre;Rosa26
eYfp mice is 
restricted to NC derived tissues as previously described (120, 198, 206). 
 
 3.3.2 NC derived cells in the foetal and newborn thymus 
 
To follow the kinetics of colonisation of the thymic rudiment by NC derived 
cells, the pattern of eYFP expression in Wnt1-Cre;Rosa26
eYfp E13.5, E15.5, 
E17.5 embryos and newborn mice was examined. At E13.5, some eYFP
+ 
cells  are  present  inside  the  thymus,  but  most  are  located  at  the  capsule 
(Figure 3.3A). At E15.5, eYFP
+ cells are again found mainly at the capsule, 
but their frequency is increased inside the thymic rudiment, where they form 
trabeculae  that  appear  to  extend  from  the  capsule  into  the  parenchyma 
(Figure 3.3B). At E17.5, eYFP
+ cells are still found at the periphery of the 
thymus,  while  those  within  the  organ  have  organised  into  a  three-
dimensional network (Figure 3.3C). Examination of sections from newborn 
Wnt1-Cre;Rosa26
eYfp thymi showed that eYFP
+ cells are still present within Chapter Three 
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the  organ,  with  many  still  associated  with  the  capsule  (Figure  3.3D).  No 
eYFP
+  cells  were  detected  in  the  embryonic  or  newborn  thymus  of  non-
transgenic mice. Thus, NC derived cells enter the thymic rudiment before 
E13.5, remain there throughout gestation and are still present in the newborn 
thymus. 
 
3.3.3 NC derived cells in the adult thymus 
 
To determine if cells derived from the NC persist in the thymus beyond birth 
the  distribution  of  eYFP
+  cells  in  three  month  old  Wnt1-Cre;Rosa26
eYfp 
thymus was analysed. eYFP expressing cells are readily detectable in the 
adult thymus at this age, forming a three dimensional network (Figure 3.4, 
left), with fewer cells found at the capsule than at embryonic stages. High 
magnification  confocal  analysis  of  thymus  sections  from  three  month  old 
mice showed that most cells are associated with structures reminiscent of 
vascular  networks  (Figure  3.4,  right).  Measurement  of  the  diameter  of 
vessel-like  structures  shows  that  cells  expressing  eYFP  are  found  in 
association with vessels ranging from 4.5 to 30µm in diameter, indicating a 
contribution  to  both  capillaries  and  larger  vessels.  This  finding  suggested 
that  NC  derived  cells  in  the  adult  thymus  at  three  months  of  age  are 
intimately associated with the blood vasculature. 
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3.3.4  Migration  and  redistribution,  rather  than  proliferation,  of  NC 
derived cells is responsible for increasing numbers within the thymus 
rudiment. 
 
During  the  development  of  the  thymus  between  E13.5  and  E17.5,  the 
number of NC derived cells within the rudiment appears to rapidly increase. 
This may be due to proliferation of the NC derived cells already within the 
organ, or continued migration of NCCs from the capsule.  To determine if 
proliferation  contributes  to  thymic  colonisation  by  NCCs  during 
organogenesis, Wnt1-Cre;Rosa26
eYfp pregnant females were injected once 
with  BrdU,  or  PBS,  at  E13.5,  E14.5  or  E15.5  and  the  embryos  were 
recovered two days later. It was found that the vast majority of eYFP
+ cells 
were BrdU negative, when compared to the extensive incorporation seen in 
haemopoietic cells. This suggested that the increase of eYFP
+ cells in the 
thymus occurs mainly by influx of new NCCs and redistribution within the 
thymus (Figure 3.5). 
 
3.3.5  NC  derived  cells  are  present  within  the  organ  and  differentiate 
into perivascular cells before E13.5 
 
NC derived mesenchymal cells have been shown to contribute to connective 
tissues surrounding the thymic blood vasculature in the chicken embryo (13). 
However, their precise function in the murine thymus remains controversial. Chapter Three 
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In order to assess the kinetics of NC derived cell contribution to connective 
tissue components such as perivascular cells, sections of thymic tissue at 
different stages of embryogenesis were stained with antibodies recognising 
markers specific for endothelial cells (endomucin, (207)), pericytes (desmin, 
(208)) and smooth muscle cells (α-SMA, (209)). Endomucin, thought to be 
expressed  on  mature  endothelial  cells  (210),  is  not  detected  until  E15.5. 
(Figure 3.6A). Cells expressing this marker appear to be distinct from eYFP
+ 
NC  derived  cells.  As  mentioned  above,  a  network  of  NC  derived  cells  is 
established  in  the  organ  by  E13.5,  and  at  this  stage,  eYFP
+  cells  also 
express  the  pericyte  marker,  desmin  (Figure  3.6B).  In  contrast,  α-SMA 
expression is not detected until after E15.5, when the formation of the blood 
vessel network is complete. From this stage onwards eYFP
+ cells also start 
expressing α-SMA (Figure 3.6C).  
 
3.3.6 NC derived perivascular cells are maintained in the thymus into 
adulthood 
 
It  has  been  suggested  that  beyond  E17.5  in  thymus  organogenesis,  NC 
derived  mesenchymal  cells  are  lost  or  replaced.  However,  as  shown  in 
Figure 3.4, NC derived cells tagged with eYFP are still detected in the three 
month old organ. In order to determine the character of the persisting NC 
derived cells in the adult thymus the expression of markers for blood vessel 
endothelium,  pericytes  and  smooth  muscle  cells  was  examined,  as Chapter Three 
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described  above  in  Figure  3.6,  at  three  months  of  age.  It  is  shown  that 
eYFP
+ cells still surround endomucin expressing endothelial cells in the adult 
(Figure 3.7A and higher magnification in D) similar to the pattern observed in 
the embryonic thymus (Figure 3.6A). Since eYFP
+ cells appear to surround 
vessel structures, expression of markers associated with pericytes (desmin 
and NG2) and smooth muscle cells (α-SMA) were examined. It is shown that 
some vessel associated eYFP
+ cells also express desmin and, in separate 
stainings, α-SMA (Figure 3.7B & C). Identical patterns of expression were 
seen for endomucin, desmin and α-SMA using another mouse strain (Sox10-
Cre;Rosa26
eYfp)  which  also  expresses  Cre  in  NC  derived  cells  and  thus 
marks  all  NC  derivatives  with  eYFP  (Figure  3.8A).  Furthermore,  flow 
cytometric  analyses  of  Wnt1-Cre;Rosa26
eYfp  and  Sox10-Cre;Rosa26
eYfp 
(209,  210)  thymi  show  that  there  is  similar  expression  of  the  endothelial 
marker CD31 (0.065% and 2.93%), pericyte marker NG2 (98.8% and 98.5%) 
and smooth muscle cell marker αSMA (16.2% and 23.4% respectively) in 
these two reporter lines (Figure 3.8B). 
 
3.3.7 Age-related changes to the NCC contribution to the thymus 
 
As the mouse ages, the perivascular space between the walls of the blood 
vessels and the surrounding cells in the thymus increases, and is infiltrated 
with  adipose  tissue  and  lymphoid  cells  (211).  This  is  correlated  with  a 
reduction in the export of new T cells into the periphery. In order to assess Chapter Three 
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whether age-related atrophy is associated with a reduction in NC derived 
cells, thymi from aged mice were analysed by both immunohistochemical 
stainings, and flow cytometry. It is shown that at ten months of age, eYFP
+ 
cells  are  still  present  within  the  thymus,  and  continue  to  surround  blood 
vessel structures, but there appears to be a reduction in the number of cells 
that  co-express  desmin  and  αSMA  (Figure  3.9A).  In  order  to  confirm  the 
decrease in the contribution of eYFP cells to the perivascular cell population 
during  thymus  organogenesis  and  ageing  thymi  from  newborn,  three  and 




+ cells which express eYFP was examined. The 
percentage of CD31
+ cells that were also positive for eYFP was consistently 
low in all time points. It is shown that the percentage of NG2
+ cells which 
express eYFP decreases from 53.6% in the newborn thymus, to 42.5% at 
three months of age, and to 4.57% by nine months. At birth the population of 
αSMA
+  cells  which  expresses  eYFP  is  approximately  24.1%  of  the  total 
thymus. Similar to the results seen by confocal microscopy in Figure 3.9A, 
there is a decrease in αSMA cells which express eYFP by nine months of 
age (21.3%) (Figure 3.9B).  
 
Taken together, these results show that NC derived cells, which populate the 
thymus  during  organogenesis,  persist  in  the  adult  thymus  having 
differentiated into at least two different cell types forming part of the same 
vascular supporting network. However, as the thymus atrophies with age, Chapter Three 
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there is a reduction in the number of NC derived cells which are associated 
with the perivascular network. Since NC derived cells persist in the thymus 
beyond E17.5 and their known role in the early stages of organogenesis, NC 
derived cells may have additional functions. For example, their differentiation 





3.4.1 NC derived cells and early thymus development 
 
Interactions  between  endothelium  and  NC  mesenchyme  initiate  thymus 
development from the third and fourth pharyngeal pouches in the mouse. A 
number of experiments have shown that, if the contribution from the NC is 
absent,  either  by  ablation  of  the  neural  folds  when  they  form  or  by 
enzymatically  stripping  mesenchyme  from  the  capsule  of  the  E12  thymic 
rudiment,  the  thymus  is  severely  hypoplastic  or  absent  (122,  123).  It  is 
widely accepted that the main role of NC derived cells in the thymus occurs 
during  early  organogenesis,  where  they  stimulate  the  proliferation  and 
maturation of epithelial cells through FGF signalling (108). This conclusion 
was  based  on  experiments  that  showed  that  thymic  lobes  devoid  of 
mesenchyme did not grow and become lobulated in culture, and there was a 
three fold decrease in BrdU incorporation in the epithelial cell compartment Chapter Three 
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(124).  Epithelial  cells  are  required  for  the  maturation  of  T  lymphocyte 
progenitors into naïve single positive CD4
+ or CD8
+ T cells. Thus, defects in 
NC mesenchyme also have an impact on T cell output from the thymus. 
Integrin  family  members,  such  as  integrin  α4,  α5,  αV,  β1  and  β3,  were 
demonstrated to be expressed on the surface of NC derived mesenchymal 
cells  present  at  the  capsule  of  the  thymus  (121).  Thus,  a  further  role  in 
attraction  of  T  lymphoid  progenitors  into  the  rudiment  before  it  is 
vascularised, was also suggested.  
 
Chick-quail chimeras first demonstrated a contribution of NC derived cells to 
the connective tissues that surround blood vessels within the thymus (13). 
These experiments were later confirmed with lineage-tracing tools, in which 
all NC derived cells were marked by LacZ expression under the control of 
Wnt1 or P0 promoter and regulatory elements (120, 121). These analyses 
showed that NC derived cells are associated predominantly with the capsule 
of the rudiment from E11.5 until E17.5, but are lost or replaced thereafter. 
This led to the hypothesis that NC derived cells were critical to the initial 
formation  of  the  thymus,  but  once  epithelial  cells  have  fully  gained  the 
competence  to  support  thymocyte  development  and  the  vasculature  is 
complete, they are no longer required.  
 
The data presented here shows a continued contribution of NC derived cells 
in the newborn and adult thymus, even persisting up to nine to ten months of Chapter Three 
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age. These data appear to contradict previous studies, but can be explained 
by differences in the experimental approach. Jiang (120), Yamazaki (121) 
and  their  colleagues,  expressed  Cre  recombinase  under  the  Wnt1  or  P0 
promoter and regulatory elements. Cre recombinase was used to drive LacZ 
expression from the Rosa26 locus. Here, a similar strategy was used, using 
eYFP knocked into the Rosa26 locus as a marker of NC derived cells, rather 
than LacZ. The apparent difference in expression or eYFP and LacZ, despite 
being under the control of the same promoter, may be due to the high CpG 
content in the LacZ gene and thus a predisposition to methylation induced 
silencing with age (212). eYFP
+ cells are detected in the three month old 
thymus  with  identical  distribution  (around  vessels)  and  characteristics 
(expressing desmin/NG2 and α-SMA) using two independent mouse lines 
(Wnt1-Cre  and  Sox10-Cre)  each  expressing  Cre  in  a  NCC  pattern.  This 
makes it unlikely that eYFP expression is due to identical ectopic activation 
of the Cre gene. 
 
The indication that the Rosa26
LacZ reporter may be silenced highlights just 
one of the caveats of lineage tracing tools. Other limitations of these tools 
include ectopic expression of Cre on other lineages, inefficient Cre-mediated 
excision and incomplete penetrance (Williams, A. PhD Thesis 2007 UCL). In 
this report Cre expressed under the control of the Wnt1 promoter was used. 
Wnt1  is  expressed  in  the  neural  plate,  dorsal  neural  tube,  and  an  early 
migratory neural crest population. It is extinguished as cells migrate away Chapter Three 
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from  the  neural  tube  and  is  not  expressed  again  at  any  other  point  in 
development or in the adult. The mice used in this report were generated by 
insertion of Cre recombinase into the endogenous locus, and thus, is less 
likely to experience position effect variegation. When crossed to Rosa26
eYFP 
reporter  mice,  eYFP
+  cells  are  present  in  an  identical  pattern  to  that 
expected of NCCs, thus there is expression of the reporter in the craniofacial 
region,  in  peripheral  neurons  and  in  the  embryonic  thymus  (251,  221). 
Moreover, the pattern of expression seen in the Wnt1-Cre;Rosa26
eYFP mice 
was confirmed with another mouse line, Sox10-Cre;Rosa26
eYFP. Thus it is 
unlikely that silencing, inefficient deletion or incomplete penetrance affects 
both of these Cre expressing lines.  
 
The experiments that used LacZ to mark NC derived cells indicate that they 
contributed mostly to the capsule, with only a few located in the parenchyma. 
However, earlier reports using chick-quail chimeras showed that NC derived 
cells  contribute  to  connective  tissues  and  surrounded  the  blood  vessels 
throughout the rudiment. These data are in support of the latter experiments, 
since  NC  derived  cells  were  found  throughout  the  organ  from  E13.5  to 
adults. Moreover, using a marker of proliferation, BrdU, it is shown for the 
first time that very few NC derived cells are proliferating between E15.5 and 
E17.5, thus favouring a mechanism by which migration and redistribution in 
the organ contributes to the formation of a three dimensional network. 
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3.4.2 NCCs differentiate into perivascular cells 
 
 NCCs  contribute  to  most  of  the  connective  tissues  in  the  head  of 
vertebrates, including, but not limited to, neurons and glia of the autonomic 
nervous  system,  tendons,  smooth  muscle,  chondrocytes,  osteocytes  and 
melanocytes  and  the  perivascular  mesenchyme  of  the  embryonic  chick 
thymus (13). In addition, all aortic arch-derived vessels and capillaries that 
supply  the  forebrain  are  ensheathed  with  pericytes  of  NC  origin,  while 
capillaries  in  the  rest  of  the  central  nervous  system  are  associated  with 
pericytes derived from mesoderm (111). Thus, there is a clear precedent for 
NC differentiation into perivascular cells elsewhere in the embryo, including 
the  embryonic  thymus.  Our  data,  and  a  recent  report  by  Muller  and 
colleagues  (213),  using  a  similar  lineage-tracing  tool,  showed  that  NC 
derived cells were not lost from the thymus and continued to be found in the 
adult organ.  
 
Contribution to the perivascular network of cells in the thymus indicates a 
further possible role for NC derived cells in organogenesis than previously 
described. Thus, NC derived cells may direct the formation and/or function of 
the  specialised  thymic  blood  vasculature,  which  has  a  double-walled 
morphology  and  constitutes  a  blood-thymus  barrier.  The  function  of  the 
blood-thymus  barrier  is  to  prevent  developing  thymocytes  in  the  thymic 
cortex from being exposed to antigen circulating in the blood.  Chapter Three 
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Data  is  presented  here  showing  that  NC  derived  perivascular  cells  are 
located  both  at  the  capsule  and  within  the  parenchyma  at  E13.5.  Blood 
vessels are postulated to form in the thymus later, at E14, from endothelial 
sprouts  which  branch  off  vessels  nearby  the  capsule.  Since  NC  derived 
perivascular  cells  are  already  present  throughout  the  rudiment,  they  may 
play a role in attracting vessels into the parenchyma. To examine such a 
possibility,  one  would  need  to  examine  thymus  vascularisation  in  the 
absence of NC derived cell contribution. Alternatively, NC differentiation into 
perivascular  cells  may  require  signals  from  endothelial  cells.  If  the  latter 
possibility is correct, then NC differentiation would be blocked in the absence 
of thymic blood vessels. The question, as to the role in NC derived cell in 
blood vessel development, will be explored in the next chapter. 
 
NC  derived  perivascular  cells  are  eventually  replaced  by  cells  of  other 
mesenchymal origin and it is intriguing that this takes place at the same time 
as thymic involution. Since NC derived cells have not been demonstrated to 
persist  in  the  adult  thymus  until  now,  the  fate  of  these  cells  in  the  aged 
thymus is unknown. Studies examining perivascular turnover in rodents and 
humans  are  rare,  but  one  such  report  gave  the  estimate  that  30%  of 
perivascular cells were replaced during a three-month period in rats (214). 
Since NC derived cells may be replaced, a number of questions arise, such 
as; What is the origin of the cells that replace them? Does the change in Chapter Three 
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origin  affect  their  function,  and/or  the  process  of  thymus  involution?  To 
address these questions, thorough analyses of the kinetics of NC derived 
perivascular cell loss are required. Moreover, it will be necessary to trace the 
origin of the replacing cells, and assess their function in comparison to NC 
derived perivascular cells. There are a number of possible ways to do this, 
including looking at the expression profile of genes known to be required for 
vessel  function  or  adhesion  in  both  subsets  of  cells  by  microarrays,  or 
assessing their proliferation and survival in vitro. 
 
3.4.3 What happens to NC derived cells in the aged thymus? 
 
Gradual replacement of NC derived perivascular cells in aged mice by cells 
of  other  mesenchymal  origin  may  contribute  to  the  mechanism  of  thymic 
involution. Involution results in a gradual loss of structure and progressive 
increase in adipocytes, disruption of endothelial vessel walls, a decrease in 
lymphoid  progenitors  and  epithelial  cell  populations  causing  a  decline  in 
thymic output (215, 216). NC derived cells have not previously been reported 
in the aged thymus, and thus, their role in involution is unknown. Loss of NC 
derived  cells  might  contribute  to  involution  by  disrupting  the  perivascular 
network of cells that supports the vasculature. Moreover, since NC derived 
cells  are  known  to  play  a  crucial  role  in  epithelial  cell  proliferation  and 
maturation, their loss may also affect epithelial-thymocyte interactions. If this 
is the case, then re-generation of the NC derived cell compartment may be Chapter Three 
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an  attractive  candidate  for  further  research.  Interestingly,  NC  stem  cells 
(NCSCs)  are  known  to  exist  in  other  adult  tissues,  albeit  with  reduced 
potential to form different types of cells, and thus may also be present in the 
adult thymus. 
 
NCSCs have been demonstrated to exist in at least two different tissues; the 
enteric nervous system of the gut and whisker follicles of the facial skin (217-
219). Gut derived NCSC progenitors, for example, have been demonstrated 
to persist in the gut as late as postnatal day 110 in the rat (217), but their 
expression of cell surface markers and ability to self renew and differentiate 
decreases with age (217). Moreover, when NCSCs from gut or sciatic nerve 
were transplanted into the NC migratory stream of the chick embryo in vivo, 
gut NCSCs gave rise primarily to neurons, while sciatic nerve NCSCs gave 
rise  exclusively  to  glial  cells  (220).  Thymus-resident  NCSCs  may  have  a 
similar limited potential that decreases further with age. 
 
The self-renewal capacity of NC derived cells from the aged thymus could be 
assessed in vitro by neurosphere assay. This method is based on the dogma 
that stem cells and their progeny can be stimulated to proliferate when they 
are  exposed  to  certain  growth  factors  (221).  When  plated  at  appropriate 
densities, continued cell division generates a non-adherent spherical cluster 
of cells, called a neurosphere (222, 223). They can be isolated, dissociated 
and re-plated to form secondary spheres, however, to ensure they are bona Chapter Three 
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fide stem cells they must demonstrate self-renewal over an extended period 
of time and generate a large number of progeny (224). If NCSCs exist in the 
adult thymus, they could be stimulated to provide new perivascular cells and 




The contribution of NC derived cells to the embryonic and adult thymus was 
analysed using a genetic lineage-tracing tool. It was found that NC derived 
cells were not lost from the organ in late gestation as previously described. 
In contrast, here it is shown that they differentiate into perivascular cells and 
continue to be present up to nine to ten months of age. Thus, NC derived 
cells  may  have  an  additional  role  in  thymic  blood  vessel  formation  or 
function, in addition to their roles in early organogenesis.  
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Figure  1:  Wnt1  and  Sox10  Cre  expression,  and  ROSA26  reporter 
transgenes. (A) Schematic diagram of the Wnt1-Cre transgene (Adapted from 
198). Top; untargeted locus. Bottom; Transgene expressing Cre. Black and white 
boxes represent, respectively, translated and untranslated parts of Wnt1 exons. 
(B)  Sox10-Cre  reporter  transgene  (Adapted  from  (199)  and  (303)).  Top; 
untargeted  locus.  Bottom;  Transgene  expressing  Cre.  Black  and  white  boxes 
represent,  respectively,  translated  and  untranslated  parts  of  Wnt1  exons.  (C) 
Structure of the untargeted ROSA26 locus (Top), the targeted locus (Middle) and 
the  targeted  locus  after  Cre-mediated  excision  of  the  loxP-flanked  (PGK-neo, 
tpA) cassette (bottom). LoxP sites are indicated by solid arrowheads (Adapted 
from 149).   113 
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Figure 2: Expression of eYFP in fetal and adult Wnt1-Cre;Rosa26eYfp mice.  
(A) Whole-mount E13.5 Wnt1-Cre;Rosa26eYfp embryos were fixed, stained with 
an  antibody  recognizing  eYFP,  optically  cleared  with  BABB  and  analyzed  by 
confocal microscopy. Serial optical sections of the whole embryo were captured 
and  reconstituted  to  form  a  three-dimensional  rendering.  White  arrow: 
Craniofacial structures. Red arrow: Trunk neurons. (B) E15.5 thymi from Wnt1-
Cre;Rosa26eYfp  (Left)  and  wild-type  littermate  control  thymi  (right)  were 
microdissected, and analyzed by stereo microscopy. Dotted grey line indicates 
outlines  of  wild-type  thymus  lobes.  Arrow:  capsule  of  thymic  lobe.  (C)  Left: 
Location of eYFP+ cells in the craniofacial region was determined in three month 
old  Wnt1-Cre;Rosa26eYfp  mice  by  stereo  microscopy.  White  arrow:  Facial 
region.  Right:  Mice  were  further  dissected  to  reveal  expression  of  eYFP  on 
peripheral nerves. White arrow: Axons. Results are indicative of four experiments 
consisting of twelve mice.   115   116 
Figure  3:  Expression  of  eYFP  in  thymi  from  E13.5,  E15.5,  E17.5  and 
newborn Wnt1-Cre;Rosa26eYfp mice. Whole-mount E13.5, E15.5, E17.5 and 
Newborn Wnt1-Cre;Rosa26eYfp (left) and control Rosa26eYfp (right) embryos 
were  fixed,  stained  with  an  antibody  recognizing  eYFP,  optically  cleared  with 
BABB and analyzed by confocal microscopy. Serial optical sections of the whole 
embryo were captured and reconstituted to form a three-dimensional rendering.    117   118 
Figure  4:  Expression  of  eYFP  in  adult  Wnt1-Cre;Rosa26eYfp  thymus. 
Whole-mount  three  month  old  adult  Wnt1-Cre;Rosa26eYfp  thymi  were  fixed, 
stained  with  an  antibody  recognizing  eYFP,  optically  cleared  with  BABB  and 
analyzed  by  confocal  microscopy.  Left;  low  magnification,  right;  high 
magnification. White arrow; capsule. Red arrow; vessel-like structure.   119   120 
Figure 5: NCCs enter the thymus by migration and redistribution, rather 
than  proliferation.  E15.5,  E16.5  and  E17.5  Wnt1-Cre;Rosa26eYfp  embryos 
were taken from pregnant female mice that had been injected with one dose of 
BrdU two days earlier (66 micrograms per gram of mouse). Thymic rudiments 
were  dissected  from  the  embryos,  processed  as  previously  described  and 
stained  with  antibodies  against  BrdU  (red)  and  eYFP  (green).  Sections  were 
optically cleared with BABB and analyzed by confocal microscopy. White arrows: 
capsule of thymic lobe.    121   122 
Figure 6: Development of blood vessel and eYFP+ networks in embryonic 
thymus. (A, B, & C) Thymi from Wnt1-Cre;Rosa26eYfp embryos were dissected 
at  E13.5  (left  column),  E15.5  (middle  column)  and  E17.5  (right  column), 
processed as previously described and stained with antibodies recognizing eYFP 
(green),  endomucin  (red)  (A),  desmin  (red)  (B)  and  α-SMA  (red)  (C),  and 
analyzed  by  confocal  microscopy.  White  arrows:  capsule  of  thymic  lobe.  Red 
arrows: Vessels.   123   124 
Figure 7: Differentiation of eYFP
+ cells in the adult thymus. (A, B & C) Thymi 
from three month old Wnt1-Cre;Rosa26
eYfp mice were dissected, processed as 
previously described and stained with antibodies against eYFP (green) and (A) 
endomucin  (red),  (B)  desmin  (red)  and  (C) α-SMA  (red),  and  analyzed  by 
confocal microscopy. White arrows: capsule of thymic lobe. Red arrow: Vessels. 
(D) Left; middle panel of (A) with box highlighting magnified section, right. 
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Figure 8: Analysis of Sox10-Cre;Rosa26eYfp mice confirms the pattern of 
eYFP expression seen in Wnt1-Cre;Rosa26eYfp mice is specific to NCCs. 
(A) Thymi from three month old Sox10-Cre;Rosa26eYfp mice were dissected, 
processed  as  previously  described  and  stained  with  antibodies  against  eYFP 
(green), endomucin (red, left) and α-SMA (red, right). White arrows: capsule of 
thymic  lobe.  Red  arrow:  Vessels.  (B)  Thymi  from  three  month  old  Wnt1-
Cre;Rosa26eYfp (top) and six week old Sox10-Cre;Rosa26eYfp  (bottom) mice 
were  digested  with  collagenase,  stained  with  markers  recognizing  endothelial 
cells (CD31), pericytes (NG2) and smooth muscle cells (αSMA), and analyzed by 
flow cytometry. Cells were gated on eYFP+ expression and the percentages of 
CD31+, NG2+ and αSMA+ cells were calculated. 
 
Genotype and ID of mouse  % CD31  % NG2  % αSMA 
Wnt1CreR26ReYFP  0.065  98.8  16.2 
  0.12  94.1  20.8 
  0.054  97.8  17.6 
Sox10Cre-R26ReYFP  2.93  98.5  23.4 
  0.53  96.8  20.6 
  1.87  97.9  19.8 
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Figure  9:  eYFP+  cells  within  the  aged  thymus.  (A)  Thymi  from  Wnt1-
Cre;Rosa26eYfp  mice  at  10  months  of  age  were  stained  with  antibodies 
recognizing  eYFP  (green)  and  endomucin  (left),  desmin  (middle)  and  αSMA 
(right). Red arrows: vessels. (B) Thymi from Wnt1-Cre;Rosa26eYfp mice at birth, 
three months and nine months of age were collagenase digested and stained 
with antibodies recognizing endothelial cells (CD31), pericytes (NG2) and smooth 
muscle  cells  (αSMA).  The  resulting  single  cell  suspension  was  first  gated  on 
CD31, NG2 and αSMA expressing cells, and then the percentages of eYFP+ 
cells within these populations was determined.  
Age and ID of mouse  %  YFP  (of 
CD31+) 
% YFP (of NG2+)  %  YFP  (of 
αSMA+) 
Newborn  0  53.6  24.1 
  0.01  62.5  28.35 
  0  53.2  22.9 
Three months old  0.24  42.5  30.2 
  0.12  56.4  35.2 
  0.01  49.1  32.8 
Nine months old  0  4.57  21.3 
  0.18  10.9  23.5 
  0.05  5.89  19.8 
Littermate control  0  0  0 
  0  0.1  0 
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Vascularisation of the thymus is thought to occur by branching 
inwards of vessels near the capsule at E14. In contrast, here it is 
shown that endothelial precursor cells are already present within 
the thymus at E13.5. Thus, it is possible that vessel structures 
form within the thymus first, or in parallel, and then connect with 
vessels  that  branch  inwards  from  the  capsule.  NC  derived 
mesenchymal cells express both PDGFRα and β receptors during 
thymus development in the embryonic period, but downregulate 
expression  of  the  α  receptor  thereafter.  Thus,  the  change  in 
receptor expression may correlate with a change in function of NC 
derived cells, from stimulating the proliferation of epithelial cells to 
supporting the thymic blood vasculature. Chapter Four 
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4.1 Experimental Rationale 
 
Results  from  the  previous  chapter  showing  that  NCCs  differentiate  into 
perivascular cells indicate a possible role in thymic blood vessel formation 
and/or function. Blood vessels are postulated to form in the thymus at E14 
by  branching  inwards  of  epithelial  sprouts  from  nearby  vessels.  As 
vascularisation is a process resulting from the interaction of different types of 
cells, and since it was shown here that NC derived perivascular cells were 
already within the thymic rudiment by E13.5, it was possible that they have a 
role in the formation of vessel structures.  
 
Endothelial  sprouts  are  formed  by  proliferation  of  endothelial  cells  from 
existing  vessels,  and  migrate  into  the  thymus  in  response  to  angiogenic 
stimuli  such  as  vascular  endothelial  growth  factor  (VEGF)  (43).  VEGF, 
produced  by  thymic  epithelial  cells  and  mesenchymal  cells  (44),  is  an 
endothelial cell mitogen and a permeability enhancing factor that stimulates 
angiogenesis (45). Recently, it has been demonstrated that pericytes are an 
important  source  of  VEGF  and  may  migrate  ahead  of  endothelial  cells 
guiding the sprouting processes  (46). Endothelial cells  on the other hand 
produce PDGF-B that in turn attracts PDGFRβ
+ perivascular mesenchyme to 
the walls of growing blood vessels (48). Perivascular cells, such as pericytes 
and smooth muscle cells, then wrap around the vessels providing structural Chapter Four 
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support  and  regulating  endothelial  cell  function.  In  the  absence  of 
perivascular cells or PDGFRβ signalling, vessel structures are abnormal and 
prone to haemorrhage (49). Indeed, this is a characteristic of pathological 
states  such  as  oedema  and  diabetic  retinopathy,  where  vessels  appear 
abnormal and fragile (50).  
 
Of  particular  importance  to  blood  vessel  development  are  the  platelet 
derived  growth  factor  (PDGF)  family  of  molecules.  PDGF  ligands  are 
composed of a disulphide-bonded dimer of two polypeptide chains, A, B, C 
or D, either as homodimers (AA, BB, CC or DD) or heterodimers (AB only). 
Their receptors, PDGFRs, are protein tyrosine kinases and consist of two 
chains, α and β. The α receptor (αR) can bind to both PDGF-A and PDGF-B, 
whereas the β receptor (βR) binds only PDGF-B with high affinity (for review, 
see (225)). Ligand binding induces the receptors to dimerise as αα, ββ, or αβ 
pairs, resulting in a conformational change that activates the kinase domain 
and a downstream signalling cascade involving molecules that interact with 
the intracellular domain of the receptor. 
 
PDGFRα  expression  is  required  for  the  development  of  craniofacial 
structures  and  the  aortic  arch.  Mice  with  the  Ph  deletion,  a  naturally 
occurring deletion of the gene encoding the PDGFRα receptor, have thymic 
defects ranging from complete absence of the organ to the diminished size 
of  one  or  both  lobes  (226).  In  contrast,  PDGFRα  deletion  specifically  on Chapter Four 
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NCCs is less severe in terms of thymus development, and a decrease in 
organ  size  is  seen  in  only  a  few  embryos  (227).  Depletion  of  PDGFRα
+ 
mesenchyme from embryonic thymi prior to their transplantation to ectopic 
sites  results  in  the  formation  of  functional  yet  hypoplastic  thymic  tissue. 
Thus, PDGFRα is clearly required at some level for the development of the 
thymus. In contrast, the role of PDGFRβ in thymus development is unknown. 
Broad  deletion  of  the  β  receptor  is  neonatal  lethal  due  to  extensive 
haemorrhaging,  oedema  and  lack  of  kidney  mesangial  cells  (204).  These 
defects  were  attributed  to  a  compromise  in  vessel  integrity  where 
perivascular cells do not adhere to vessel walls correctly. 
 
Since  NCCs  differentiate  into  perivascular  cells,  which  are  important  for 
remodelling of the vasculature by expressing, amongst others, PDGFRs, the 
role of this signalling axis was investigated during embryonic thymic blood 
vessel development.  
 
4.2 Experimental Strategy 
 
A. PDGFRβ
-/- knock out mice 
 
In  order  to  determine  whether  PDGFRβ  signalling  has  a  role  in  thymus 
development embryos lacking this receptor were analysed. PDGFRβ
-/- mice 
were generated by replacing parts of exon 1 and 2 with a promoterless β-Chapter Four 
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geo gene in the PDGFRβ locus by homologous recombination, creating a 
null allele (204). The structure of the blood vasculature was assessed by 
staining with endothelial and perivascular markers, and imaged by confocal 
microscopy. 
 
B. Inhibition of thymic vascularisation 
 
Endothelial cells may appear before NC derived cells within the developing 
rudiment, and thus it is possible that they induce the differentiation of NCCs 
into  perivascular  cells.  In  order  to  investigate  this  possibility,  vessel 
development  was  blocked  in  foetal  thymic  organ  culture  (FTOC)  and  the 
contribution to, and differentiation of, NC derived cells within the rudiments 
were assessed. For this purpose, a biochemical inhibitor and a monoclonal 
antibody that have been demonstrated to inhibit blood vessel formation were 
used. Sunitinib Malate, an anti-angiogenic inhibitor, has been approved for 
the treatment of certain cancers. It mediates its affects by targeting multiple 
receptor  tyrosine  kinases  (RTKs),  including  PDGFRs,  VEGFs  and  KIT 
resulting in reduced vascularisation. It also targets FLT3, a receptor tyrosine 
kinase, by inhibiting its phosphorylation and thereby inhibiting proliferation 
and inducing apoptosis (228-231). DC101 is an anti-angiogenic monoclonal 
antibody  specific  for  one  of  the  VEGF  receptors,  VEGFR-2,  (encoded  by 
FLK1 in mice and KDR in humans). DC101 application to tumour bearing 
mice  first  stabilises  tumour  vessel  structures  by  increasing  pericyte Chapter Four 
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coverage. Stabilisation of vessels is followed by pericyte loss and decreased 
basement  membrane  thickness,  vessel  diameter  and  density.  The 
physiological  effect  is  a  decrease  in  microvessels,  increased  tumour  cell 
apoptosis, decreased tumour cell proliferation and extensive tumour necrosis 
(232, 233). 
 
C. Ablation of NC derived cells in mouse embryos 
 
It is equally possible that NC derived cells are present within the rudiment 
first, and direct the formation of the thymic blood vasculature. To determine 
whether  NC  derived  cells  were  required  for  the  formation  of  the  blood 
vessels  in  the  thymus,  mice  were  generated  in  which  these  cells  were 
ablated.  To  this  end,  Wnt1-Cre;Rosa26
eYfp  mice  were  crossed  to  DIP-R1 
mice,  which  carry  a  conditional  expression  construct  for  diphtheria  toxin. 
Diphtheria toxin is secreted from Corynebacterium diphtheriae and cleaved 
by the protease furin, generating two fragments; DT-A and DT-B (234, 235). 
The DT-A fragment is extremely toxic, a single molecule of the protein is 
sufficient to induce cell death, whereas DT-B is responsible for cell surface 
binding and translocation of the DT-A fragment into the cytosol (236). An 
expression construct was generated in which a transcriptional stop signal 
flanked by LoxP sites upstream of the DT-A gene, and was inserted into the 
ubiquitously  expressed  Rosa26  locus.  Transcription  of  the  cDNA  is 
prevented by the presence of the upstream triple polyadenylation signal, but Chapter Four 
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upon Cre expression under the control of the Wnt1 promoter, the stop signal 
is excised and DT-A is expressed (Williams A, Ph.D Thesis 2007). However, 
due to the extensive role of NCCs in formation of craniofacial structures and 
heart development, these embryos died at E12 and it was not possible to 




4.3.1 NC derived cells in the thymus express PDGF receptors 
 
PDGF  receptor  expression  is  characteristic  of  mesenchymal  cells  and 
binding of PDGF mitogens directs a number of processes including gene 
regulation  and  cell  cycle  control,  and  plays  a  crucial  role  in  blood  vessel 
development.  To  determine  which  cellular  compartments  express  PDGF 
receptors in the thymus, the expression of PDGFRα and β was assessed on 
perivascular  (NG2
+),  endothelial  (CD31
+),  haematopoietic  (CD45
+)  and 
epithelial (CD45
- MHC Class II
+) cell populations in thymi from three month 
old  C57BL/6  mice.  PDGFRα
+  cells  can  be  fractionated  into  different  cell 
lineages; 73.9% of perivascular cells (NG2); 11.7% endothelial cells (CD31); 
9.05% haematopoietic cells (CD45) and 6.6% thymic epithelial cells (MHC 
Class II). PDGFRβ has a similar pattern of expression; 52.6% perivascular 
cells  (NG2);  10%  endothelial  cells  (CD31);  15.5%  hematopoietic  cells 
(CD45) and 18.7% thymic epithelial cells (MHC Class II) (Figure 4.1). Thus, Chapter Four 
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PDGFRα and β are preferentially expressed by cells of mesenchymal nature 
including pericytes. 
 
In  order  to  determine  whether  NC  derived  cells  are  also  involved  in  the 
PDGFR/PDGF axis of signalling during thymic development, the expression 
of PDGFRα and PDGFRβ on thymic eYFP
+ cells, from Wnt1-Cre;Rosa26
eYfp 
embryos  and  adult  mice,  were  studied  by  flow  cytometry.  In  one  such 
analysis of E15.5 thymic rudiments, 63.1% of eYFP
+ cells express PDGFRα 
and 92.8% express PDGFRβ (Figure 4.2A, top two panels). In contrast, in 
the three month old thymus the majority (97.7%) of eYFP
+ cells still express 
PDGFRβ, but PDGFRα was found only on 9.2% of the cells (Figure 4.2A, 
bottom  two  panels).  This  was  confirmed  by  confocal  microscopy  which 
showed that PDGFRα is expressed only by eYFP
+ cells found in the capsule 
of the three month old thymus, whereas PDGFRβ was expressed by eYFP
+ 
cells found both at the capsule and within the organ (Figure 4.2B). 
 
4.3.2 Thymus development is normal in PDGFRβ
-/- mice 
 
Mutations which knockout the function of PDGFRα often result in hypoplastic 
but functional thymi (49, 204), however the role of PDGFRβ signalling in the 
thymus  is  unknown.  It  has  been  shown  that  PDGFRβ  is  required  for 
recruitment  of  pericytes  to  the  walls  and  subsequent  blood  vessel 
stabilisation. Indeed, embryos deficient in PDGFRβ do not survive beyond Chapter Four 
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birth due to sudden microvascular haemorrhaging and oedema (49, 204). 
Here, it is shown that in both the embryonic and three month old thymus, NC 
derived cells are PDGFRβ
+ (Figure 4.2A), suggesting a mechanism by which 
NC  derived  cells  are  recruited  to  the  blood  vasculature.  However,  by 
examining markers specific for pericytes and endothelial cells in E15.5 and 
E18.5 PDGFRβ deficient embryos, it is shown here that in the absence of 
this  signalling  receptor  the  thymic  blood  vasculature  appears  to  have 
developed normally (Figure 4.3). 
 
4.3.3  Co-development  of  blood  vasculature  and  NC  derived  cell 
networks 
 
It  is  thought  that  the  thymus  becomes  vascularised  at  E14.5  whereby 
angiogenic  growth  factors  produced  in  the  thymus  activate  growth  factor 
receptors on endothelial cells present on blood vessels near the developing 
thymus  anlagen  (43).  The  activated  endothelial  cells  release  proteases 
which  degrade  the  basement  membrane,  allowing  endothelial  cells  to 
escape the original vessel wall and proliferate into the surrounding matrix 
and parenchyma of the organ, forming sprouts. Since NC derived cells of 
perivascular character are present within the thymus before E13.5 (Figure 
3.6),  it  is  possible  that  these  cells  are  the  source  of  angiogenic  growth 
factors and thus direct the development of the blood vasculature. In order to 
determine  which  develops  first,  the  blood  vasculature  or  the  NC  derived Chapter Four 
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perivascular  cell  network,  the  expression  of  the  early  endothelial  marker, 
CD31  was  examined.  At  E13.5,  CD31
+  cells  were  already  present 
throughout  the  thymic  rudiment  indicating  that  endothelial  cells,  or 
endothelial  precursor  cells,  are  already  present  at  this  stage ( Figure  4.4) 
(This experiment was performed by Julie Sheridan, University of Edinburgh). 
Together  these  data  indicate  that  the  thymic  blood  vasculature  may  form 
from thymus-resident endothelial stem cells, or angioblasts, which proliferate 
into de novo endothelial cell structures that connect up with vessels at the 
periphery,  rather  than  from  endothelial  sprouts  from  vessels  nearby  the 
capsule that migrate into and colonise the rudiment. 
 
4.3.4 Blocking blood vessel formation in the thymus may disrupt the 
development of the NC derived perivascular network 
 
Since both NC derived perivascular cells and endothelial precursor cells are 
present  within  the  rudiment  at  E13.5,  it  remains  unclear  which  network 
develops first and, thus, whether the development of one network influences 
that of the other. It was not possible to determine whether ablating the NCC 
component of the embryonic thymi perturbs vascularisation of the thymus, 
due  to  early  death  of  Wnt1-Cre;Rosa26
eYFP;DIP-R1  embryos.  However,  it 
was possible to assess the contribution and differentiation of NCCs in the 
absence  of  blood  vessel  development  using  a  VEGFR-2  blocking  DC101 
antibody, or in other cultures, Sunitinib Malate, a receptor tyrosine kinase Chapter Four 
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inhibitor. The cultured foetal thymi were fixed and stained with blood vessel 
markers after four days incubation with inhibitor, and analysed by confocal 
microscopy. 
 
Incubating foetal thymi with DC101 antibody for four days does not appear to 
affect the development of thymic blood vessels or their density (Figure 4.5, 
left).  Moreover,  NC  derived  cells  were  still  associated  with  endomucin
+ 
endothelial cells, similar to those seen in foetal thymi cultured with a control 
antibody, biotinylated anti-human CD2 (IgG1) (Figure 4.5, right). However, 
incubation with Sunitinib Malate for four days resulted in a marked absence 
of blood vessel development, with only clumps of endothelial cells observed. 
In these cultures, NC derived cells did not form their usual three dimensional 
network of cells throughout the parenchyma (Figure 4.6A, left), compared 
with  thymi  incubated  without  inhibitor  (Figure  4.6A,  right).  However,  the 
remaining  NC  derived  cells,  mostly  located  at  the  capsule,  continued  to 
express  the  perivascular  marker  desmin  (Figure  4.6B).  These  results 
indicate that the development of a three dimensional NC derived cell network 
throughout  the  rudiment  was  perturbed  in  the  absence  of  blood  vessel 
formation. Nevertheless, differentiation of NCCs into perivascular cells did 
occur indicating that this process may be independent of vessel formation. 
However, since this inhibitor blocks several other receptor tyrosine kinases 
including PDGFR and c-Kit, in addition to VEGF signalling, it is difficult to 
interpret the mechanism of blood vessel development in the thymus. Chapter Four 




4.4.1 Blood vessel development in the thymus 
 
Blood vessel development generally occurs by one, or a combination, of two 
mechanisms.  Endothelial  cells  may  sprout  from  existing  vessels  into 
immature structures that in turn attract perivascular cells to wrap around the 
newly  formed  structures,  providing  structural  support.  Alternatively,  in  the 
absence of existing vessels, endothelial precursors, or angioblasts, adhere 
to  each  other  and  assemble  into  new  vascular  structures.  Blood  vessel 
development in the thymus is thought to occur at around E14 in gestation by 
sprouting  of  existing  vessels  nearby  to  the  capsule  into  the  parenchyma. 
VEGF, produced by TECs and mesenchymal cells within the rudiment, is 
considered to be the main angiogenic stimulus for sprout migration into the 
organ.  Very  few  reports  have  been  published  regarding  thymic 
vascularisation during organogenesis, and the principle that vessel formation 
occurs by sprouting of vessels outside the thymus has not previously been 
questioned (42, 237).  
 
Since it was found that NC derived cells differentiate into perivascular cells 
before the proposed time of vessel formation, it is possible that they may 
play  a  role  in  attracting  endothelial  sprouts  into  the  rudiment  and  their Chapter Four 
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organisation. For this reason, the expression of a marker for blood vessel 
structures,  endomucin,  was  examined.  Similar  to  previously  published 
reports, mature blood vessels were not detected in the thymus until E15.5. 
However,  in  contrast  to  the  proposed  mechanism  where  endothelial  cells 
sprout into the organ, endothelial precursor cells were already present by 
E13.5 scattered throughout the rudiment. Thus, an immature vessel network 
may form de novo from precursor cells, which connect up with endothelial 
sprouts  as  they  enter  the  rudiment.  In  support  of  this  hypothesis  were 
experiments  with  cultured  foetal  thymic  lobes.  Since  tissues  surrounding 
foetal lobes were removed before they were cultured, vascularisation could 
not occur from branching of existing vessels nearby the thymus. After four 
days in culture the control rudiments, which were not incubated with vascular 
inhibitor,  had  developed  blood  vessel  structures  which  were  endomucin
+. 
These vessels may have formed from endothelial precursor cells that were 
already present within the rudiment before it was dissected from the embryo. 
The origin of endothelial precursor cells is currently unknown, but a lineage 
analysis could be performed using an endothelial cell specific-Cre, such as 
Tie2-Cre (238), to activate the Rosa26 eYFP reporter. This method would 
allow tracing of the origin of blood vessel endothelial cells and the timing of 
their contribution to the thymic rudiment. 
 
NC derived cells were already present within the thymic rudiment at E13.5, 
concurrent with endothelial precursor cells, forming a network throughout the Chapter Four 
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organ reminiscent of capillaries and expressing the pericyte marker, desmin. 
By examining markers for blood vessel endothelium and perivascular cells at 
different stages of thymus organogenesis, it was not possible to determine 
whether  the  endothelial  vessel  structures  or  NC  derived  perivascular  cell 
network develops first. Thus, a number of possible mechanisms for thymic 
blood vessel development are possible. Endothelial precursor cells resident 
within the thymus may attract NCCs into the rudiment and, subsequently, 
induce their differentiation into perivascular cells. Equally, it is possible that 
NC derived cells, having already differentiated into perivascular cells, enter 
the  rudiment  first  and  influence  the  migration  of  endothelial  cells  and  the 
development of vascular networks by the production of molecules including 
VEGF.  
 
In order to determine which of these mechanisms is correct, a number of 
questions need to be addressed. For example, do blood vessels form in the 
thymus in the absence of NC derived perivascular cells? Or, conversely, do 
NCCs differentiate in the absence of endothelium? To address these two 
questions, thymic rudiments were examined in the absence of NCCs or by 
blocking blood vessel development in vitro. NCC-deficient embryos died at 
E12 and thus it was not possible to examine thymic development using this 
tool.  However,  it  may  be  possible  to  use  a  Cre-inducible  diphtheria  toxin 
receptor (DTR) transgenic system to delete NCCs in FTOC, similar to the 
one described in Experimental Strategy 4.2C. In this system however, mice Chapter Four 
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express a transcriptional stop cassette flanked by two LoxP sites upstream 
of  the  Diphtheria  Toxin  Receptor  (DTR),  rather  than  the  Diphtheria  Toxin 
itself. Cre-mediated excision of the stop sequence, under the control of the 
Wnt1  promoter  and  regulatory  elements,  renders  the  cells  sensitive  to 
diphtheria toxin (DT), thus addition of soluble DT would selectively kill NC 
derived cells. Thymic rudiments could be taken at E13.5, before blood vessel 
development, and cultured in the presence of DT. After two to four days in 
culture,  blood  vessel  development  could  be  assessed  by  staining  with 
antibodies and imaging by confocal microscopy.  
 
To address the question as to whether NCCs differentiate and form their 
characteristic three dimensional networks of cells in the absence of blood 
vessels,  vascular  inhibitors  were  used.  Development  of  blood  vessels  in 
FTOC  was  prevented  using  Sunitinib  Malate.  In  these  cultures,  NCCs 
continued  to  differentiate  into  cells  of  perivascular  character,  expressing 
desmin, but they did not enter the rudiment and redistribute into a network. 
These  results  suggest  that  NCCs  may  have  an  intrinsic  ability  to  form 
perivascular  cells,  or,  that  they  had  already  differentiated  before  the 
rudiments  were  dissected  from  the  embryos  and  cultured  with  vascular 
inhibitors. In contrast, NC derived cell migration into the rudiment did appear 
to require blood vessel formation. However, Sunitinib Malate may block other 
receptor  tyrosine  kinases  in  addition  to  those  previously  described.  Thus, Chapter Four 
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these analyses were inconclusive in demonstrating a role of vascularisation 
in NCC colonisation of the thymus rudiment. 
 
In order to determine the mechanism of blood vessel development in the 
thymus,  a  more  detailed  analysis  of  the  kinetics  of  the  emergence  of 
endothelial and differentiation and colonisation of perivascular cells needs to 
be performed. Moreover, an earlier analysis of NCCs associated with the 
thymic rudiment at E11.5 and E12.5 may indicate when differentiation into 
perivascular cells occurs. In addition to inducing deletion of NC derived cells, 
it may be possible to ablate blood vessel endothelium using an endothelial 
cell-specific Cre mouse line crossed to the DTR expressing mice mentioned 
above.  Thus,  thymic  rudiments  could  be  cultured  in  the  presence  of  DT, 
which would induce Cre-expressing endothelial cells to die. This would allow 
one to determine whether NC derived cell differentiation and colonisation of 
the thymus require blood vessel development.  
 
4.4.2 PDGFRα/β expression on NCCs 
 
Mesenchymal cells, which derive from the NC, surround the epithelium of the 
foetal thymus and express PDGFRα (226, 239), and play an important role in 
stimulating  proliferation  of  the  thymic  epithelium  (240).  Jenkinson  and 
colleagues showed that loss of PDGFRα
+ mesenchyme is associated with a 
downturn  in  epithelial  proliferation  later  in  gestation  and,  thus,  they Chapter Four 
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speculated that the main role of NC derived mesenchyme is to stimulate the 
proliferation  of  epithelial  cells.  Jenkinson  and  colleagues  suggested  that 
once  epithelial  cells  are  competent  to  support  thymocyte  maturation,  NC 
derived  mesenchyme  is  no  longer  required  and  is  lost  from  the  thymus. 
Similar  to  these  results,  NC  derived  mesenchymal  cells  in  the  embryonic 
thymus were found to express PDGFRα. In addition, they also expressed 
PDGFRβ  at  this  stage.  As  mentioned  in  chapter  three  however,  our 
experiments indicate that NC derived cells are not lost from the thymus and 
instead they differentiate into perivascular cells and continue to be present in 
the postnatal thymus at least to nine to ten months of age. The apparent 
contradiction between our data, which shows that NC derived cells remain in 
the post natal thymus and those already published that suggest that they are 
lost, may be explained by the downregulation of PDGFRα, whilst remaining 
PDGFRβ
+,  in  later  stages  of  thymus  organogenesis.  Since  PDGFRα  was 
used in previous studies as a marker to detect NC derived cells, its absence 
in later embryonic and adult thymus was taken as evidence to support the 
hypothesis that NC derived cells were no longer required and were lost or 
replaced. However, it is shown here that NC derived cells lose expression of 
PDGFRα and thus is not a suitable marker to detect NC derived cells. 
 
A  similar  downregulation  of  PDGFRα  has  also  been  observed  during 
pericyte differentiation in the brain, indicating similarities in differentiation of 
perivascular cells in these two organs (241, 242). The reason for the change Chapter Four 
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in  PDGF  receptor  expression  in  the  brain  is  not  clear,  however  in  vitro 
experiments suggest that it could be due to a change in function of these 
cells.  For  example,  PDGFs  have  been  demonstrated  to  stimulate 
proliferation and inhibit differentiation of 3T3-Li and smooth muscle cells in 
vitro (243, 244). It is also a potent mitogen for myogenic C2C12 cells, but 
inhibits  their  differentiation  into  myotubes  (245).  Thus,  the  balance  of 
expression between the two PDGF receptors may govern a cell’s decision to 
proliferate  or  undergo  growth  arrest  and  terminal  differentiation.  For 
instance,  in  the  thymus,  loss  of  PDGFRα  expression  on  NC  derived 
mesenchymal cells correlates with their differentiation into perivascular cells. 
In  order  to  test  this  hypothesis  it  will  be  necessary  to  determine  the 
functional capacity of PDGFRα and –β expressing cells. This could be done 
in vitro by assessing the proliferation of thymic epithelial cells when cultured 
with α or β receptor expressing NC derived cells. Additionally, analysis of the 
expression profile of certain genes may indicate that those involved in vessel 
development or function are upregulated, whilst those involved in stimulating 




-/- mice do not exhibit thymus defects 
 
In mice deficient for PDGFRα expression on NCCs, a small number of thymi 
are  hypoplastic  due  to  a  lack  in  epithelial  cell  proliferation,  but  are 
functionally competent (227). In contrast, broad deletion of PDGFRα results Chapter Four 
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in a significantly more severe phenotype of craniofacial and cardiac defects, 
including a lack of, or hypoplastic, thymic rudiments (226). The results from 
these experiments may seem to contradict each other, but can be explained 
by the different mutations in the two experimental systems. Broad deletion of 
PDGFRα is a result of the naturally occurring Ph mutation, which is a large 
deletion encompassing more than just the PDGFRα gene. It is also possible 
that PDGFRα was deleted in additional cell lineages, such as somite-derived 
mesoderm,  which  could  have  contributed  to  the  severe  craniofacial 
phenotype in mice with the broad deletion. Conversely, conditional deletion 
of the α receptor specifically in NCCs may have been incomplete with the 
remaining PDGFRα
+ NCCs moderating the effects. These concerns make it 
difficult to ascertain that the phenotypes are due to the PDGFRα gene alone. 
 
The function of PDGFRβ in thymus development has not previously been 
characterised. One of the ligands for this receptor, PDGF-B, is produced by 
endothelial cells resulting in the recruitment of pericytes to the walls of blood 
vessels. Elsewhere in the embryo, the absence of either PDGFRβ or PDGF-
B  is  associated  with  a  reduction  in  the  number  of  perivascular  cells 
associated with vessels and there is a defect in endothelial cell proliferation. 
Here  it  is  shown  that  in  the  thymus  of  PDGFRβ
-/-  embryos,  thymic  blood 
vascular development and perivascular cell recruitment to vessels appears 
normal. These results appear to contradict evidence for the role of PDGF-B-
PDGFRβ signalling in blood vessel development, but can be explained by Chapter Four 
  149 
the redundant expression of PDGFRα on the perivascular cells, which also 
bind the PDGF-B ligand.  
 
Redundancy  between  PDGF  receptors  was  demonstrated  in  experiments 
where deletion of PDGFRβ resulted in a phenotype only in certain tissues 
(204). These authors suggest that if the downstream signalling pathways of 
α and β receptors are the same, the expression of PDGFRα should be able 
to  rescue  the  mutant  phenotype.  They  show  that  in  the  tissues  where 
deletion of PDGFRβ does not affect blood vessel development, PDGFRα is 
also expressed, which assuages the vascular defects. Here, it is shown that 
the  thymic  blood  vessels  are  likewise  not  affected  by  deletion  of  the  β 
receptor. As NC derived mesenchymal cells are both PDGFRα
+ and β
+ at 
E15.5, when blood vessel development occurs, in the absence of PDGFRβ, 
PDGFRα  may  substitute  its  function  and  permit  normal  blood  vessel 
development.  Since  the  α  receptor  is  subsequently  down-regulated,  it  is 
possible  that  vascular  defects  in  the  thymus  would  present  in  the  adult. 
Since  β  receptor  mutants  are  neonatal  lethal,  these  analyses  were  not 
possible. However, it may be possible to indirectly test this hypothesis by 
examining  thymic  rudiments  from  PDGF-B  ligand  deficient  mice.  If  the 
signalling pathways downstream of the α and β receptors are the same, thus 
accounting for their redundancy, deletion of the B ligand will result in thymic 
vascular defects. 
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4.4.4 Summary 
 
Previous results from chapter three indicated that NCCs differentiated into 
perivascular  cells  and  were  present  in  the  thymic  rudiment  before  the 
proposed immigration of endothelial sprouts. This result suggested that NC 
derived cells may play a role in blood vessel development and/or function. 
Vascularisation of the thymus was examined and endothelial precursor cells 
were found to be present inside the parenchyma at E13.5, suggesting that 
vessel  development  may  occur  by  vasculogenesis,  creating  de  novo 
structures that connect up with endothelial sprouts as they migrate through 
the capsule of the organ. It was not possible to determine the role of NC 
derived cells in this process, but their location and postulated expression of 
molecules  required  for  vessel  formation  and  function  is  intriguing  and 
warrants further investigation. 
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Figure 4.1: PDGFRα and β are expressed in the perivascular compartment 
of the thymus. Thymi from three month old C57BL/6 mice were digested with 
collagenase, stained with antibodies recognising PDGFRα, β, NG2, CD31, CD45 
and MHC II and analysed by flow cytometry. Cells were first gated PDGFRα
+ 
(blue line) or β
+ (red line) and further analysed for the expression of NG2, CD31, 
CD45 and MHC II. 
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Figure 4.2: PDGFRα and β expression in embryonic and adult thymus. A 
Thymi  from  E15.5  (top)  and  adult  (bottom)  Wnt1-Cre;Rosa26
eYfp  mice  were 
digested with collagenase, stained for PDGFRα (left) and β (right) and analysed 
by flow cytometry. Isotype control, Goat IgG, is shown below. B Thymi from three 
month  old  adult  Wnt1-Cre;Rosa26
eYfp  mice  were  stained  with  antibodies 
detecting  PDGFRα  (left)  and  β  (right)  and  analysed  by  flow  cytometry.  White 
arrows; capsule. 
 



















63.2  91.7  13.5  96.1 Chapter Four 
  154 Chapter Four 
  155 
Figure 4.3: Normal thymus blood vessel development in PDGFRβ
-/- mice. 
Thymi from E15.5 (top) and E18.5 (bottom) PDGFRβ
-/- (left) and C57BL/6 (right) 
embryos were stained with antibodies recognising desmin (blue) and endomucin 
(red) and analysed by confocal microscopy. White arrows; capsule. Chapter Four 
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Figure 4.4: Endothelial precursor cells are present within the thymus by 
E13.5. Thymi from E13.5 (left) and E15.5 (right) C57BL/6 embryos were snap 
frozen  in  OCT  embedding  compound,  sectioned  and  stained  with  antibodies 
detecting  CD31  (red)  and  pan-cytokeratin  (PanK,  green)  and  analysed  by 
confocal  microscopy.  Red  arrows;  endothelial  cells.  Green  arrows;  epithelial 
cells.  This  experiment  was  performed  in  collaboration  with  Julie  Sheridan, 
University of Edinburgh. 
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Figure  4.5:  Monoclonal  antibody  DC101  does  not  block  blood  vessel 
formation. Foetal thymic organ cultures were incubated with anti-human CD2 
antibody (left) or DC101 antibody (right) for four days, stained with antibodies 
recognising  eYFP  (green)  and  endomucin  (red)  and  analysed  by  confocal 
microscopy. Area within white box of upper panels are magnified in the lower 
panels. Results are indicative of three independent experiments consisting of two 
to three rudiments for each condition. Chapter Four 
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Figure  4.6:  Blocking  the  formation  of  the  blood  vasculature  with  a 
biochemical inhibitor disrupts the NC derived cell network. (A) Foetal thymic 
organ  cultures  were  incubated  without  inhibitor  (left)  or  with  Sunitinib  Malate 
(right)  for  four  days,  stained  with  antibodies  recognising  eYFP  (green)  and 
endomucin (red) and analysed by confocal microscopy. Area within white box is 
magnified in the lower panels. (B) Foetal thymic organs cultured with (top two 
rows) and without (bottom two rows) Sunitinib Malate for four days, fixed and 
stained with antibodies recognising eYFP (left, green) and Desmin (middle, red). 
Merge  of  eYFP  and  Desmin  (left).  Results  are  indicative  of  four  independent 
experiments consisting of three rudiments for each condition. Area within white 
box of upper panels is magnified in the lower panels. Chapter Four 
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In addition to the previously described roles of NC derived cells in 
the thymus, evidence is presented here indicating that they are 
further required for the relocation of the thymic rudiment to the 
thoracic cavity during organogenesis. NCCs express members of 
the  Eph/ephrin  family  of  signalling  molecules,  and  in  their 
absence the location of the thymus is abnormal. However, this is 
not  due  to  a  lack  in  NCC  contribution  to  the  organ.  Thus,  the 
ectopic  location  of  the  thymus  in  mice  lacking  ephrin-B2 
expression on NCCs may result from impaired separation of the 
rudiment from the third pharyngeal pouch or impaired migration 
through the cervical structures into the thoracic cavity. Chapter Five 
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5.1 Experimental Rationale 
 
Thymus development in the mouse begins at E9.5 with the formation of the 
third pharyngeal pouches and subsequent expression of transcription factors 
including Hoxa3, Pax1/9, Eya1 and Six1/4 within the third pharyngeal pouch 
endoderm, initiating the processes of patterning and initial organogenesis (3-
8). Soon after, NC derived mesenchymal cells from the posterior hindbrain 
undergo EMT, delaminate, migrate towards and surround the pouch, which 
simultaneously begins to grow and bud into a separate structure containing 
the thymus and parathyroid primordia. By E12.5 the thymic primordium is 
completely detached from both the pharyngeal pouch and the parathyroid 
primordium. After separation, the bilateral lobes gradually descend possibly 
following the common carotid artery into the thoracic cavity where they finally 
settle in the upper mediastinum just above the heart at E13.5 (79) (Figure 
5.1).  
 
The function of NC derived cells in the patterning of the rudiment and its 
separation from the pharynx and/or parathyroid are unknown. Expression of 
the Eph family of tyrosine kinase receptors and their ligands, ephrins, may 
be attractive candidates since these molecules are required for a number of 
developmental  processes,  particularly  patterning  and  morphogenesis.  For 
example  Eph/ephrins  are  implicated  in;  blood  vessel  formation  through 
capillary sprouting (176); demarcation of arteries and veins (175-177) and Chapter Five 
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NCC  migration  to  the  pharyngeal  arches  (174,  180,  181,  184).  The 
mechanisms by which Eph/ephrins control these processes are thought to 
involve regulation of actin cytoskeleton dynamics, cell-substrate adhesion, 
intercellular junctions, cell shape and cell movement (reviewed in (130, 131). 
Thus,  Eph/ephrin  expression  by  NCCs  may  have  at  least  three  roles  in 
thymus  development;  NCC  migration  to  the  pharyngeal  pouches  where 
thymus  development  initiates,  the  separation  of  the  combined 
thymus/parathyroid rudiment from the pharynx and the separation of thymus- 
and parathyroid-fated cells at the border between the two rudiments.  
 
5.2 Experimental Strategy 
 
Due  to  the  importance  of  ephrin  ligands  in  craniofacial  development  by 
influencing NCC migration and their role in thymus function by influencing 
the  stromal  compartment,  their  role  in  thymus  organogenesis  was 
investigated. A significant number of Eph receptors and ephrin ligands are 
expressed in the thymus (132-136), and are also known to have immuno-
regulatory properties (140). The defects seen in thymocyte maturation in Eph 
or ephrin-deficient thymi are thought to result from abnormal development of 
the stromal cell compartments (196) and by modulation of T cell responses 
(246). For example; EphB2 and/or EphB3 deficient mice exhibit decreased 
numbers of thymocyte subsets (191); lack of EphA4 expression results in 
hypoplastic thymi and decreased numbers of double-positive (CD4
+ CD8
+) Chapter Five 
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thymocytes (196); and blocking foetal thymic organ cultures with EphB2/Fc 
or ephrin-B1/Fc fusion proteins decreases double positive and single positive 
T cell populations (190). 
 
In order to determine whether ephrin-B2 and its preferred receptor EphB4 
are  expressed  on  TEC  and  NC  derived  cell  thymic  stromal  populations, 
thymi  from  adult  mice  were  digested  with  collagenase,  stained  with 
antibodies recognising CD45, ephrin-B2 and EphB4 and analysed by flow 
cytometry. To mark NC derived cells, expression of the yellow fluorescent 
protein  (eYFP)  reporter  was  activated  with  Cre  recombinase  expressed 
under  the  control  of  the  Wnt1  promoter  (198,  201).  Previously  published 
reports have shown this tool identifies reliably NC derived cells (213, 247). 
Cells  were  first  gated  on  eYFP  and  CD45  expression  and  were  further 
analysed  for  the  presence  of  ephrin-B2  and  EphB4  using  antibodies 
recognising  these  molecules.  In  one  such  analysis,  84.3%  and  94.8%  of 
TECs (CD45
- and eYFP
-) and 98.7% and 99.5% NC derived cells (CD45
- 
and eYFP
+) expressed ephrin-B2 and EphB4 respectively (Figure 5.2A, B). 
 
Since ephrin-B2 is highly expressed on the TEC and NCC compartments 
within the thymus, and NCC specific ephrin-B1 deletion has been described 
elsewhere (184), ephrin-B2 was specifically deleted from TECs and NCCs 
using Cre-Lox genetic tools. To this end, mice with LoxP sites flanking exon 
2 of the Efnb2 gene (Figure 5.3) (202) were crossed with mice expressing Chapter Five 
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Cre  recombinase  in  TECs  under  the  control  of  either  the  IL7  (200)  or  in 
NCCs under the control of Wnt1 (198) promoter and regulatory elements. 
Cre  activity  was  reported  via  activation  of  a  ‘silent’  enhanced  yellow 




5.3.1  ephrin-B2  expression  on  TECs  is  not  necessary  for  correct 
positioning of the thymus and thymocyte development. 
 
In  order  to  study  the  role  of  ephrin-B2  on  TECs,  mice  with  LoxP  sites 
flanking exon 2 of the gene were used (Figure 5.3A) (202). These were bred 
to mice in which Cre recombinase is expressed under the control of the IL7 
promoter (Figure 5.3B) (200). The Rosa26
eYfp reporter was also included in 
order  to  indelibly  mark  TECs  and  their  progeny  with  eYFP.  Deletion  of 
ephrin-B2 from IL7
+ TECs resulted in no gross abnormalities of the thymus. 
The organ was found in its normal anatomical location, was of normal size 
(Figure  5.4A)  and  the  mice  exhibited  no  apparent  immunological  defect. 
Thymi from mutant mice contained similar numbers of cells and proportions 
of  the  different  sub-populations  to  those  from  control  mice  (Figure  5.4B) 
indicating no defect in thymocyte development. Moreover, peripheral T and 
B cell populations were very similar in cells obtained from the spleen of mice 
deficient  in  ephrin-B2  expression  on  TECs  and  wild  type  controls  (Figure Chapter Five 
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5.5).  Thus,  ephrin-B2  expression  on  TECs  is  not  required  for  thymus 
organogenesis, morphogenesis or TEC differentiation. 
 
5.3.2 ephrin-B2 expression on NC derived cells is required for correct 
positioning of the thymus, but not for thymocyte development. 
 
To  study  the  role  of  ephrin-B2  expression  on  NC  derived  cells  a  similar 
strategy to that described in the previous section was used, except that Cre 
recombinase was expressed under the control of the Wnt1 promoter. In mice 
that had deleted ephrin-B2 specifically from NC derived cells, the thymus 
was  absent  from  its  normal  anatomical  location  above  the  heart  (Figure 
5.6A,  bottom  right).  Instead,  two  large  bilateral  lymphoid  structures  were 
found in the cervical region (Figure 5.6A, top right). In a small number of 
embryos, one thymus lobe was found within the superior mediastinum above 
the heart, with a concomitant presence of a large lymphoid structure in the 
contralateral region of the neck.  
 
In order to determine the cellular composition of these lymphoid structures 
they were dissected and digested with collagenase. The resulting single cell 
suspension was counted and stained with antibodies detecting CD4, CD8 
(Figure  5.6B,  top)  and  TCRβ  (Figure  5.6B,  bottom)  to  label  T  cells,  and 
CD19 (Figure 5.7) for B cells, and analysed by flow cytometry. Expression 
patterns of T cell markers and a lack of B cell markers indicated that the Chapter Five 
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ectopic  structures  were  thymus  lobes  and  not  lymph  nodes.  Moreover, 
normal  cervical  lymph  nodes  were  found  correctly  located  in  mice  with 
ectopic thymi. Peripheral T and B cell populations were also very similar in 
cells isolated from the spleen of mice deficient in ephrin-B2 expression on 
NC derived cells and wild type controls (Figure 5.8). 
 
Thus,  whereas  absence  of  ephrin-B2  from  NCCs  does  not  affect  the 
development  of  thymocytes,  it  results  in  ectopic  thymus  located  in  the 
cervical region. 
 
5.3.4  NCCs  colonise  and  differentiate  normally  within  the  thymic 
rudiment in the absence of ephrin-B2. 
 
In splotch mice, which are Pax3 null, the observed ectopic location of the 
thymus is caused by a deficiency in NC derived mesenchymal cell migration 
to the third pouch. In order to determine whether ephrin-B2 deficient NCC 
mutants had a similar failure of NCC contribution, thymi from control and 
mutant  three  month  old  adult  mice  both  expressing  eYFP  in  NCCs  were 
digested  with  collagenase  and  analysed  by  flow  cytometry.  One  such 
analysis showed very similar numbers of eYFP
+ cells in the adult mutant, 
5.8% (Figure 5.9A, right), compared to 6.4% in the control (Figure 5.9A, left). 
Additionally,  thymi  from  E15.5  control  Ephrin-B2
+/+;Wnt1-Cre;Rosa26
eYfp 
(Figure  5.9B,  left)  and  mutant  Ephrin-B2
Lx/Lx;Wnt1-Cre;Rosa26
eYfp ( Figure Chapter Five 
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5.9B,  right)  embryos  were  dissected,  fixed,  stained  with  an  antibody 
detecting YFP and imaged by confocal analysis. These analyses revealed 
that similar numbers of NC derived cells migrate into the mutant compared to 
control  rudiments,  thus,  there  are  no  changes  in  the  colonisation  of  the 
primordium by NC derived cells. 
 
NC derived cells in the thymus normally differentiate into cells characteristic 
of  pericytes  and  smooth  muscle  cells  associated  with  blood  vessel  walls 
(213, 247). ephrin-B2 and its preferred receptor EphB4 are known to play a 
role in normal blood vasculature development, and broad deficiency in these 
molecules is embryonic lethal (183). In order to determine whether ephrin-B2 
expression is required for NC derived mesenchyme attachment to the walls 
of  blood  vessels,  100µm  vibratome  sections  were  examined  from  three 
month  old  adult  control  Ephrin-B2
+/+;Wnt1-Cre;Rosa26
eYfp  and  mutant 
Ephrin-B2
Lx/Lx;Wnt1-Cre;Rosa26
eYfp  thymi.  The  sections  were  stained  with 
antibodies detecting eYFP, the pericyte marker desmin, and the endothelial 
marker  endomucin.  These  analyses  revealed  that  blood  vessels  in  the 
mutant thymus develop normally with desmin
+ perivascular cells surrounding 
endomucin
+ vascular endothelium (Figure 5.10A, right) when compared to 
control thymi (Figure 5.10A, left). In addition, detection of eYFP
+ perivascular 
cells  in  the  adult  thymus  suggests  that  they  are  NC  derived  and  are  not 
replaced by cells of other mesenchymal origin with age (Figure 5.10B). 
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Wnt1 is expressed on neurons in addition to other NC derived tissues. Thus, 
the neurons that innervate the thymus may also be affected by the deletion 
of ephrin-B2. In order to determine whether the neuronal component of the 
thymus was compromised in the mutant mice described here with ectopic 
thymi,  sections  of  thymus  from  three  month  old  adult  control  Ephrin-
B2
+/+;Wnt1-Cre;Rosa26
eYfp  and  mutant  Ephrin-B2
Lx/Lx;Wnt1-Cre;Rosa26
eYfp 
mice were stained with antibodies detecting TUJ1, a neuronal marker, and 
eYFP. Similar patterns of TUJ1 staining were observed in the mutant mice 
when  compared  with  control  thymi,  thus,  it  appears  that  ephrin-B2  is  not 
required for innervation of the thymus (Figure 5.11).  
 
Together  these  analyses  revealed  that  ephrin-B2  deficient  NC  cells 
delaminate  normally,  migrate  to  the  thymic  rudiment  and  form  a  three 
dimensional network of cells, similar to that observed in control embryos and 
reported previously (213, 247). Thus ephrin-B2 appears not to be necessary 
for NCC association with the rudiments and this raises the possibility that 




5.4.1 The ectopic location of the thymus 
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There are a number of key steps that occur during thymus organogenesis, 
starting  with  the  initial  induction  of  a  common  primordium  containing  the 
thymus-  and  parathyroid-specific  domains  from  the  endoderm  of  the  third 
pharyngeal  pouch.  Next,  patterning  of  the  common  primordia  into  organ-
specific  domains  from  morphologically  indistinguishable  epithelial  cells  is 
established.  The  shared  primordia  then  detach  from  the  pharyngeal 
endoderm  at  around  E12,  followed  by  separation  of  the  thymus  and 
parathyroid  rudiments  from  each  other.  Once  separated,  the  thymus 
migrates down into the superior mediastinum where it finally rests above the 
heart. Shortly after thymus migration is complete, the thoracic cavity closes 
by midline fusion of paired cartilage bars (79). The mechanism leading to the 
collective migration of the thymus primordium is unknown. Several different 
mouse mutants have been described that have ectopic thymi located in the 
neck.  These  mutants  have  complex  defects  involving  predominantly 
patterning  and  separation  of  the  rudiment  from  the  pharynx  and/or  the 
parathyroid (See table for details and references). 
 
For  example,  Hoxa3  mutant  mice  exhibit  a  very  early  failure  of  thymus 
organogenesis, in fact, initiation of the rudiment at the third pouch does not 
occur (3). Deletion of one allele of Hoxa3 in Hoxb3
-/- Hoxd3
-/- mutant mice, 
however,  resulted  in  the  formation  of  an  ectopic  thymic  rudiment  in  the 
cervical region (22). Additionally, RARα/γ double mutants also have ectopic 
organs, and it is thought that this is due to the lack of activation of Hox genes Chapter Five 
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by retinoic acid (248). Likewise, Pbx1 mutant mice also exhibit early defects 
in thymus formation. In these mice, there is delayed or absent formation of 
the  pharyngeal  pouches  and,  in  particular,  disorganised  patterning  of  the 
third  pouch  (249).  In  a  few  mutants,  a  thymus  does  arise,  but  it  is  often 
ectopic and the thymic epithelium does not expand. Due to the similarities 
between the Pbx1 and Hoxa3
+/- Hoxb3
-/- Hoxd3
-/- compound mutants, it was 
suggested  that  these  genes  act  together  in  the  development  of  the 
pharyngeal pouches. Thus, defects in the initial formation of the rudiment are 
implicated in some of the mutants with ectopic thymi. 
 
Defects that result in ectopic thymi can also manifest later in organogenesis, 
as a result of the aberrant separation of the rudiment from the pharyngeal 
pouch and/or the parathyroid. Hox3
+/- Pax1
-/- mutants, in addition to impaired 
development of appropriate numbers of epithelial cells causing hypoplasia, 
exhibit a delay in the separation of the combined thymus and parathyroid 
rudiment  from  the  pharynx  (5).  By  the  time  separation  has  occurred,  the 
environment  though  which  the  thymic  rudiment  migrates  has  developed 
further,  preventing  movement  of  the  anlagen  as  a  secondary  defect. 
Likewise, in Pax9 null mice, the thymus develops as an ectopic polyp-like 
structure in the larynx as a result of impaired separation of the rudiment from 
the pharynx. Whilst the rudiment is colonised by mesenchymal and lymphoid 
cells,  it  is  also  severely  reduced  in  size  from  E14.5  onwards  (21).  The 
ectopic location of the thymus in Splotch, or Pax3 null, mice is thought to Chapter Five 
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result  from  abnormal  boundary  formation  between  the  thymus-  and 
parathyroid-domains and thus a defect in the separation of the two organs, 
which holds the thymus in the neck. Interestingly, this defect was attributed 
to  a  deficiency  in  NCCs  that  surround  the  rudiment  and  contribute  to 
boundary formation between the two domains. Alk5 mutants, which have a 
mutation in the TGFβ-type1 receptor on NCCs, also exhibit ectopic thymi as 
a  result  of  delayed  separation  of  the  parathyroid  and  thymus.  In  these 
mutants the NCCs migrate normally to the pouch, but it is thought that an 
increase in apoptosis of postmigratory NCCs perturbs separation and as a 
result the thymic rudiment is held in the cervical region (25). FGFs have also 
been implicated in the separation of the rudiment from the pharynx, since 
Sprouty mutants, which are deficient in FGF signal transduction, also exhibit 
ectopic thymi that remain attached to the pharynx (250).  
 
Ectopia  of  the  thymus  can  thus  result  from  defects  in  early  stages  of 
thymus/parathyroid  patterning  or  impaired  separation  of  the  combined 
rudiment from the pharynx and from each other. In addition to separation 
from the pharynx, the thymus rudiment must undergo a process of migration 
into the thoracic cavity, however, the mechanism of migration is unknown 
and, to date, no mutants have been described which have a primary defect 
in rudiment migration without major earlier defects in rudiment formation and 
patterning.  
 Chapter Five 
  175 
Interestingly,  a  number  of  the  mutants  described  with  ectopic  thymi  are 
thought to result from defects in functions of the NC derived cell population. 
Likewise, the mutants described here lack expression of ephrin-B2 on NCCs 
and have ectopic thymi in the cervical region. In contrast to some of the 
mutants described above, the thymus in the mutants described in this study 
appears to function normally and is not reduced in size compared to wild 
type control organs. To our knowledge, this is the first report demonstrating a 
role  for  the  Eph/ephrin  family  of  molecules  and  NC  derived  cells  in  the 
positioning of the thymus. Since Eph/ephrins are required for NCC migration, 
the abnormal location of the thymi may result from a lack of NC derived cell 
contribution to the rudiment. However, mutant NCCs were found to associate 
with the ectopic thymus in similar numbers to wild type NCCs and formed 
three dimensional networks normally. Thus, the position of the thymus may 
result from either a delay or defect in the separation of the rudiment from the 
pharynx and/or the parathyroid, or an impairment in organ migration. This 
question, as to whether impaired separation or migration causes the ectopic 
location in the absence of ephrin-B2 expression on NCCs, will be explored in 
the next chapter. 
 
5.4.2 NC derived cell function in the ectopic thymus 
 
Eph/ephrins are known to play a key role in the migration of NCCs, dictating 
the timing and patterning of their migration. Knocking out ephrin-B1 on NCCs Chapter Five 
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resulted in defects in pharyngeal organ development including a cleft palate. 
Likewise, these defects were caused by abnormal migration of the NCCs, 
thus,  instead  of  migrating  along  their  specified  pathways  they  seemed  to 
exhibit  a  wandering  behaviour  and  invaded  improper  territories  normally 
devoid  of  NCCs  (184).  In  the  mouse,  ephrin-B2  is  expressed  on  the 
underlying mesoderm along the pathway which NCCs migrate (174). Thus, 
deletion of the ligand prevented NCC migration into the second pharyngeal 
pouch but NCCs migrated normally to the third pharyngeal pouch. ephrin-B2 
has not been deleted on NCCs specifically, but mice deficient for ephrin-B2 
on all cells have been described (176). 
 
For  this  reason  ephrin-B2  was  deleted  specifically  from  NCCs,  using  a 
similar strategy to that used previously to delete ephrin-B1 on these cells. 
Thus, mice with exon two of the ephrin-B2 gene floxed with LoxP sites on 
both sides, were crossed with mice expressing Cre recombinase under the 
control of the Wnt1 promoter and regulatory elements. In contrast to ephrin-
B1 deficient NCCs, ephrin-B2 deficient NCCs still appeared to migrate to 
third pouch. Thus, the ectopic thymic rudiment was surrounded and invaded 
by  NCCs  in  a  similar  pattern  to  that  seen  in  control  embryos  and  those 
described in chapter 3 of this thesis. Thus, NCC migration was not affected 
in the absence of ephrin-B2 indicating that other Eph/ephrin molecules were 
probably required for this function. It will be interesting to see the effect of Chapter Five 
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deletion both ephrin-B1 and ephrin-B2 on NC derived cells and TECs, thus 
these mice are currently being generated. 
 
What perhaps is surprising from these results is that blood vessels in the 
thymus of mice that were deficient for ephrin-B2 expression on NCCs did not 
appear abnormal. In mice deficient for ephrin-B2 or its preferred receptor, 
EphB4,  on  all  cells,  angiogenic  remodelling  is  defective.  Moreover,  when 
ephrin-B2  was  specifically  deleted  on  perivascular  cells  using  a  similar 
strategy to that used here, blood vessels frequently ruptured releasing blood 
cells into the surrounding tissue. In contrast, it is shown here that deletion of 
ephrin-B2  on  NC  derived  perivascular  cells  does  not  cause  an  obvious 
defect in vessel structure and function. The differences between these two 
results may be due to the deletion of Cre on different subsets of perivascular 
cells.  Previous  experiments  deleted  ephrin-B2  using  PDGFRβ-Cre,  whilst 
here an NC specific Wnt1-Cre was used to drive deletion of the ligand. It is 
possible that not all of the perivascular cells in the thymus are derived from 
the  NC,  therefore  driving  ephrin-B2  deletion  with  the  PDGFRβ-Cre  may 
affect more cells than deleting the ligand just on those deriving from the NC. 
It is possible that there are subtle defects in perivascular cell attachment to 
endothelial cell-vessel walls that become more apparent with age. Indeed, a 
number of adult mutant mice described here die at 8-12 weeks of age due to 
haemorrhaging in the brain, thus vessel defects do become apparent with 
age.  To  investigate  this  further,  it  will  be  necessary  to  compare  vessel Chapter Five 
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structure by TEM analysis of aged mutant and control mice. Moreover, H&E 
analysis of thymus sections from aged mice may show haemorrhaging into 
the parenchyma. 
 
5.4.3 T cell development in the absence of ephrin-B2 
 
Most Eph receptors and ephrin ligands are known to be expressed in the 
thymus in an overlapping pattern (135, 251). Several Eph and ephrins can 
appear on the same thymic compartment and at the same developmental 
stage, allowing for different combinations of signals and there is functional 
redundancy  between  different  receptors  or  ligands  (138,  252).  T  cell 
development requires contact between stromal cells and thymocytes, and 
this cell contact-dependent mechanism appears to require the expression of 
a  number  of  Eph/ephrins.  For  example,  ephrin-B1  and  its  receptors  are 
critical for T cell development (138). Thus, perturbing Eph/ephrin interactions 
in foetal thymic organ culture with fusion proteins interferes with thymocyte 
survival  and  maturation.  EphB  receptors  modulate  T  cell  responses  in  a 
number of ways; they cluster with activated T cell receptors in aggregated 
lipid rafts, and clustering with immobilised anti-EphB6 antibodies or ephrin-B 
Fc fusion proteins lowers the activation threshold of T cells responding to 
suboptimal  TCR  ligation  (140,  190,  196).  Moreover,  EphB  activation 
promotes T cell proliferation, production of interferon γ and cytotoxic T cell 
activity,  and  EphB6  knockout  mice  show  impaired  cellular  immune Chapter Five 
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responses  despite  having  normal  T  cell  numbers  (252).  EphA4  knockout 
mice exhibit defects in thymocyte maturation and have greatly decreased 
numbers of peripheral T cells. Interestingly, these defects appear to result 
from  abnormal  development  of  the  stromal  cells  of  the  thymus  (196). 
Recently, it was reported that EphB2 and EphB3 double knockout mice also 
have  disorganised  thymic  architecture  and  decreased  numbers  of 
thymocytes  (253),  thus  Eph/ephrin  signalling  clearly  plays  some  role  in 
thymus organogenesis and function.  
 
Although most Eph/ephrins have been described to be expressed within the 
thymus, it is unclear which cell type within the organ expresses ephrin-B2. 
Yu and colleagues (136) reported that ephrin-B2 mRNA was prominent in 
the thymic cortex, and was present at the protein level mainly on monocytes, 
macrophages and T cells (7.1%). Moreover, these authors also reported that 
the receptors for ephrin-B2 were expressed on T cells. In contrast, here it is 
shown  that  few  (2.2%)  T  cells  were  positive  for  ephrin-B2  but,  similar  to 
previously published reports, more (14.4%) were EphB4
+. The differences 
between  the  number  of  T  cells  which  express  ephrin-B2  in  the  results 
reported here and those previously published may be due to the differences 
in experimental procedure. In the report by Yu and colleagues, ephrin-B2 
expression  was  measured  on  T  cells  stimulated  with  anti-CD3  in  culture. 
Thus, it will be necessary to isolate T cells from mice in which ephrin-B2 was Chapter Five 
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deleted on either NCCs or TECs and culture them in conditions described in 
the report by Yu and colleagues. 
 
To our knowledge, this is the first report in which ephrin ligands have been 
deleted  specifically  from  the  stromal  compartments  of  the  thymus. 
Considering the large amount of evidence supporting a role for Eph/ephrin 
signalling in thymus development and function, it is perhaps surprising that 
deletion of ephrin-B2 from NC derived cells and TECs did not result in an 
overt immune phenotype. In these mice, the proportions of SP and DP T 
cells were not altered, and these mice did not exhibit any obvious immune 
defects. However, these mice were not immunologically challenged, and it is 
possible  that  subtle  defects  in  TCR  signalling  or  T  cell  proliferation  or 
cytokine production may be present in these mice.  
 
It  is  equally  possible  that  functional  redundancy  between  ephrin  ligands 
compensated  for  the  loss  of  ephrin-B2  in  these  mice,  or  that  ephrin-B2 
expressed by stromal cells does not have a role in thymus function. The 
PDZ-binding  domains  of  all  three  ephrin-B  ligands  are  100%  identical, 
indicating  that  they  might  activate  indistinguishable  signalling  cascades. 
Additionally, ephrin-B1 and -B2 can bind to similar EphB receptors, although 
ephrin-B2 has a higher affinity for EphB4, and both genes are co-expressed 
in  a  number  of  tissues  and  cells  during  mouse  embryonic  development. 
Moreover, functional redundancy has been previously demonstrated for Eph Chapter Five 
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receptors  and  GPI-linked  ephrins  (the  ephrin-As)  (254,  255).  However, 
ephrin-B1  and  -B2  null  mice  exhibit  different  phenotypes  and  thus  have 
specific, non-redundant functions (184, 185, 256, 257).  
 
In order to clarify the role of specific Eph/ephrins in thymus development, it 
will be necessary to delete one or more Eph/ephrins on both the stromal and 
thymocyte compartments. For instance, deletion of both ephrin-B1 and –B2 
on NCCs or TECs may result in defects in thymus development or function 
that was not apparent when deleting ephrin-B2 alone. Moreover, it will be 
necessary  to  challenge  the  immune  system,  and  test  TCR  signalling, 
proliferative capacity and cytokine secretion of T cells from these mice. 
 
Thymus function in an ectopic location 
 
Similar to reports that the cervical thymus functions equally as well as the 
thoracic thymus (258, 259), our data indicates that the location of the organ 
bears little, if any, functional consequence. It has been demonstrated that 
cervical thymi from adult Balb/C mice grafted under the kidney capsule of 
adult C57BL/6 nude mice are capable of reconstituting the immune system. 
In contrast to transplanted foetal thymus grafts, cervical thymus grafts did 
not grow but, similar to foetal grafts, they were able to support thymocyte 
selection  and  export  T  cells  bearing  diverse  TCRs  into  the  peripheral 
lymphoid  organs.  Likewise,  ectopic  thymi,  which  resulted  from  the  NC Chapter Five 
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specific deletion of ephrin-B2, apparently function normally and this raises 
the  interesting  question  of;  why  does  the  thymus  migrate  during 
organogenesis?  
 
The location of the organ is only one of a number of differences between 
thymi  of  different  species.  The  origin  of  the  gland  from  the  pharyngeal 
pouches varies between species, as does the final number of organs. Thus, 




rd in reptiles and 3
rd or 4
th in bony fish, birds and mammals. 
Sharks have five pairs of thymic glands, whilst caecilian amphibians have 
four  pairs,  urodele  amphibians  have  three  pairs  and  many  teleost  fish 
species, anuran amphibians and many mammals have just one pair. The 
position of the thymus also varies between species and it only migrates into 
the  thoracic  cavity  of  higher  vertebrates.  For  instance,  the  koala  has  a 
cervical  thymus,  the  kangaroo  has  both  cervical  and  thoracic  thymi,  and 
cattle and sheep often have a thoracic and cervical organs, which may be 
connected (260). 
 
One possible reason for the thoracic location of the thymus may be simply 
that  there  is  not  enough  space  in  the  cervical  region.  In  support  of  this 
hypothesis  are  numerous  reports  of  cervical  thymus  tissue  causing 
respiratory  distress  in  young  children,  as  a  result  of  narrowing  or 
displacement of the airway. However, the mice with ectopic thymi that are Chapter Five 
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described here do not exhibit stridor, thus, it is likely that there are other 




Deletion of the ligand ephrin-B2 from NC derived cells causes ectopia of the 
thymus. Confocal microscopy and flow cytometry indicated that this is not 
due to a lack of NCC contribution to the rudiment. Thus, the position of the 
thymus does not appear to impact on the function of the organ. Furthermore, 
it was shown that ephrin-B2 expression on NCCs is not required for T cell 
development.  Thus,  a  role  for  Eph/ephrin  signalling  on  NCCs  in  the 
separation  from  the  pharynx  and/or  the  parathyroid  or  migration  of  the 
rudiment into the thoracic cavity is likely.  
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Figure 5.1. Thymus formation and migration. A E11.5-12.5: Outgrowth and 
Patterning  of  the  Rudiment.  Specification  of  the  rudiment  into  thymus-  and 
parathyroid-specific  domains.  Patterning  begins  at  E10  with  the  expression  of 
GCM2 (red) in the third pouch, controlled at least in part by the Hox-Pax-Eya-Six 
cascade.  High-level  expression  of  Fonx1  (blue)  begins  at  E11.25.  B  E12.5 
Separation  from  the  Pharynx  and  Migration  of  the  Rudiment.  Prior  to 
migration,  the  rudiment  must  separate  from  both  the  pharynx  and  the 
parathyroid. (Adapted from Figure 5 of {Blackburn, 2004 #510}). C E12.5-E13.5 
Caudal  and  Ventral  Migration.  Once  separated  from  the  pharynx  and 
parathyroid, the thymic rudiment migrates down into the thoracic cavity, following 
the common carotid artery. D E13.5 Final Resting Place Above the Heart. The 
thymic rudiments reach their final destination, just above the heart and fuse in the 
midline by E13.5. Chapter Five Chapter Five 
Figure  5.2.  Expression  of  ephrin-B2  ligand  and  EphB4  receptor  on  NC 
derived  mesenchyme  and  TECs.  Thymus  lobes  from  E15.5  Wnt1-
Cre;Rosa26
eYfp embryos were digested with collagenase, stained with antibodies 
recognising CD45, ephrin-B2 and EphB4 and analysed by flow cytometry. Cells 
were first gated CD45
+ (thymocytes) (A, B left), eYFP
+ (NC derived)
 (A, B middle) 
or eYFP
-CD45
- (predominantly thymic epithelium) (A, B right) cells and further 
analysed  for  expression  of  ephrin-B2  (A)  and  EphB4  (B).  Red  line;  specific 
antibody, black line; isotype control. Chapter Five Chapter Five 
Figure 5.3. Expression construct of ephrin-B2
Lx/Lx and IL-7 Cre mice. A The 
expression construct used to generate mice with exon 2 of the ephrin-B2 gene 
floxed with LoxP sites. Top; untargeted locus, bottom; targeting locus. LoxP sites 
indicated  by  solid  arrow-heads.  Adapted  from  Grunwald  et  al  2004.  B  IL-7 
expression  construct  generated  in  which  Cre  was  inserted  into  the  locus, 
replacing exon 1 of the gene. Top; untargeted locus, middle and bottom; targeted 
locus. Adapted from {Repass, 2009 #302}. Filled boxes indicate exons. Chapter Five Chapter Five 
Figure  5.4:  The  thymus  appears  normal  in  the  absence  of  ephrin-B2 
expression on TECs. A Three month old adult Ephrin-B2
+/+;IL7-cre (left) and 
Ephrin-B2
Lx/Lx;IL7-Cre (right) mice were dissected to reveal the thoracic cavity in 
order to visualise the location of the thymus lobes. Red arrows; thymus, green 
arrows; heart. B Thymi from three month old Ephrin-B2
Lx/+ and Ephrin-B2
Lx/Lx;IL7-
Cre  mice  were  dissected,  digested  with  collagenase,  stained  with  antibodies 
recognising CD4, CD8 (top) and TCRβ (bottom) and analysed by flow cytometry. 
Similar results were obtained in two independent experiments consisting of six 
and four mice respectively. 
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Figure 5.5: Normal peripheral T and B cell populations in the absence of 
ephrin-B2 expression on TECs. Spleens from three month old adult Ephrin-
B2
+/+;IL7-cre  (top),  Ephrin-B2
Lx/Lx;IL7-Cre  (middle)  and  C57Bl6  (bottom)  mice 
were  dissected,  digested  with  collagenase  and  stained  with  antibodies 
recognising CD4 and CD8 (left column), TCRβ (middle column) and CD19 (right 
column). Similar results were obtained from three mice of each genotype. 
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Figure 5.6: Expression of ephrin-B2 on NC derived cells is required for the 
normal anatomical position of the thymus. A Three month old adult control 
Ephrin-B2
+/+;Wnt1-Cre;Rosa26
eYfp  (left)  and  mutant  Ephrin-B2
Lx/Lx;Wnt1-
Cre;Rosa26
eYfp (right) mice were dissected to reveal the cervical region (top) and 
thoracic cavity (bottom) in order to visualise the location of the thymus lobes. 
White arrows; clavicle, red arrows; thymus, green arrows; heart. B Thymi from 
three  month  old  control  Ephrin-B2
Lx/Lx  and  mutant  Ephrin-B2
Lx/Lx;Wnt1-
Cre;Rosa26
eYfp  mice  were  dissected,  digested  with  collagenase,  stained  with 
antibodies recognising CD4, CD8 (top) and TCRβ (bottom), and analysed by flow 
cytometry.  Similar  results  were  obtained  from  more  than  three  experiments 
consisting of fourteen Ephrin-B2
Lx/Lx;Wnt1-Cre mice. 
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Figure 5.7. Ectopic structures are not lymph nodes. Thymi from adult control 
Ephrin-B2
Lx/Lx  (left)  and  ectopic  structures  from  mutant  Ephrin-
B2
Lx/Lx;Wnt1Cre;Rosa26
eYfp  (right)  mice  were  digested  with  collagenase  and 
stained with an antibody detecting CD19 and analysed by flow cytometry. Isotype 
control  (Mouse  IgA)  is  shown.  Similar  results  were  obtained  from  two 
experiments consisting of six Ephrin-B2
Lx/Lx;Wnt1Cre;Rosa26
eYfp mice and three 
controls. 
 
Mouse ID  % CD19 
Ephrin-B2
Lx/Lx  0.1 
  0.2 
  0.05 
Ephrin-B2
Lx/Lx;Wnt1Cre;Rosa26eYFP  0.1 
  0.1 
  0.05 
  0.1 
  0.2 
  0.1 
 
 Chapter Five Chapter Five 
Figure 5.8: Normal peripheral T and B cell populations in  the absence of 
ephrin-B2 expression on NC derived cells. Spleens from three month old adult 
Ephrin-B2
+/+;Wnt1-cre  (top),  Ephrin-B2
Lx/Lx;Wnt1-Cre  (middle)  and  C57Bl6 
(bottom)  mice  were  dissected,  digested  with  collagenase  and  stained  with 
antibodies recognising CD4 and CD8 (left column), TCRβ (middle column) and 
CD19  (right  column).  Similar  results  were  obtained  from  three  mice  of  each 
genotype. 
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Figure  5.9:  NC  derived  mesenchymal  cells  associate  normally  with  the 
ectopic thymus. Thymi from three month old adult control Ephrin-B2
Lx/+;Wnt1-
Cre;Rosa26
eYfp (A, B left) and mutant Ephrin-B2
Lx/Lx;Wnt1-Cre;Rosa26
eYfp mice 
(A,  B  right)  were  dissected,  digested  with  collagenase  and  analysed  by  flow 
cytometry  A  or  fixed  with  4%  paraformaldehyde,  stained  with  an  anti-eYFP 





Mouse ID  % YFP 
Ephrin-B2
Lx/+;Wnt1Cre;Rosa26eYfp  6.4 
  5.9 
Ephrin-B2
Lx/Lx;Wnt1Cre;Rosa26eYfp  5.8 
  5.7 
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Figure  5.10:  NC  derived  cells  associated  with  the  ectopic  thymus 
differentiate normally into perivascular cells. A Thymi from three month old 
adult control Ephrin-B2
Lx/Lx (left) and mutant Ephrin-B2
Lx/Lx;Wnt1-Cre;Rosa26
eYfp 
(right)  mice  were  dissected,  fixed  in  4%  paraformaldehyde,  cut  into  100µm 
sections, stained with antibodies recognising endomucin (red) and desmin (blue) 
and  analysed  by  confocal  microscopy.  B  Thymi  from  three  month  old  adult 
control  Wnt1-Cre;Rosa26
eYfp  (left)  and  mutant  Ephrin-B2
Lx/Lx;Wnt1-
Cre;Rosa26
eYfp (right) mice were dissected, fixed in 4% paraformaldehyde, cut 
into  100µm  sections,  stained  with  antibodies  recognising  eYFP  (green)  and 
endomucin (red), and analysed by confocal microscopy.  Chapter Five Chapter Five 
Figure 5.11 Ablation of ephrin-B2 from NC derived cells does not affect the 
neurons  of  the  thymus.  Three  month  old  adult  thymus  from  control  Ephrin-
B2
+/+;Wnt1-Cre;Rosa26
eYfp (left) and mutant Ephrin-B2
Lx/Lx;Wnt1-Cre;Rosa26
eYfp 
(right)  mice  were  fixed  with  4%  paraformaldehyde,  cut  into  100µm  sections, 
stained with antibodies recognising Tuj1 (neurons, red) and eYFP (green), and 
analysed by confocal microscopy. Top panels; three-dimensional reconstruction 
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Chapter Six: What is the mechanism of thymus migration into the 




In mice with ephrin-B2 specifically deleted on NCCs, the thymic 
rudiment  detaches  normally  from  the  pharynx,  but  there  is 
delayed  separation  of  the  combined  thymus  and  parathyroid 
domains. Moreover, the migratory behaviour of individual NCCs is 
abnormal in these mice. Thus, it is proposed that NC derived cells 
that surround and invade the thymic rudiment direct the migration 
of  the  thymus  by  a  process  of  collective  cell  migration.  This 
mechanism  requires  intrinsic  signals  from  the  NCCs,  combined 
with environmental signals from the surrounding tissues to move 
the organ from the cervical region into the thoracic cavity. Chapter Six 
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6.1 Experimental Rationale 
 
The mechanisms that control the various morphogenetic events during early 
thymus  organogenesis  are  still  largely  unknown,  although  some  genetic 
pathways have been identified that affect these processes. The Hoxa3 and 
Pax1/9  transcription  factors  are  required  for  proper  separation  of  the 
developing thymic and parathyroid primordia from the pharynx, and may also 
contribute to their separation from the pharynx or each other, although the 
cell-type-specificity  of  these  functions  is  poorly  understood  (5,  21,  22). 
Splotch embryos, which have a null allele of Pax3 and are largely deficient of 
NCCs, also exhibit pharyngeal pouch defects including an ectopic thymus 
(23, 24). This NCC deficiency resulted in delayed separation of the thymus 
and parathyroid from the pharynx, and the boundary between thymus and 
parathyroid-fated domains was abnormal. These results strongly implicated 
that NCC migration to the third pharyngeal pouch is required for patterning 
and  morphogenesis  of  the  thymus  and  parathyroids  (23).  Interestingly, 
embryos  which  have  deleted  the  TGF-β  type-1  receptor,  ALK5,  in  NC 
derived  cells  also  have  ectopically  located  thymi  as  a  result  of  delayed 
separation of the parathyroid and thymic rudiments without histological or 
other  differentiation  defects.  Moreover,  this  latter  defect  was  not  due  to 
impaired NC migration to the third pharyngeal pouch, but was thought to be 
due to increased apoptosis in post-migratory NCCs (25). 
 Chapter Six 
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In the previous chapter, it was shown that the thymus is also ectopic in mice 
deficient  in  ephrin-B2  on  NCCs.  This  could  be  due  to  defects  that  occur 
during initiation, patterning, separation or migration of the thymus. In order to 
determine how ephrin-B2 affects thymus development, it was necessary to 
examine  the  processes  of  separation  and  migration  in  mice  with  ectopic 
thymi. 
 
6.2 Experimental Strategy 
 
To investigate the mechanism by which the thymus, which originates at the 
pharyngeal pouches and migrates into the thoracic cavity, a similar strategy 
to  that  described  in  chapter  five  was  used.  Thus,  mice  with  LoxP  sites 
flanking exon 2 of the Efnb2 gene (202) were crossed with mice expressing 
Cre recombinase in NCCs under the control of Wnt1 (198) promoter and 
regulatory  elements.  Cre  activity  was  reported  via  activation  of  a  ‘silent’ 
enhanced  yellow  fluorescent  protein  (eYFP),  expressed  from  the  Rosa26 
locus (201). 
 
The ectopic location of the thymus could result from defective separation of 
the thymic rudiment from the pharynx and/or from the parathyroid. In order to 
determine whether separation from the pharynx and parathyroid occurs at 
the normal time in the mutant mice described here, H&E stained sections 
through the cervical and thoracic regions were examined from E12.5 and Chapter Six 
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E13.5  Wnt1-Cre;Rosa26
eYfp  and  Ephrin-B2
Lx/Lx;Wnt1-Cre;Rosa26
eYfp 
embryos.  Moreover,  it  was  also  possible  that  delayed  or  abnormal 
separation  might  result  from  defects  in  the  formation  of  the  boundary 
between thymus and parathyroid domains. In order to investigate whether 
there  is  mixing  of  thymus  and  parathyroid  fated  cells  in  the  mutant  mice 
described here, an in situ hybridisation analysis of genes associated with 
thymus (FoxN1) and parathyroid (GCM2) were carried out on E11.5 sections 
from mutant and wild type mice. 
 
In a second set of experiments, the movements of single cells, and whole 




eYfp  embryos  were  enzymatically 
digested  and  left  to  attach  onto  glass-bottom  culture  dishes.  Additionally, 
whole thymic rudiments were embedded in a collagen gel and cultured for 48 
hours. EphB4-Fc and ephrin-B2-Fc cross linked with goat anti-human IgG, 
and control Fc cross linked with IgG, were added to the culture medium in 
order  to  block  or  stimulate  signalling  artificially.  The  Fc  chimeric  proteins 
consist of the extracellular domain of either EphB4 or ephrin-B2, fused to the 
carboxy-terminal 6X histidine-tagged Fc region of human IgG. When added 
to the culture medium, EphB4-Fc binds to ephrin-B2 ligands expressed on 
the cell surface. Binding of EphB4-Fc to ephrin-B2 ligands on the cell surface 
blocks signalling downstream of the ephrin ligand (reverse signalling). When 
cross linked with IgG, ephrin-B2-Fc mimics a cell surface bound ligand and Chapter Six 
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is able to induce forward signalling through the receptor with which it binds. 





6.3.1  Deletion  of  ephrin-B2  does  not  disrupt  separation  of  the 
thymus/parathyroid rudiment from the third pharyngeal pouch. 
 
The ectopic thymus location in the mutant mice described here could be the 
result of a delay in the separation of the organ primordia from the pharynx, 
and  subsequent  inability  of  the  thymus  rudiment  to  reach  the  superior 
mediastinum before the thoracic cavity closes. Since Eph/ephrins have been 
shown  to  play  a  role  in  boundary  formation  and  maintenance  between 
discrete structures in other organs and tissues, it is possible that they could 
also  be  involved  in  this  process.  The  combined  thymus  and  parathyroid 
primordium,  which  starts  forming  at  E11  detaches  from  the  third  pouch 
endodermal epithelium by E12. In order to assess whether the defect seen in 
Ephrin-B2
Lx/Lx;Wnt1-Cre    mice  is  due  to  a  failure  in  forming  a  boundary 
between  the  combined  rudiment  and  the  pharyngeal  pouch  leading  to 




eYfp  embryos  were  sectioned  and 
stained with haematoxylin and eosin (Figure 6.1A & B). Analysis of serial Chapter Six 
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sections through the neck and thoracic cavity revealed that the combined 
rudiment does separate fully from the third pharyngeal pouch with normal 
timing (Figure 6.1A & B). These experiments were performed in collaboration 
with Julie Gordon, University of Georgia, USA. 
 
In  addition  to  separating  from  the  third  pharyngeal  pouch,  the  combined 
thymus  and  parathyroid  rudiments  also  divide  from  each  other  into  two 
separate structures; the thymus migrates into the thoracic cavity, whereas 
the parathyroid remains in the neck adjacent to the thyroid gland. In order to 
determine whether deletion of ephrin-B2 on NCCs disrupts the separation of 
the thymus and parathyroid rudiment from each other, serial sections of the 
cervical  and  thoracic  regions  were  examined.  H&E-stained  transverse 
sections  through  the  neck  and  thoracic  regions  of  E12.5-13.5  mutant 
embryos  showed  a  defect  in  separation  of  the  thymus  and  parathyroid 
domains from each other when compared to control embryos (Figure 6.2). 
This phenotype was due to a delay, rather than failure, since dissection of 
adult  mutant  mice  showed  that  the  thymus  and  parathyroid  eventually 
separate  from  each  other.  To  investigate  whether  this  delayed  organ 
separation  was  due  disruption  of  the  boundary  between  thymus  and 
parathyroid, in situ hybridisation for Foxn1 (thymus, Figure 6.3, right) and 
Gcm2 (parathyroid, Figure 6.3, left) was carried out on sagittal sections of 
E11.5 wild type Ephrin-B2
+/+ and mutant Ephrin-B2
Lx/Lx;Wnt1-Cre embryos. 
There  was  no  mixing  of  parathyroid  and  thymus  cells  in  the  absence  of Chapter Six 
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ephrin-B2 expression on NCCs (Figure 6.3, bottom) when compared to the 
wild  type  control  (Figure  6.3,  top).  These  experiments  were  performed  in 
collaboration with Julie Gordon, University of Georgia, USA. 
 
Together, these results indicate that deletion of ephrin-B2 from NC derived 
cells  does  not  affect  or  delay  the  separation  of  the  thymus/parathyroid 
combined rudiment from the third pharyngeal pouch, but it does affect the 
separation of the thymus and parathyroid rudiments from each other. 
 
6.3.2 Forward signalling through Eph receptors is required for normal 
thymus positioning 
 
In  addition  to  the  forward  signalling  through  Eph  receptors,  the  ephrin-B 
ligands  themselves  are  also  able  to  signal;  this  is  known  as  reverse 
signalling. Ablation of the receptor or ligand blocks both forward and reverse 
pathways.  However,  it  is  possible  to  block  either  the  forward  or  reverse 
pathway  without  additionally  blocking  the  reciprocal  pathway,  by  mutating 
protein sequences that code for one or more of the signalling domain of the 
receptor or ligand. For example, the intracellular domain of ephrin-B2 has 
five  conserved  tyrosine  residues  and  a  PDZ  domain  which  mediate  two 
reverse signalling pathways. Mice lacking the c-terminal PDZ interaction site 
(ephrin-B2
ΔV/ΔV) exhibit major defects in the lymphatic system and problems 
in  vascular  development  and  are  neonatal  lethal;  mice  lacking  the  five Chapter Six 
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conserved  tyrosine  residues  (ephrin-B2
5Y/5Y)  only  have  a  very  minor 
phenotype (203). The phenotypic differences between ephrin-B2
ΔV/ΔV, which 
blocks only the reverse signalling pathway, and ephrin-B2
-/-, which blocks 
both  pathways,  are  probably  a  result  of  the  different  pathways  that  are 
activated  downstream  of  the  receptor  and  ligand.  In  order  to  determine 
whether  forward  signalling  or  reverse  signalling  is  responsible  for  thymus 







the  thymus  was  normally  sited,  thus,  the  signalling  domains  disrupted  in 
these mutants appear to be not required for correct thymus migration (Figure 
6.4).  These  results  provide  some  but  by  no  means  definitive  proof  that 
reverse  signalling  may  not  be  involved  in  the  proper  positioning  of  the 
thymus and suggesting that forward signalling plays the dominant role in this 
process. 
 
6.3.3  Eph/ephrin  signalling  is  required  for  normal  migration  of  NC-
derived mesenchymal cells 
 
The  normal  separation  of  the  combined  rudiment  from  the  pharynx 
suggested that thymus migration itself may be delayed. To examine whether 
ephrin-B2 expression on NCCs is involved in their mobility, E13.5 mutant 
Ephrin-B2
Lx/Lx;Wnt1-Cre;Rosa26
eYfp  and  control  Ephrin-B2
+/+;Wnt1-
Cre;Rosa26
eYfp  embryonic  thymi  were  digested  with  collagenase  and  the Chapter Six 
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resulting  cell  suspension  was  incubated  in  glass-bottom  culture  dishes 
overnight. The next day eYFP
+ cell movements were imaged by time-lapse 
widefield microscopy over a period of 4 hours. Deletion of ephrin-B2 resulted 
in marked changes in the cells’ motile behaviour. Mutant cells appeared to 
form many unstable lamellipodial protrusions, were unable to retract these 
protrusions,  and  had  frequent  changes  in  overall  direction  of  movement 
(Figure 6.5B). Tracking these cells indicated a displacement of 6.4µm over 
four  hours  (Figure  6.5E)  and  a  low  meandering  index  (a  measure  of 
directionality where 1 = migration in one direction, and 0 = totally random 
movement)  of  0.19  (Figure  6.5F).  In  contrast,  control  cells  appeared 
polarised, migrated to a total displacement of 45.5µm over four hours and 
exhibited a meandering index of 0.67 (Figure 6.5A, E & F). 
 
It was possible to induce control cell behaviour similar to that seen in the 
mutants  using  an  EphB4  fusion  protein  that  blocks  signalling  from  this 
receptor. Under these conditions control cells became unable to polarise, 
acquired many unstable lamellipodial protrusions, exhibited a displacement 
of  5.89µm  over  four  hours  and  a  decreased  meandering  index  of  0.16 
(Figure 6.5C, E & F). In contrast, incubation of mutant cells with an ephrin-
B2 fusion protein cross linked with IgG, which binds and activates signalling 
by the EphB receptors, restored polarisation and directional migration. Thus 
the cells showed a 23.6µm displacement over four hours and an increased 
meandering index of 0.55 (Figure 6.5D, E & F). It is possible that this is the Chapter Six 
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result of a cell autonomous function, or could be due to either previous cell-
cell interactions or cross talk with other receptor signalling pathways in the 
same cell.  
 
6.3.4 Analysis of whole organ cultures indicate that the thymus may 
relocate into the thoracic cavity by collective cell migration 
 
The migration of individual NCCs may direct the relocation of the thymus into 
the  thoracic  by  a  process  of  collective  cell  migration.  This  mechanism 
requires  that  the  cells  within  the  organ  are  tightly  adhered  to  each  other 
whilst those at the leading edge migrate forward, dragging with it the rest of 
the  rudiment.  This  would  suggest  that  there  is  an  overall  polarity  of  the 
thymus, with NCCs at the front behaving differently to those at the back. In 
order to examine this possibility whole thymic rudiments from E13.5 mutant 
Ephrin-B2
Lx/Lx;Wnt1-Cre;Rosa26
eYfp  and  control  Ephrin-B2
+/+;Wnt1-
Cre;Rosa26
eYfp embryos were embedded into a collagen gel that mimics the 
three-dimensional structure of living tissues. Explants were cultured in the 
gels for 48 hours, after which they were fixed with paraformaldehyde and 
stained with an antibody detecting eYFP. 
 
NC  derived  cells  from  control  thymi  appear  to  migrate  away  from  the 
rudiment preferentially towards one axis (Figure 6.6, left). Moreover, a small 
fragment  of  thymic  tissue  appears  to  have  been  dragged  away  from  the Chapter Six 
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rudiment in the same direction as the migrating NCCs (Figure 6.6, top left, 
red arrow). Fragments of thymus tissue that appear to have broken off from 
the  main  thymic  rudiment  were  observed  in  five  out  of  eight  control 
rudiments examined. In contrast, fewer NCCs appear to migrate away from 
ectopic thymi and they exit equally at all axes of the rudiment (Figure 6.6, 
right). In addition, thymic tissue did not detach and move away from any of 
the three ectopic rudiments examined.  
 
Together these results indicate that the motility of NCCs is disrupted in the 
absence of ephrin-B2, and this may correlate with defective migration of the 
whole thymic rudiment. Whole organ cultures of wild type and ectopic thymi 
suggest that there may be an inherent polarity to the thymic rudiment, which 
is determined by the NCCs and that loss of ephrin-B2 prevents the NCCs 




6.4.1 Separation or Migration; which is defective in mice with ephrin-B2 
deficient NCCs? 
 
As discussed in chapter five, ectopia of the thymus can result from defects in 
a number of stages of thymus organogenesis, from initial patterning of the 
pharyngeal  pouch  to  migration  of  the  rudiment.  In  the  mutants  described Chapter Six 
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here, initiation of organ formation is apparently normal since functional thymi 
and parathyroid epithelium develop. Moreover, NCCs contributed normally to 
ectopic  thymic  in  mice  deficient  for  ephrin-B2  expression  on  NC  derived 
cells, thus, the defect in organ location may result from impaired separation 
from the pharynx and/or parathyroid, or migration into the thoracic cavity. 
 
In order for the thymus to migrate into the thoracic cavity it must be released 
from  the  pharynx.  A  number  of  mutants  have  been  described  that  have 
defects  in  separation  of  the  combined  rudiment  from  the  pharynx.  In 
contrast, the mutants described here do not exhibit a defect in separation 
from the pharynx, although they do remain attached to the parathyroid for a 
longer  time  than  in  control  embryos.  The  defect  in  thymus-parathyroid 
separation is a delay rather than complete block, since in the adult they are 
no longer joined but are discrete organs. However, the delay in separation 
may  hold  the  thymic  rudiment  in  the  cervical  region  long  enough  for  the 
thoracic cavity to close so that the thymus can no longer migrate caudally 
and ventrally. It is not clear why there is a difference in the mechanism of 
separation from the pharynx than from the parathyroid. One possibility may 
be that release from the pharynx is an active process controlled by the NCCs 
surrounding the capsule, but separation from the parathyroid is a passive 
process that requires the migration of the thymus away from the parathyroid 
domain. Support for this hypothesis was provided by the finding that motility 
of NC derived cells surrounding the rudiment was defective. Chapter Six 
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Mutants  with  ectopic  thymi  have  been  described  that  result  from  an 
abnormal  boundary  between  the  thymus-  and  parathyroid-domains  of  the 
common  primordium  (23).  The  authors  suggested  that  a  decrease  in  the 
number  of  NCCs  was  the  cause  of  the  irregular  boundary,  and  this 
prevented the separation of the two organs. Eph/ephrins expression often 
demarcates boundaries, such as in the hindbrain and on veins and arteries, 
suggestive of a mechanism of repulsion between Eph and ephrin-expressing 
cells. Thus, it is possible that repulsion of thymus- and parathyroid-specific 
cells that express different Eph or ephrin molecules drives them into distinct 
domains, creating a tight boundary between the two rudiments. However, in 
contrast  to  previously  published  reports  showing  mixing  between  the  two 
domains, the mutants described here do not exhibit intermingling of FoxN1-
and GCM2-expressing cells. These results would support the hypothesis that 
the  delay  in  division  of  the  rudiments  is  not  actually  a  separation  defect, 
instead, a lack of migration pulling the two organs apart.  
 
Since  the  parathyroid  and  thymus  rudiments  develop  together  from  a 
combined  rudiment,  the  parathyroid  might  also  exhibit  location  defects. 
Moreover, it has been suggested that the parathyroids are pulled with the 
thymus  as  it  migrates  caudally  and  ventrally,  but  they  detach  from  the 
thymus and are left in the cervical region near the thyroid. The function of the 
parathyroid does not appear to be affected by loss of ephrin-B2 on NCCs, Chapter Six 
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since  the  mice  do  not  exhibit  defects  relating  to  its  role  as  an  endocrine 
gland. Nevertheless, it would be interesting to determine the position, and 
the contribution of the NC, of the parathyroid in the mutant mice described 
here.  
 
6.4.2 Ectopic thymi are not equivalent to the cervical thymus 
 
The  existence  of  cervical  thymi  was  recently  reported  in  the  mouse.  The 
cervical  thymi  only  expand  after  birth,  but  are  known  to  support  T  cell 
development and can correct T cell deficiencies in athymic nude mice upon 
transplantation (258, 259). Since the ectopic thymi described here are found 
in a similar location as the cervical thymi reported in a few mouse strains, it 
is  tempting  to  dismiss  their  existence  as  merely  enlarged  cervical  thymi. 
However, there are a number of reasons why this is unlikely. The cervical 
thymus expands after birth, probably from fragments of thymic tissue that 
break  off  from  the  rudiment  as  it  descends  into  the  thoracic  cavity.  In 
contrast,  the  ectopic  thymi  are  present  in  the  cervical  region  from  mid-
gestation.  Moreover,  although  the  cervical  organ  has  a  typical  medulla-
cortex region, it consists of just one lobule and is much smaller than the 
thoracic and ectopic thymi. This is not the case in the thoracic and ectopic 
thymi, where both consist of many lobules that each harbour medullary and 
cortical regions, and both thoracic and ectopic thymi exhibited very similar 
cellularity. In addition, there were subtle structural changes in the cervical Chapter Six 
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thymus that are not apparent in the ectopic organs described here. Thus, the 
mesenchymal fibroblastic compartment was less integrated with the mTECs 
when compared to the thoracic thymus.  
 
It is possible that there are similar deficiencies in cell migration in mice with 
ectopic  thymi  and  those  with  cervical  thymi.  For  this  reason,  it  would  be 
interesting to investigate the cause of cervical thymi and why they only arise 
in certain genetic backgrounds. To do this, it may be useful to compare the 
expression  of  Eph/ephrin  molecules  on  NCCs  from  ectopic  and  cervical 
thymi.  In  addition,  the  mobility  of  NCCs  from  cervical  thymi  could  be 
assessed by a similar method to that described here.   
 
6.4.3  Forward  signalling  through  Eph  receptors  appears  to  direct 
thymus migration 
 
Signalling can occur downstream of both Eph receptors and ephrin ligands. 
Ablation  of  either  the  receptor  or  the  ligand  disrupts  both  forward  and 
reverse  pathways,  making  it  difficult  to  establish  whether  molecules 
downstream of the Eph receptor or ephrin ligands are responsible for the 
normal  positioning  of  the  thymus.  However,  ephrin-B  signalling  mutants, 
which  only  block  reverse  signalling  by  disrupting  the  PDZ  domain  or 
phosphotyrosine docking sites of ephrin-B2 showed no disruption in thymus Chapter Six 
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location,  indicating  that  forward  signalling  through  EphB  receptors  is 
probably responsible for the observed phenotype. 
 
Neither  of  the  ephrin-B2  signalling  mutants  reflected  a  complete  block  in 
reverse signalling through the ligand, since in one case the PDZ domain is 
disrupted leaving the phosphotyrosine docking sites intact and in the other 
the phosphotyrosine docking sites were mutated whilst the PDZ domain was 
still  functional.  Thus,  there  may  be  biological  activity  elsewhere  in  the 
transmembrane  ligand.  In  support  for  the  role  of  EphB  receptors  in  the 
mechanism of thymus migration were experiments using cross linked ephrin-
B2/Fc  chimeric  proteins  to  activate  forward  signalling  and  rescue  the 
migration defect of individual cells. However, there may be crosstalk with 
other signalling pathways that are blocked or activated using this technique. 
Thus,  it  will  be  necessary  to  examine  ephrin-B2  and  EphB4  signalling 
mutants  that  completely  block  either  the  reverse  or  forward  signalling 
pathways to define which pathway is responsible for thymus migration. 
 
Signalling molecules downstream of Eph receptors include small GTPases 
of the Rho and Ras families, focal adhesion kinase, the JAK/STAT and PI3K 
pathways  (261,  262).  Rho  family  molecules  such  as  Rac  mediate  actin 
dynamics,  which  controls  cell  shape  and  movement  by  promoting  the 
formation of lamellipodia, filopodia and stress fibres (143, 144, 263). In vitro 
experiments described here demonstrate that in the absence of ephrin-B2 Chapter Six 
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expression, polarisation and migration of NC derived cells is defective. This 
phenotype was rescued by exposure of the mutant cells to soluble ephrin-
B2/Fc cross-linked with IgG, thus providing a substitute ligand to activate the 
receptor.  Together,  these  results  strongly  suggest  that  signalling 
downstream  of  EphB  receptors  is  required  for  normal  mobility  of  thymic 
mesenchyme  and  for  correct  positioning  of  the  thymus.  To  test  this 
hypothesis,  embryos  with  NCCs  deficient  for  Rac1  were  examined. 
However, due to the role of Rac1 signalling elsewhere in development, the 
embryos died at E12 from severe cardiac defects and other malformations. 
Thus, it was not possible to examine the thymus of these mice. 
 
6.4.4 Migration of NCCs is impaired in the absence of ephrin-B2 
 
In  order  to  assess  a  potential  defect  in  the  migration  of  the  organ,  the 
mobility  of  NCCs  deficient  in  ephrin-B2  was  examined.  Similar  to 
experiments  that  showed  that  smooth  muscle  cells  were  defective  in 
spreading, focal-adhesion formation and polarised migration in the absence 
of ephrin-B2, it was found that the NCCs were likewise affected. Thus, they 
were unable to polarise and exhibited a greatly reduced displacement. Foo 
and colleagues suggested that impaired motility caused defective mural-cell 
coverage  of  the  vasculature  (179).  Likewise,  it  is  possible  that  impaired 
mobility  of  NC  derived  cells,  which  surround  the  capsule  of  the  thymic Chapter Six 
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rudiment,  causes  a  failure  in  the  migration  of  the  organ  into  the  thoracic 
cavity. 
 
It  is  unclear  as  to  why  NCCs  are  able  to  migrate  into  the  pharyngeal 
pouches, but once associated with the thymus they then exhibit impaired 
mobility.  It  is  possible  that  there  are  two  different  mechanisms,  and  thus 
different  molecules,  directing  migration  at  these  two  different  stages.  In 
which case, migration from the neural tube to the pharyngeal pouch involves 
the migration of single cells that is independent of ephrin-B2 expression. In 
contrast,  collective  migration  of  the  whole  organ,  which  requires  tightly 
adhered  NC  derived  cells  surrounding  the  rudiment  to  co-ordinate  the 
movement of the organ is dependent upon the expression of ephrin-B2. 
 
It is possible that the behaviour of NCCs is different in culture than in vivo, 
since two dimensional cultures may not provide an accurate representation 
of the environment of living tissues. To investigate this possibility, and to 
definitively  answer  the  question  as  to  whether  separation  or  migration  is 
impaired in the mutant mice described here, it might be possible to observe 
thymus development in vivo. Using multi-photon microscopy to image live 
embryos that have NCCs marked with eYFP, it may be possible to examine 
the processes of separation and migration of the thymic rudiment as they 
occur. Alternatively, dissection and culturing of the whole pharyngeal pouch, 
including the combined thymus- and parathyroid-rudiment at E11.5-E12, in a Chapter Six 
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collagen gel may provide similar answers. The three-dimensional structure of 
the  collagen  gel  would  provide  an  alternative,  more  physiological, 
environment  for  the  rudiment  to  migrate  through  (264).  If  a  delay  in  the 
separation of the rudiment from the parathyroid and subsequent closure of 
the  thoracic  cavity  does  prevent  thymus  migration,  the  thymic  rudiment 
would  continue  to  migrate  in  the  collagen  gel  in  response  to  a 
chemoattractant,  such  as  FGF  ligands.  However,  if  the  rudiments  do  not 
migrate in comparison to wild type thymi, this would indicate that migration 
rather than separation defects were the cause of ectopia.  
 
6.4.5 Collective cell migration of the thymic rudiment 
 
The  data  presented  here  raises  an  interesting  question;  How  does  the 
mobility  of  individual  cells  influence  the  migration  of  the  whole  thymus? 
There are precedents for the movement of cell groups, sheets, or strands 
consisting of multiple cells that are mobile yet simultaneously connected by 
cell-cell  junctions  elsewhere  in  embryogenesis  (265,  266).  During 
morphogenesis  a  number  of  developmental  steps  require  collective  cell 
migration;  cells  of  the  inner  blastocyst  (267);  epithelial  sprouts  (268); 
migration of drosophila border cells (269) and movement of epithelial cells at 
the rim of the otic and thyroid placodes (270). This process requires that the 
migrating mass comprising of cells that are tightly adhered to each other by 
cell-cell junctions is dragged forward by the cells at the leading edge, whilst Chapter Six 
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the relative position of the cells within the group is maintained (271). Thus, it 
is  possible  that  signalling  downstream  of  ephrin-B2-EphB  interactions 
contributes  to  the  formation  of  lamellipodia  by  NC  derived  cells,  which 
protrude into the surrounding extracellular matrix. Subsequent shortening of 
actin filaments then results in retraction of the trailing edge and movement of 
the cell body, which drags behind it the whole rudiment.  
 
In  support  of  this  hypothesis  are  experiments  in  which  whole  thymic 
rudiments were cultured in a three dimensional collagen gel. After 48 hours, 
NCCs leave the organ preferentially at one axis of the control rudiments, and 
in some cases it appears that a piece of thymus detaches and is dragged 
away.  In  ectopic  rudiments,  a  much  reduced  number  of  NCCs  appear  to 
leave the organ and they appear to exit at all axes. It is important to note that 
these  results  may  be  an  artefact  of  the  experimental  technique,  thus 
examining  development  of  the  thymus  in  situ  is  needed  to  reveal  the 
answers to these questions.  
 
A mechanism by which collective cell migration drives the relocation of the 
thymic rudiment would suggest that the organ has an inherent polarity. Thus, 
the NCCs at the leading edge may be somehow different to those at the 
back, perhaps in the expression of certain signalling molecules or receptors. 
In the migrating lateral line of zebrafish, Wnt, β-catenin and FGF signalling 
control primordium polarity by differential regulation of gene expression in Chapter Six 
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the leading versus trailing edge. Moreover, blocking FGF signalling with a 
biochemical inhibitor prior to organ migration leads to stalling. It was shown 
that Wnt and β-catenin signalling is activated only in leading cells, which 
leads to the production of an inhibitor that confines activation of this pathway 
to  the  leading  zone  (272).  A  similar  mechanism,  or  others,  may  exist  to 
establish and maintain polarity of the thymic rudiment. In order to determine 
the validity of this hypothesis, it will be necessary to examine the expression 
of genes, including FGFs, Wnt and β-catenin in the NCCs of E12.5-E13.5 




The ectopic thymi from mice with ephrin-B2 deficient NCCs was examined, 
and shows that, unlike other mutants with ectopia described previously, this 
does  not  result  from  impaired  separation  from  the  pharynx.  However, 
separation of the thymus from the parathyroid is delayed, thus there are two 
possibilities  for  the  ectopic  location  of  the  thymus;  either  the  delay  in 
separation from the parathyroid that holds the thymus in the cervical region, 
or,  a  there  is  a  defect  in  organ  migration.  The  latter  mechanism  is  more 
likely,  since  the  migration  of  individual  NCCs  is  blocked  in  the  ectopic 
thymus. Thus, a mechanism of collective cell migration is proposed, directed 
by molecules downstream of the Eph receptor on NCCs, for the relocation of 
the thymus into the thoracic cavity.  Chapter Six 
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Figure  6.1:  The  combined  thymus  and  parathyroid  rudiment  detaches 
normally  from  the  pharynx.  A&B  Histological  analyses  of  cervical  region  in 
E12.5 and E13.5 wild type (Ephrin-B2
+/+, top) and mutant (Ephrin-B2
Lx/Lx;Wnt1-
Cre;Rosa26
eYfp,  bottom)  embryos.  A  Transverse  sections  through  E12.5  wild 
type (top left; upper cervical region, top right; lower cervical region), and mutant 
embryos (bottom left; upper cervical region, bottom right; lower cervical region). 
Top and bottom panels are at equivalent positions along the anterior-posterior 
axis, thus left panels are higher in the cervical region than right panels, indicating 
the slightly more anterior location of the mutant thymus lobes. * in top left panel 
indicates  the  area  corresponding  the  location  of  the  mutant  thymus  lobe  in 
bottom  left  panel.  B  Transverse  sections  through  E13.5  wild  type  (top  left; 
cervical  region,  top  right;  thoracic  region),  and  mutant  embryos  (bottom  left; 
cervical  region,  bottom  right;  thoracic  region).  Top  and  bottom  panels  are  at 
equivalent  positions  along  the  anterior-posterior  axis,  again  indicating  the 
significantly more anterior location of the mutant thymus lobes. * in top left panel 
indicates the equivalent positions of the mutant thymus lobes in bottom left panel. 
* in bottom right panel indicates the equivalent position of the normal thymus in 
top right panel. th, thymus. Scale bar = 100µm. This experiment was performed 
in collaboration with Julie Gordon, University of Georgia. Chapter Six 
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Figure 6.2: Separation of the thymus and parathyroid is delayed in ectopic 
thymi. Histological analyses of cervical region in E12.5 (left) and E13.5 (right) 
wild  type  (Ephrin-B2
+/+,  top)  and  mutant  (Ephrin-B2
Lx/Lx;Wnt1-Cre;Rosa26
eYfp, 
bottom) embryos, indicating parathyroid position. Top panels indicate the normal 
location of the parathyroids, attached to the thymus at E12.5 (left) and detached 
from the thymus and adjacent to the thyroid gland at E13.5 (right). In mutant 
embryos (bottom), the parathyroids remain attached to the thymus lobes at both 
E12.5 (left) and E13.5 (right). th, thymus. pt, parathyroid. ty, thyroid. Scale bar = 
100µm.  This  experiment  was  performed  in  collaboration  with  Julie  Gordon, 
University of Georgia. Chapter Six 
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Figure  6.3:  Patterning  of  thymus  and  parathyroid  domains  is  normal  in 
mice  with  ectopic  thymi.  Sagittal  sections  through  the  common  thymus-
parathyroid primordium at E11.5 showing prospective organ domains, marked by 
Foxn1 (thymus, left) and Gcm2 (parathyroid, right). Top panels; adjacent sections 
through wild type primordium, Bottom panels; adjacent sections through mutant 
primordium.  Dotted  line  in  left  panels  indicate  thymic  rudiment,  and  in  right 
panels,  parathyroid  rudiment.  Scale  bars  =  100µm.  This  experiment  was 
performed in collaboration with Julie Gordon, University of Georgia. Chapter Six 
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Figure  6.4.  Reverse  signalling  through  ephrin-B2  and  the  anatomical 
location  of  the  thymus.  E18.5  mutant  ephrin-B2
ΔV/ΔV  (left),  mutant  ephrin-
B2
5Y/5Y (middle) and control ephrin-B2
+/+ (right) embryos were dissected to reveal 
the thymus in the thoracic cavity. Black arrows; thymus. Chapter Six 
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Figure  6.5.  NC  derived  cells  deficient  in  ephrin-B2  exhibit  abnormal 
polarisation  and  migration.  (A-D)  Cells  from  E13.5  control  Wnt1-
Cre;Rosa26
eYfp  or  mutant  Ephrin-B2
Lx/Lx;Wnt1-Cre;Rosa26
eYfp    thymi  were 
incubated with or without ephrin-B2/Fc cross-linked with IgG or EphB4/Fc for 2 
hours  in  serum-free  IMDM,  as  indicated  on  the  figure,  and  imaged  by 
fluorescence microscopy. Images of cells are shown at 0, 2 and 4 hour time 
points.  All  images  are  60x  magnification.  (E)  Total  displacement  of  the  cells 
shown in figures A-D. T-test; A-B p=0.000315, A-C p=0.000374, B-D p=0.0228. 
(F)  Meandering  index  was  calculated  for  each  cell  shown  in  A-D.  1  indicates 
directional movement, 0 indicates random movement. T-test; A-B p=0.00101, A-
C  p=0.00134,  B-D  p=0.0769.  Similar  results  were  obtained  from  at  least  3 
experiments for each condition. Chapter Six 
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Figure 6.6. Whole organ culture of wildtype and ectopic thymic rudiments. 
Whole  thymic  rudiments  from  E13.5  control  Wnt1-Cre;Rosa26
eYfp  (left)  and 
mutant Ephrin-B2
Lx/Lx;Wnt1-Cre;Rosa26
eYfp (right) embryos were dissected and 
embedded in a collagen gel. The gels were incubated for 48 hours, fixed with 
paraformaldehyde and stained with an antibody detecting eYFP. The thymi were 
imaged by confocal microscopy and are presented as single confocal sections 
(top)  or  a  three  dimensional  rendering  (bottom).  Red  arrow  indicates  a  small 

























































































































































































































































Chapter Seven: General Discussion 
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How  does  NC  derived  mesenchyme  influence  the  migration  of  the 
thymus into the thoracic cavity? 
 
The data presented in this thesis implicate Eph/ephrin expression by NCCs 
in the positioning of the thymic rudiment. However the mechanism by which 
this occurs is unclear. It is possible that NCCs surrounding and within the 
organ have an intrinsic ability to direct the migration of the organ. Equally, 
molecules expressed by cells surrounding the thymus could be involved in 
attracting  or  repelling  the  rudiment,  or,  a  combination  of  intrinsic  and 
extrinsic signals could be responsible for organ migration. 
 
NC  derived  cells  exit  the  dorsal  neural  tube  and  migrate  extensively, 
colonising almost all tissues of the embryo. Individual NCCs migrate with 
high persistence towards their targets (188), but the mechanism that controls 
directionality are unknown. A number of molecules are known to have a role 
in NC migration, including ephrins, semaphorins, Roundabout (Robo) and its 
ligand Slit, and Glial cell-line Derived Neurotrophic Factor (GDNF), but the 
majority appear to act by repulsing the NCCs into specific domains. So far, 
no  chemoattractant  molecules  have  been  described  for  the  NC.  Instead, 
regulation of the cell’s cytoskeleton through GTPases and, thus, its polarity 
are  proposed  to  regulate,  at  least  partly,  directional  NC  migration.  It  was 
recently  shown  that  Syndecan  4  inhibition  of  Rac  activity  and  planar  cell 
polarity (PCP) signalling promotes RhoA activity. These molecules regulate Chapter Seven 
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cell polarity and the cytoskeletal machinery that controls the formation of cell 
protrusions (273).  
 
Since  Eph/ephrins  regulate  members  of  the  Rho  and  Ras  families  of 
GTPases, including Rac, it is possible that deficiencies in Eph signalling in 
the  mutants  described  here  causes  a  loss  in  cell  polarity  and  inhibits 
changes in cytoskeletal structure, which renders the cell unable to migrate. 
In  order  to  investigate  this  possibility  it  will  be  necessary  to  determine 
whether polarity or the cytoskeleton is disrupted in the ephrin-B2 deficient 
NCCs. There are a number of ways to do this including imaging molecules 
involved  in  polarity,  such  as  Cdc42,  Par3,  Par6  and  aPKC  in  the  mutant 
cells.  Additionally,  it  will  be  necessary  to  establish  whether  molecules 
downstream  of  the  Eph  receptor  are  downregulated  in  the  ephrin-B2 
deficient NCCs. To do this, it may be possible to compare the expression of 
genes  involved  in  cell  polarity  and  regulation  of  the  cytoskeleton  from 
microarray data obtained from wild type NCCs and those deficient for ephrin-
B2. Moreover, interfering with the putative signalling pathways downstream 
of Eph receptors, by blocking Rac, Cdc42 or the polarity proteins of cells in 
vitro may indicate how Eph/ephrin signalling controls migration. This could 
be  done  using  a  similar  method  to  that  used  here,  where  individual  NC 
derived cells from control or mutant embryos are cultured in the presence of 
molecules that inhibit Rac, Cdc42 or polarity proteins. If interfering with these 
proteins in wild type NCCs produces a similar phenotype to the mutant cells, Chapter Seven 
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this  would  indicate  that  they  could  be  members  of  the  same  signalling 
pathway  as  Eph  receptors.  Likewise,  it  may  be  possible  to  change  the 
phenotype of the mutant NCCs back to polarised and migratory wild type 
NCCs by stimulating molecules that are thought to be downstream of EphB 
receptors.  
 
In addition to intrinsic signals from NCCs, the environment that surrounds 
the thymic rudiment may also play an important role in thymus migration. 
There  are  many  possible  candidates  for  this  function,  including  the  FGF 
family of proteins. FGFs play a crucial role in embryogenesis, including the 
collective  cell  migration  of  the  lateral  line  in  zebrafish  (272),  and  NCC 
migration  (274).  Interestingly,  FRS2a  mutant  mice  that  have  a  targeted 
disruption in their binding site also exhibit ectopic thymi (26). It is tempting to 
suggest that the ectopic location of thymi in these mice is due to a defect in 
migration, but it was demonstrated that incomplete separation was actually 
the  cause  of  the  thymus  location  defect.  Overexpression  of  FGFs  also 
results in ectopic organs. Sprouty mutants, which are deficient in inhibiting 
FGF signalling, also have ectopic thymi and general separation defects from 
the pharynx (250). Thus, a tight balance of FGF signalling is important for 
thymus development, however, it is not clear how these signals function and 
whether they are involved in the ectopic thymus in the mutants described 
here. 
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Semaphorins (Sema) are secreted or membrane-bound proteins and may be 
attractive  candidates  in  determining  the  migratory  path  of  the  thymus. 
Members of the semaphorin family were originally characterised as repulsive 
guidance cues for neuronal precursors in the nervous system. Semaphorins 
are also implicated in the segregation of NCCs into migration streams in the 
hindbrain  of  in  the  chick  and  zebrafish  (275,  276).  Recently,  it  was 
demonstrated  that  they  also  may  have  a  role  in  organogenesis  in  other 
tissues,  for  instance,  the  heart.  Mice  deficient  for  Sema  3A  have  heart 
defects resulting from abnormalities during morphogenesis (277, 278).  
 
Sema  3D  and  Sema  3F  are  expressed  specifically  in  the  developing 
parathyroid  and  thymus.  Receptors  for  Class  3  Semaphorins,  including 
Neuropilin-1 and Neuropilin-2, are detected on the arterial vessel walls and 
peripheral nerves adjacent to the third pharyngeal pouch (279). Moreover, 
expression of Neuropilin-1 and -2 were detected at E12.5, just before the 
thymus  and  parathyroid  glands  migrate,  on  the  cells  that  surround  both 
organs.  These  data  suggest  that  interactions  between  Semaphorins 
expressed on cells associated with the thymus and parathyroid, and their 
receptors  including  Neuropillins  on  the  mesenchyme,  vessels  and  nerves 
around  the  third  pouch,  could  have  a  role  in  organ  migration.  Signalling 
downstream of semaphorins is unclear, but may regulate the cytoskeleton 
and the organisation of actin filaments and the microtubule network. 
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It is possible that the thymic rudiment follows arteries, which arise in the 
pharyngeal arches, down into the thoracic cavity where they form the major 
vessels  of  the  heart,  similar  to  the  proposed  mechanism  of  thyroid 
development.  Like  the  thymus,  the  thyroid  derives  from  the  pharyngeal 
pouch endoderm and separates by E11.5. By E13.5, it has relocated to its 
final  resting  position  in  the  midline  at  the  ventral  side  of  the  trachea.  It 
subsequently bifurcates to form two lobes that develop in close contact with 
the  carotid  arteries,  which  appear  to  determine  its  location.  Alt  and 
colleagues  (280)  recently  demonstrated  that  ectopic  vascular  cells  are 
sufficient to mislocate thyroid tissue in a non-cell autonomous manner. Since 
the thyroid is formed in close proximity to the carotid arteries, these authors 
concluded  that  vessels  may  determine  the  position  of  the  thyroid.  It  is 
possible  that  vessels  also  direct  the  relocation  of  the  thymus  from  the 
pharyngeal pouches to the thoracic cavity in a similar mechanism. In support 
of  this  hypothesis  are  the  data  presented  here  indicating  that  Eph  and 
ephrins are expressed on the NC derived mesenchymal cells present around 
and within the rudiment, and that in the absence of ephrin-B2 the location of 
the  organ  is  ectopic.  Thus,  interactions  with  reciprocal  Eph  receptors  for 
ephrin-B2  expressed  on  the  vessels  that  form  nearby  in  the  pharyngeal 
arches could direct the migration of the rudiment towards the heart.  
 
Although  both  thymus  and  thyroid  partly  derive  from  the  NC,  there  are 
differences  between  the  development  and  function  of  the  two  organs.  In Chapter Seven 
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contrast  to  the  thymus,  the  function  of  the  thyroid  is  compromised  in  an 
ectopic  location,  resulting  in  congenital  hypothyroidism  (281).  However, 
since  the  NC  contributes  mesenchyme  to  both  organs  and  they  undergo 
similar  relocalisation,  it  will  be  important  to  determine  whether  the  blood 
vasculature  plays  a  role  in  thymus  positioning.  This  could  be  done  in  a 
similar way to experiments that showed that thyroid tissue was attracted by 
ectopic vascular cells. In these experiments, cells which have been forced to 
adopt an endothelial fate by injection of Scl and Lmo2, transcription factors 
specifically  required  for  haematopoiesis  and  angiogenesis  (282),  were 
injected into wild-type hosts. This created a mosaic of wild-type and ectopic 
endothelial  cells.  In  these  experiments,  tissue  from  the  thyroid  projected 
towards the grafted cells. It may be possible to use the same technique to 
determine  whether  cells  from  the  thymus  are  attracted  to  blood  vessels. 
Alternatively,  culturing  endothelial  cells  and  thymic  rudiments  in  a  three 
dimensional collagen gel may produce similar results. 
 
Interestingly, PDGFRα was also recently implicated in NCC migration. In the 
absence or knock-down of PDGFRα using a hypomorphic allele or antisense 
morpholinos, NCCs failed to migrate rostrally and ventrally around the eye 
when compared to wild type control embryos. When the ligand, PDGF-AA, 
was  overexpressed  by  injecting  a  pdgfaa  morpholino  in  zebrafish,  NCCs 
bunched at the optic stalk and failed to continue their migration to the palatal 
precursor (283). These authors suggest that this is the cause of the facial Chapter Seven 
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and  palatal  cleft  defects  in  the  PDGFRα  mutant  mice.  It  was  further 
suggested  that  a  micro  RNA,  Mirn140,  binds  to  the  3’  end  UTR  of  the 
PDGFRα mRNA and interferes with its translation (283). Thus, PDGFRα first 
attracts NCCs then its expression is reduced allowing the NCCs to continue 
along their normal pathway of migration. In chapter four it was shown that 
PDGFRα is downregulated after E15.5 in the NCCs that contribute to the 
thymic rudiment, and this coincides with the thymus reaching its destination. 
It is possible that interactions between PDGFRα expressed by the NCCs and 
PDGF-AA ligand, expressed by surrounding tissues may be the attractant for 
thymus migration. In order to examine this possibility, expression levels of 
PDGFRα should be determined in wild type NCCs and in those deficient in 
ephrin-B2. In addition, ephrin-B2 expression on NCCs should be measured 
in mice lacking the PDGFRα receptor. 
 
The signalling molecules and transcription factors mentioned here are by no 
means an exhaustive review of all the molecules potentially involved in NCC, 
or thymus, migration. Clearly the mechanism of NCC migration is complex 
and  may  be  regulated  through  a  delicate  equilibrium  of  attractant  and 
repellent signals, and intrinsic and environmental signals. Eph/ephrin signals 
may be chemokinetic, thus, they stimulate the migration of NCCs but with no 
directionality. Subsequently, directionality is determined by signals extrinsic 
to the NCC, which remain to be defined. Investigations into these signals 
should include members of the Hox, Pax, BMP, SHH and FGF families of Chapter Seven 
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genes,  since  mice  with  mutations  in  these  genes  also  have  thymus 
abnormalities including ectopia. To do this, expression of ephrin-B2 or its 
preferred receptor, EphB4, should be examined in other mutants with ectopic 
thymi. Likewise, genes including the Hox, Pax, BMP, SHH and FGF families 
should be examined during thymus development in the mutants with ephrin-




The aim of this thesis was to analyse the role of NC derived cells in thymus 
organogenesis. Previously published reports indicated that NC derived cells 
are  crucial  in  the  development  of  the  thymic  rudiment  through  their 
interactions with endoderm derived TECs. However, once vascularisation of 
the rudiment occurs, and TECs are competent in their ability to support T cell 
development, NCCs were thought to be lost or replaced by cells of other 
mesenchymal  origin.  Using  the  NC  specific  Wnt1-Cre  and  Sox10-Cre 
transgenes  to  drive  expression  of  eYFP  from  the  ubiquitously  expressed 
Rosa26 locus, NC derived cells were observed in the newborn and adult 
thymus. Similar to an earlier report in 1975, which showed that NC derived 
cells  formed  the  connective  tissues  surrounding  the  blood  vessel  in  the 
thymus  of  chick-quail  chimeras  (13),  it  was  demonstrated  here  that  NC 
derived cells differentiate into perivascular mesenchyme.  
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The processes of patterning of the third pharyngeal pouch into thymus and 
parathyroid fated domains, and their subsequent separation from each other 
and the pharynx, have been described elsewhere. However, mechanisms of 
thymus relocation into the thoracic cavity are unknown. In order to dissect 
the roles of NCCs and TECs in these processes ephrin-B2, a member of a 
family  of  tyrosine  kinase  receptors  and  their  ligands  that  are  required  for 
processes including cell sorting, boundary formation, adhesion and migration 
elsewhere in the developing embryo, was ablated. ephrin-B2 ablation from 
TECs and NCCs does not appear to result in an overt immune phenotype. In 
contrast,  ephrin-B2  expression  on  NCCs  was  required  for  the  normal 
relocation of the thymic rudiment into the thoracic cavity. Other mutant mice 
have been described with ectopically located thymus organs in the cervical 
region, however, all exhibited defects in initial patterning or separation of the 
rudiment from the pharynx and/or parathyroid gland. Evidence is presented 
that indicates initial patterning of the thymus/parathyroid combined rudiment 
is normal in the mutant mice described here, and that separation from the 
pharyngeal  pouch  is  likewise  not  affected.  In  contrast,  separation  of  the 
combined thymus/parathyroid domains is delayed in the ephrin-B2 deficient 
NCC mice. Thus, there are two possible explanations for the ectopic location 
of the thymic rudiment in the mutant mice described in this report. Delayed 
separation  of  the  thymus  and  parathyroid  primordia  may  hold  the  thymic 
rudiment in the cervical region whilst the physical pathway of migration into 
the  thoracic  cavity  no  longer  permits  relocation  of  the  rudiment.  Equally Chapter Seven 
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possible,  the  process  of  migration  of  the  thymus  may  be  impaired  in  the 
absence of ephrin-B2 expression on NCCs. In order to distinguish between 
these  two  possibilities,  the  migration  of  individual  NC  derived  cells  was 
examined.  NC  derived  cells  deficient  in  ephrin-B2  exhibited  defects  in 
polarisation and, thus, were unable to migrate. Thus, it is proposed that the 
migration of individual NC derived cells directs the relocation of the thymic 
rudiment by a process of collective cell migration. To our knowledge, this is 
the first report that implicates Eph/ephrin signalling on NC derived cells in 
the  relocation  of  the  thymus,  which  appears  to  occur  by  a  process  of 
collective  cell  migration.  Collective  cell  migration  occurs  in  a  number  of 
processes such as morphogenesis, tissue repair and cancer invasion and 
metastasis.  Thus,  understanding  the  molecular  mechanisms  which  bring 
about the collective migration of the thymic rudiment are of interest to a wide 
range of biologists. Chapter Eight 
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